201
|
Fu CY, Zheng Y, Hu YB, Xu W, Liu J, Zhang FJ. [Anterior segment OCT-assisted PTK combined with PRK in the treatment of myopia associated with cornea macula: a case report]. [ZHONGHUA YAN KE ZA ZHI] CHINESE JOURNAL OF OPHTHALMOLOGY 2021; 57:614-617. [PMID: 34344123 DOI: 10.3760/cma.j.cn112142-20210227-00097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Nowadays, myopia morbidity keeps increasing in China. As the improvements of technique and safety in corneal refractive surgeries, an increasing number of patients with refractive error tend to choose these treatments. The 26-year-old woman with myopia in this case, whose UCVA was 0.1 in OD and 0.2 in OS, had corneal macula in the nasal side of the left eye owing to a corneal trauma occurred more than 10 years ago. After sufficient preoperative examinations, FS-LASIK was performed on the right eye and PTK combined with PRK was performed on the left eye. The UCVA was 1.2 in both eyes 3 months postoperatively, and the corneal macula was mostly cleared in the left eye. It is demonstrated that PTK combined with PRK is an effective and safe way to correct the diopter as well as remove the lesions for the lowly or moderately myopic patients accompanied with superficial corneal opacity. (Chin J Ophthalmol, 2021, 57: 614-617).
Collapse
|
202
|
Xu CF, Xu W. [Drug resistance of Acinetobacter baumannii in pediatric intensive care unit]. ZHONGHUA ER KE ZA ZHI = CHINESE JOURNAL OF PEDIATRICS 2021; 59:651-657. [PMID: 34333917 DOI: 10.3760/cma.j.cn112140-20210117-00053] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the drug resistance and related gene expression of Acinetobacter baumannii (AB) among the patients in pediatric intensive care unit (PICU). Methods: Drug resistance of 311 clinical cultured AB strains in PICU of Shengjing Hospital of China Medical University between January 2014 to December 2018 were analyzed retrospectively. According to the results of drug resistance test, all strains were divided into carbapenem-resistant Acinetobacter baumannii (CRAB) and non-carbapenem-resistant Acinetobacter baumannii (non-CRAB). The CRAB closely related genes were tested by real time quantitative polymerase chain reaction (RT-PCR). Comparison between the groups was analyzed by t test, Mann-Whitney U test, Chi-square test or Fisher exact test. Multivariate logistic regression was used for multivariate statistics. Results: A total of 166 patients with 311 AB strains were enrolled in this research, including 101 males and 65 females. The children's age ranged from 1 month to 14 years. The main primary diseases of 166 children were severe pneumonia (66/166, 39.8%), central nervous system infection (28/166, 16.9%), and trauma (17/166, 10.2%). Drug sensitivity tests showed that AB was sensitive to tigecycline (280/311, 90.0%), amikacin (250/311, 80.4%), and cefoperazone-sulbactam (193/311, 62.1%). However, most of AB strains were resistant to ciprofloxacin (247/311, 79.4%), ampicillin (244/311, 78.5%), and ceftazidime (245/311, 78.8%). In 311 isolated strains, 82.6% (257/311) strains were CRAB, and 65.9% (205/311) strains were multidrug-resistant Acinetobacter baumannii (MDRAB). Carbapenems were used more often in CRAB group than non-CRAB group before Acinetobacter baumannii cultured (26.2% (34/130) vs. 8.3% (3/36), χ²=5.169, P=0.023), and more patients in CRAB group used the third-generation cephalosporins for more than 7 days (43.8% (57/130) vs. 22.2% (8/36), χ²=5.533, P=0.019). Other broad-spectrum antibiotics or combined antibiotics in CRAB group were also more frequently used than in non-CRAB group (47.7% (62/130) vs. 13.9% (5/36), 46.9%(61/130) vs. 22.2%(8/36); χ²=13.383, 7.082; P<0.01, P=0.008). More patients in CRAB group received interventional procedures than those in non-CRAB group (75.4% (98/130) vs. 50.0% (18/36), χ²=8.631, P=0.003). Multivariate logistic regression showed that using carbapenem antibiotics (OR=3.179, 95%CI 1.247-8.107, P=0.015) and interventional procedures (OR=5.107, 95%CI 1.446-18.042, P=0.011) were independent risk factors for causing CRAB. Both IPM and OXA-24 genes had high expressions in CRAB and non-CRAB groups (89.2% (116/130) vs. 86.1% (31/36), P=0.565; 77.7% (101/130) vs. 72.2% (26/36), P=0.49). VIM and OXA-58 genes were not detected in any group. The expression rates of OXA-23, OXA-51, and efflux pump-related genes AdeABC and AdeFGH in CRAB group were significantly higher than in non-CRAB group (all P<0.01). Conclusions: In PICU, the proportions of CRAB and MDRAB were high and most of AB strains are only sensitive to tigecycline, amikacin, cefoperazone or sulbactam. Using carbapenems and interventional operation are independent risk factors for causing CRAB. Compared with non-CRAB, CRAB had higher expression of β-lactamase-related genes OXA-23 and OXA-51, and efflux pump-related genes AdeABC and AdeFGH.
Collapse
|
203
|
Yang J, Wang H, Zhang J, Xu W, Weng W, Lv S, Dong M. Sestamibi Single-Positron Emission Computed Tomography/Diagnostic-quality Computed Tomography for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism: What clinicopathologic factors affect its accuracy? J Endocrinol Invest 2021; 44:1649-1658. [PMID: 33393058 DOI: 10.1007/s40618-020-01471-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2020] [Accepted: 11/18/2020] [Indexed: 02/07/2023]
Abstract
PURPOSE Sestamibi Single-Positron Emission Computed Tomography/Diagnostic-quality Computed Tomography (MIBI-SPECT/CT) is a common technology used for primary hyperparathyroidism (PHPT) localization in clinical practice. However, the clinicopathologic factors affecting the accuracy of MIBI-SPECT/CT and the potential limitations remain unclear. METHODS Retrospectively enrolled PHPT patients (n = 280) were analyzed from August 2017 to December 2019. RESULTS Of 96 patients with PHPT (mean age, 54 years; 63 females), 17 had discordance between MIBI-SPECT/CT and intraoperative findings. Among the 17 patients with discordance, 58.8% had major discordance, which occurred in most patients with multigland disease (MGD). Compared with concordant patients, discordant patients exhibited increased frequencies of autoimmune thyroid disease (29.4% vs 10.1%, p = 0.035), MDG (41.2% vs 3.8%, p = 0.035), higher PTH (296 pg/mL vs 146 pg/mL; p = 0.012),and lower phosphorus levels (0.77 mmol/L vs 0.90 mmol/L; p = 0.024). MDG (odds ratio [OR], 16.95; 95% CI 2.10-142.86), parathyroid lesion size of 12 mm or less (OR, 6.93; 95% CI 1.41-34.10), and a PTH level higher than 192.5 pg/mL (OR, 12.66; 95% CI 2.17-71.43) were independently associated with discordant MIBI-SPECT/CT results. CONCLUSION MGD was most strongly associated with discordance between MIBI-SPECT/CT and intraoperative findings followed by a PTH level higher than 192.5 pg/mL and parathyroid lesion size of 12 mm or less. Surgeons should recognize these potential limitations, which may improve the preoperative procedure by encouraging further localization imaging and promptly facilitate intraoperative troubleshooting.
Collapse
|
204
|
Lassen P, Huang S, Su J, O’Sullivan B, Waldron J, Andersen M, Primdahl H, Johansen J, Andrup Kristensen C, Andersen E, Eriksen J, Rønn Hansen C, Alsner J, Lilja-Fisher J, Bratman S, Ringash J, Kim J, Hope A, Spreafico A, de Almeida J, Xu W, Overgaard J. PH-0051 Outcomes after definitive (C)RT in HPV+ OPC: Largescale comparison of two population-based cohorts. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07233-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
205
|
Aad G, Abbott B, Abbott DC, Abed Abud A, Abeling K, Abhayasinghe DK, Abidi SH, AbouZeid OS, Abraham NL, Abramowicz H, Abreu H, Abulaiti Y, Acharya BS, Achkar B, Adam L, Adam Bourdarios C, Adamczyk L, Adamek L, Adelman J, Adiguzel A, Adorni S, Adye T, Affolder AA, Afik Y, Agapopoulou C, Agaras MN, Aggarwal A, Agheorghiesei C, Aguilar-Saavedra JA, Ahmad A, Ahmadov F, Ahmed WS, Ai X, Aielli G, Akatsuka S, Akbiyik M, Åkesson TPA, Akilli E, Akimov AV, Al Khoury K, Alberghi GL, Albert J, Alconada Verzini MJ, Alderweireldt S, Aleksa M, Aleksandrov IN, Alexa C, Alexopoulos T, Alfonsi A, Alfonsi F, Alhroob M, Ali B, Ali S, Aliev M, Alimonti G, Allaire C, Allbrooke BMM, Allport PP, Aloisio A, Alonso F, Alpigiani C, Alunno Camelia E, Alvarez Estevez M, Alviggi MG, Amaral Coutinho Y, Ambler A, Ambroz L, Amelung C, Amidei D, Amor Dos Santos SP, Amoroso S, Amrouche CS, Anastopoulos C, Andari N, Andeen T, Anders JK, Andrean SY, Andreazza A, Andrei V, Anelli CR, Angelidakis S, Angerami A, Anisenkov AV, Annovi A, Antel C, Anthony MT, Antipov E, Antonelli M, Antrim DJA, Anulli F, Aoki M, Aparisi Pozo JA, Aparo MA, Aperio Bella L, Aranzabal N, Araujo Ferraz V, Araujo Pereira R, Arcangeletti C, Arce ATH, Arguin JF, Argyropoulos S, Arling JH, Armbruster AJ, Armstrong A, Arnaez O, Arnold H, Arrubarrena Tame ZP, Artoni G, Asada H, Asai K, Asai S, Asawatavonvanich T, Asbah N, Asimakopoulou EM, Asquith L, Assahsah J, Assamagan K, Astalos R, Atkin RJ, Atkinson M, Atlay NB, Atmani H, Atmasiddha PA, Augsten K, Austrup VA, Avolio G, Ayoub MK, Azuelos G, Babal D, Bachacou H, Bachas K, Backman F, Bagnaia P, Bahmani M, Bahrasemani H, Bailey AJ, Bailey VR, Baines JT, Bakalis C, Baker OK, Bakker PJ, Bakos E, Bakshi Gupta D, Balaji S, Balasubramanian R, Baldin EM, Balek P, Balli F, Balunas WK, Balz J, Banas E, Bandieramonte M, Bandyopadhyay A, Barak L, Barbe WM, Barberio EL, Barberis D, Barbero M, Barbour G, Barillari T, Barisits MS, Barkeloo J, Barklow T, Barnett BM, Barnett RM, Barnovska-Blenessy Z, Baroncelli A, Barone G, Barr AJ, Barranco Navarro L, Barreiro F, Barreiro Guimarães da Costa J, Barron U, Barsov S, Bartels F, Bartoldus R, Bartolini G, Barton AE, Bartos P, Basalaev A, Basan A, Bassalat A, Basso MJ, Basson CR, Bates RL, Batlamous S, Batley JR, Batool B, Battaglia M, Bauce M, Bauer F, Bauer P, Bawa HS, Bayirli A, Beacham JB, Beau T, Beauchemin PH, Becherer F, Bechtle P, Beck HP, Becker K, Becot C, Beddall AJ, Bednyakov VA, Bee CP, Beermann TA, Begalli M, Begel M, Behera A, Behr JK, Beisiegel F, Belfkir M, Bella G, Bellagamba L, Bellerive A, Bellos P, Beloborodov K, Belotskiy K, Belyaev NL, Benchekroun D, Benekos N, Benhammou Y, Benjamin DP, Benoit M, Bensinger JR, Bentvelsen S, Beresford L, Beretta M, Berge D, Bergeaas Kuutmann E, Berger N, Bergmann B, Bergsten LJ, Beringer J, Berlendis S, Bernardi G, Bernius C, Bernlochner FU, Berry T, Berta P, Berthold A, Bertram IA, Bessidskaia Bylund O, Bethke S, Betti A, Bevan AJ, Bhatta S, Bhattacharya DS, Bhattarai P, Bhopatkar VS, Bi R, Bianchi RM, Biebel O, Biedermann D, Bielski R, Bierwagen K, Biesuz NV, Biglietti M, Billoud TRV, Bindi M, Bingul A, Bini C, Biondi S, Birch-Sykes CJ, Birman M, Bisanz T, Biswal JP, Biswas D, Bitadze A, Bittrich C, Bjørke K, Blazek T, Bloch I, Blocker C, Blue A, Blumenschein U, Bobbink GJ, Bobrovnikov VS, Bogavac D, Bogdanchikov AG, Bohm C, Boisvert V, Bokan P, Bold T, Bomben M, Bona M, Bonilla JS, Boonekamp M, Booth CD, Borbély AG, Borecka-Bielska HM, Borgna LS, Borisov A, Borissov G, Bortoletto D, Boscherini D, Bosman M, Bossio Sola JD, Bouaouda K, Boudreau J, Bouhova-Thacker EV, Boumediene D, Bouquet R, Boveia A, Boyd J, Boye D, Boyko IR, Bozson AJ, Bracinik J, Brahimi N, Brandt G, Brandt O, Braren F, Brau B, Brau JE, Breaden Madden WD, Brendlinger K, Brener R, Brenner L, Brenner R, Bressler S, Brickwedde B, Briglin DL, Britton D, Britzger D, Brock I, Brock R, Brooijmans G, Brooks WK, Brost E, Bruckman de Renstrom PA, Brüers B, Bruncko D, Bruni A, Bruni G, Bruschi M, Bruscino N, Bryngemark L, Buanes T, Buat Q, Buchholz P, Buckley AG, Budagov IA, Bugge MK, Bulekov O, Bullard BA, Burch TJ, Burdin S, Burgard CD, Burger AM, Burghgrave B, Burr JTP, Burton CD, Burzynski JC, Büscher V, Buschmann E, Bussey PJ, Butler JM, Buttar CM, Butterworth JM, Buttinger W, Buxo Vazquez CJ, Buzykaev AR, Cabras G, Cabrera Urbán S, Caforio D, Cai H, Cairo VMM, Cakir O, Calace N, Calafiura P, Calderini G, Calfayan P, Callea G, Caloba LP, Caltabiano A, Calvente Lopez S, Calvet D, Calvet S, Calvet TP, Calvetti M, Camacho Toro R, Camarda S, Camarero Munoz D, Camarri P, Camerlingo MT, Cameron D, Camincher C, Campanelli M, Camplani A, Canale V, Canesse A, Cano Bret M, Cantero J, Cao Y, Capua M, Cardarelli R, Cardillo F, Carducci G, Carli T, Carlino G, Carlson BT, Carlson EM, Carminati L, Carney RMD, Caron S, Carquin E, Carrá S, Carratta G, Carter JWS, Carter TM, Casado MP, Casha AF, Castiglia EG, Castillo FL, Castillo Garcia L, Castillo Gimenez V, Castro NF, Catinaccio A, Catmore JR, Cattai A, Cavaliere V, Cavasinni V, Celebi E, Celli F, Cerny K, Cerqueira AS, Cerri A, Cerrito L, Cerutti F, Cervelli A, Cetin SA, Chadi Z, Chakraborty D, Chan J, Chan WS, Chan WY, Chapman JD, Chargeishvili B, Charlton DG, Charman TP, Chatterjee M, Chau CC, Chekanov S, Chekulaev SV, Chelkov GA, Chen B, Chen C, Chen CH, Chen H, Chen H, Chen J, Chen J, Chen J, Chen S, Chen SJ, Chen X, Chen Y, Chen YH, Cheng HC, Cheng HJ, Cheplakov A, Cheremushkina E, Cherkaoui El Moursli R, Cheu E, Cheung K, Chevalérias TJA, Chevalier L, Chiarella V, Chiarelli G, Chiodini G, Chisholm AS, Chitan A, Chiu I, Chiu YH, Chizhov MV, Choi K, Chomont AR, Chou Y, Chow YS, Christopher LD, Chu MC, Chu X, Chudoba J, Chwastowski JJ, Cieri D, Ciesla KM, Cindro V, Cioară IA, Ciocio A, Cirotto F, Citron ZH, Citterio M, Ciubotaru DA, Ciungu BM, Clark A, Clark PJ, Clawson SE, Clement C, Clissa L, Coadou Y, Cobal M, Coccaro A, Cochran J, Coelho Lopes De Sa R, Cohen H, Coimbra AEC, Cole B, Collot J, Conde Muiño P, Connell SH, Connelly IA, Conventi F, Cooper-Sarkar AM, Cormier F, Corpe LD, Corradi M, Corrigan EE, Corriveau F, Costa MJ, Costanza F, Costanzo D, Cowan G, Cowley JW, Crane J, Cranmer K, Creager RA, Crépé-Renaudin S, Crescioli F, Cristinziani M, Cristoforetti M, Croft V, Crosetti G, Cueto A, Cuhadar Donszelmann T, Cui H, Cukierman AR, Cunningham WR, Czekierda S, Czodrowski P, Czurylo MM, Da Cunha Sargedas De Sousa MJ, Da Fonseca Pinto JV, Da Via C, Dabrowski W, Dachs F, Dado T, Dahbi S, Dai T, Dallapiccola C, Dam M, D'amen G, D'Amico V, Damp J, Dandoy JR, Daneri MF, Danninger M, Dao V, Darbo G, Dartsi O, Dattagupta A, D'Auria S, David C, Davidek T, Davis DR, Dawson I, De K, De Asmundis R, De Beurs M, De Castro S, De Groot N, de Jong P, De la Torre H, De Maria A, De Pedis D, De Salvo A, De Sanctis U, De Santis M, De Santo A, De Vivie De Regie JB, Dedovich DV, Deiana AM, Del Peso J, Delabat Diaz Y, Delgove D, Deliot F, Delitzsch CM, Della Pietra M, Della Volpe D, Dell'Acqua A, Dell'Asta L, Delmastro M, Delporte C, Delsart PA, Demers S, Demichev M, Demontigny G, Denisov SP, D'Eramo L, Derendarz D, Derkaoui JE, Derue F, Dervan P, Desch K, Dette K, Deutsch C, Deviveiros PO, Di Bello FA, Di Ciaccio A, Di Ciaccio L, Di Donato C, Di Girolamo A, Di Gregorio G, Di Luca A, Di Micco B, Di Nardo R, Di Sipio R, Diaconu C, Dias FA, Dias Do Vale T, Diaz MA, Diaz Capriles FG, Dickinson J, Didenko M, Diehl EB, Dietrich J, Díez Cornell S, Diez Pardos C, Dimitrievska A, Ding W, Dingfelder J, Dittmeier SJ, Dittus F, Djama F, Djobava T, Djuvsland JI, Do Vale MAB, Dobre M, Dodsworth D, Doglioni C, Dolejsi J, Dolezal Z, Donadelli M, Dong B, Donini J, D'onofrio A, D'Onofrio M, Dopke J, Doria A, Dova MT, Doyle AT, Drechsler E, Dreyer E, Dreyer T, Drobac AS, Du D, du Pree TA, Duan Y, Dubinin F, Dubovsky M, Dubreuil A, Duchovni E, Duckeck G, Ducu OA, Duda D, Dudarev A, Dudder AC, D'uffizi M, Duflot L, Dührssen M, Dülsen C, Dumancic M, Dumitriu AE, Dunford M, Dungs S, Duperrin A, Duran Yildiz H, Düren M, Durglishvili A, Dutta B, Duvnjak D, Dyckes GI, Dyndal M, Dysch S, Dziedzic BS, Eggleston MG, Eifert T, Eigen G, Einsweiler K, Ekelof T, El Jarrari H, El Moussaouy A, Ellajosyula V, Ellert M, Ellinghaus F, Elliot AA, Ellis N, Elmsheuser J, Elsing M, Emeliyanov D, Emerman A, Enari Y, Erdmann J, Ereditato A, Erland PA, Errenst M, Escalier M, Escobar C, Estrada Pastor O, Etzion E, Evans G, Evans H, Evans MO, Ezhilov A, Fabbri F, Fabbri L, Fabiani V, Facini G, Fakhrutdinov RM, Falciano S, Falke PJ, Falke S, Faltova J, Fang Y, Fang Y, Fanourakis G, Fanti M, Faraj M, Farbin A, Farilla A, Farina EM, Farooque T, Farrington SM, Farthouat P, Fassi F, Fassouliotis D, Faucci Giannelli M, Fawcett WJ, Fayard L, Fedin OL, Fehr A, Feickert M, Feligioni L, Fell A, Feng C, Feng M, Fenton MJ, Fenyuk AB, Ferguson SW, Ferrando J, Ferrari A, Ferrari P, Ferrari R, Ferrere D, Ferretti C, Fiedler F, Filipčič A, Filthaut F, Finelli KD, Fiolhais MCN, Fiorini L, Fischer F, Fischer J, Fisher WC, Fitschen T, Fleck I, Fleischmann P, Flick T, Flierl BM, Flores L, Flores Castillo LR, Follega FM, Fomin N, Foo JH, Forcolin GT, Forland BC, Formica A, Förster FA, Forti AC, Fortin E, Foti MG, Fournier D, Fox H, Francavilla P, Francescato S, Franchini M, Franchino S, Francis D, Franco L, Franconi L, Franklin M, Frattari G, Freeman PM, Freund B, Freund WS, Freundlich EM, Frizzell DC, Froidevaux D, Frost JA, Fujimoto M, Fullana Torregrosa E, Fusayasu T, Fuster J, Gabrielli A, Gabrielli A, Gadow P, Gagliardi G, Gagnon LG, Gallardo GE, Gallas EJ, Gallop BJ, Gamboa Goni R, Gan KK, Ganguly S, Gao J, Gao Y, Gao YS, Garay Walls FM, García C, García Navarro JE, García Pascual JA, Garcia-Sciveres M, Gardner RW, Gargiulo S, Garner CA, Garonne V, Gasiorowski SJ, Gaspar P, Gaudio G, Gauzzi P, Gavrilenko IL, Gavrilyuk A, Gay C, Gaycken G, Gazis EN, Geanta AA, Gee CM, Gee CNP, Geisen J, Geisen M, Gemme C, Genest MH, Geng C, Gentile S, George S, Geralis T, Gerlach LO, Gessinger-Befurt P, Gessner G, Ghasemi Bostanabad M, Ghneimat M, Ghosh A, Ghosh A, Giacobbe B, Giagu S, Giangiacomi N, Giannetti P, Giannini A, Giannini G, Gibson SM, Gignac M, Gil DT, Gilbert BJ, Gillberg D, Gilles G, Gillwald NEK, Gingrich DM, Giordani MP, Giraud PF, Giugliarelli G, Giugni D, Giuli F, Gkaitatzis S, Gkialas I, Gkougkousis EL, Gkountoumis P, Gladilin LK, Glasman C, Gledhill GR, Gnesi I, Goblirsch-Kolb M, Godin D, Goldfarb S, Golling T, Golubkov D, Gomes A, Goncalves Gama R, Gonçalo R, Gonella G, Gonella L, Gongadze A, Gonnella F, Gonski JL, González de la Hoz S, Gonzalez Fernandez S, Gonzalez Lopez R, Gonzalez Renteria C, Gonzalez Suarez R, Gonzalez-Sevilla S, Gonzalvo Rodriguez GR, Goossens L, Gorasia NA, Gorbounov PA, Gordon HA, Gorini B, Gorini E, Gorišek A, Goshaw AT, Gostkin MI, Gottardo CA, Gouighri M, Goussiou AG, Govender N, Goy C, Grabowska-Bold I, Gramstad E, Grancagnolo S, Grandi M, Gratchev V, Gravila PM, Gravili FG, Gray C, Gray HM, Grefe C, Gregor IM, Grenier P, Grevtsov K, Grieco C, Grieser NA, Grillo AA, Grimm K, Grinstein S, Grivaz JF, Groh S, Gross E, Grosse-Knetter J, Grout ZJ, Grud C, Grummer A, Grundy JC, Guan L, Guan W, Gubbels C, Guenther J, Guerrero Rojas JGR, Guescini F, Guest D, Gugel R, Guida A, Guillemin T, Guindon S, Guo J, Guo Z, Gupta R, Gurbuz S, Gustavino G, Guth M, Gutierrez P, Gutierrez Zagazeta LF, Gutschow C, Guyot C, Gwenlan C, Gwilliam CB, Haaland ES, Haas A, Haber C, Hadavand HK, Hadef A, Haleem M, Haley J, Hall JJ, Halladjian G, Hallewell GD, Hamano K, Hamdaoui H, Hamer M, Hamity GN, Han K, Han L, Han L, Han S, Han YF, Hanagaki K, Hance M, Hank MD, Hankache R, Hansen E, Hansen JB, Hansen JD, Hansen MC, Hansen PH, Hanson EC, Hara K, Harenberg T, Harkusha S, Harrison PF, Hartman NM, Hartmann NM, Hasegawa Y, Hasib A, Hassani S, Haug S, Hauser R, Havranek M, Hawkes CM, Hawkings RJ, Hayashida S, Hayden D, Hayes C, Hayes RL, Hays CP, Hays JM, Hayward HS, Haywood SJ, He F, He Y, Heath MP, Hedberg V, Heggelund AL, Hehir ND, Heidegger C, Heidegger KK, Heidorn WD, Heilman J, Heim S, Heim T, Heinemann B, Heinlein JG, Heinrich JJ, Heinrich L, Hejbal J, Helary L, Held A, Hellesund S, Helling CM, Hellman S, Helsens C, Henderson RCW, Henkelmann L, Henriques Correia AM, Herde H, Hernández Jiménez Y, Herr H, Herrmann MG, Herrmann T, Herten G, Hertenberger R, Hervas L, Hessey NP, Hibi H, Higashino S, Higón-Rodriguez E, Hildebrand K, Hill JC, Hill KK, Hiller KH, Hillier SJ, Hils M, Hinchliffe I, Hinterkeuser F, Hirose M, Hirose S, Hirschbuehl D, Hiti B, Hladik O, Hobbs J, Hobincu R, Hod N, Hodgkinson MC, Hoecker A, Hohn D, Hohov D, Holm T, Holmes TR, Holzbock M, Hommels LBAH, Hong TM, Honig JC, Hönle A, Hooberman BH, Hopkins WH, Horii Y, Horn P, Horyn LA, Hou S, Howarth J, Hoya J, Hrabovsky M, Hrynevich A, Hryn'ova T, Hsu PJ, Hsu SC, Hu Q, Hu S, Hu YF, Huang DP, Huang X, Huang Y, Huang Y, Hubacek Z, Hubaut F, Huebner M, Huegging F, Huffman TB, Huhtinen M, Hulsken R, Hunter RFH, Huseynov N, Huston J, Huth J, Hyneman R, Hyrych S, Iacobucci G, Iakovidis G, Ibragimov I, Iconomidou-Fayard L, Iengo P, Ignazzi R, Iguchi R, Iizawa T, Ikegami Y, Ilic N, Imam H, Introzzi G, Iodice M, Iordanidou K, Ippolito V, Isacson MF, Ishino M, Islam W, Issever C, Istin S, Iturbe Ponce JM, Iuppa R, Ivina A, Izen JM, Izzo V, Jacka P, Jackson P, Jacobs RM, Jaeger BP, Jäkel G, Jakobi KB, Jakobs K, Jakoubek T, Jamieson J, Janas KW, Jansky R, Janus PA, Jarlskog G, Jaspan AE, Javadov N, Javůrek T, Javurkova M, Jeanneau F, Jeanty L, Jejelava J, Jenni P, Jézéquel S, Jia J, Jia X, Jia Z, Jiang Y, Jiggins S, Jimenez Morales FA, Jimenez Pena J, Jin S, Jinaru A, Jinnouchi O, Jivan H, Johansson P, Johns KA, Johnson CA, Jones E, Jones RWL, Jones SD, Jones TJ, Jovicevic J, Ju X, Junggeburth JJ, Juste Rozas A, Kaczmarska A, Kado M, Kagan H, Kagan M, Kahn A, Kahra C, Kaji T, Kajomovitz E, Kalderon CW, Kaluza A, Kamenshchikov A, Kaneda M, Kang NJ, Kang S, Kano Y, Kanzaki J, Kar D, Karava K, Kareem MJ, Karkanias I, Karpov SN, Karpova ZM, Kartvelishvili V, Karyukhin AN, Kasimi E, Kato C, Katzy J, Kawade K, Kawagoe K, Kawaguchi T, Kawamoto T, Kawamura G, Kay EF, Kaya FI, Kazakos S, Kazanin VF, Keaveney JM, Keeler R, Keller JS, Kelsey D, Kempster JJ, Kendrick J, Kennedy KE, Kepka O, Kersten S, Kerševan BP, Ketabchi Haghighat S, Khalil-Zada F, Khandoga M, Khanov A, Kharlamov AG, Kharlamova T, Khoda EE, Khoo TJ, Khoriauli G, Khramov E, Khubua J, Kido S, Kiehn M, Kilgallon A, Kim E, Kim YK, Kimura N, Kirchhoff A, Kirchmeier D, Kirk J, Kiryunin AE, Kishimoto T, Kisliuk DP, Kitali V, Kitsaki C, Kivernyk O, Klapdor-Kleingrothaus T, Klassen M, Klein C, Klein L, Klein MH, Klein M, Klein U, Klimek P, Klimentov A, Klimpel F, Klingl T, Klioutchnikova T, Klitzner FF, Kluit P, Kluth S, Kneringer E, Knue A, Kobayashi D, Kobel M, Kocian M, Kodama T, Kodys P, Koeck DM, Koenig PT, Koffas T, Köhler NM, Kolb M, Koletsou I, Komarek T, Köneke K, Kong AXY, Kono T, Konstantinides V, Konstantinidis N, Konya B, Kopeliansky R, Koperny S, Korcyl K, Kordas K, Koren G, Korn A, Korolkov I, Korolkova EV, Korotkova N, Kortner O, Kortner S, Kostyukhin VV, Kotsokechagia A, Kotwal A, Koulouris A, Kourkoumeli-Charalampidi A, Kourkoumelis C, Kourlitis E, Kowalewski R, Kozanecki W, Kozhin AS, Kramarenko VA, Kramberger G, Krasnopevtsev D, Krasny MW, Krasznahorkay A, Kremer JA, Kretzschmar J, Kreul K, Krieger P, Krieter F, Krishnamurthy S, Krishnan A, Krivos M, Krizka K, Kroeninger K, Kroha H, Kroll J, Kroll J, Krowpman KS, Kruchonak U, Krüger H, Krumnack N, Kruse MC, Krzysiak JA, Kubota A, Kuchinskaia O, Kuday S, Kuechler D, Kuechler JT, Kuehn S, Kuhl T, Kukhtin V, Kulchitsky Y, Kuleshov S, Kulinich YP, Kumar M, Kuna M, Kupco A, Kupfer T, Kuprash O, Kurashige H, Kurchaninov LL, Kurochkin YA, Kurova A, Kurth MG, Kuwertz ES, Kuze M, Kvam AK, Kvita J, Kwan T, Lacasta C, Lacava F, Lack DPJ, Lacker H, Lacour D, Ladygin E, Lafaye R, Laforge B, Lagouri T, Lai S, Lakomiec IK, Lambert JE, Lammers S, Lampl W, Lampoudis C, Lançon E, Landgraf U, Landon MPJ, Lang VS, Lange JC, Langenberg RJ, Lankford AJ, Lanni F, Lantzsch K, Lanza A, Lapertosa A, Laporte JF, Lari T, Lasagni Manghi F, Lassnig M, Latonova V, Lau TS, Laudrain A, Laurier A, Lavorgna M, Lawlor SD, Lazzaroni M, Le B, Lebedev A, LeBlanc M, LeCompte T, Ledroit-Guillon F, Lee ACA, Lee CA, Lee GR, Lee L, Lee SC, Lee S, Lefebvre B, Lefebvre HP, Lefebvre M, Leggett C, Lehmann K, Lehmann N, Lehmann Miotto G, Leight WA, Leisos A, Leite MAL, Leitgeb CE, Leitner R, Leney KJC, Lenz T, Leone S, Leonidopoulos C, Leopold A, Leroy C, Les R, Lester CG, Levchenko M, Levêque J, Levin D, Levinson LJ, Lewis DJ, Li B, Li B, Li CQ, Li F, Li H, Li H, Li J, Li K, Li L, Li M, Li QY, Li S, Li X, Li Y, Li Z, Li Z, Li Z, Li Z, Liang Z, Liberatore M, Liberti B, Lie K, Lin CY, Lin K, Linck RA, Lindley RE, Lindon JH, Linss A, Lionti AL, Lipeles E, Lipniacka A, Liss TM, Lister A, Little JD, Liu B, Liu BX, Liu JB, Liu JKK, Liu K, Liu M, Liu MY, Liu P, Liu X, Liu Y, Liu Y, Liu YL, Liu YW, Livan M, Lleres A, Llorente Merino J, Lloyd SL, Lobodzinska EM, Loch P, Loffredo S, Lohse T, Lohwasser K, Lokajicek M, Long JD, Long RE, Longarini I, Longo L, Longo R, Lopez Paz I, Lopez Solis A, Lorenz J, Lorenzo Martinez N, Lory AM, Lösle A, Lou X, Lou X, Lounis A, Love J, Love PA, Lozano Bahilo JJ, Lu M, Lu S, Lu YJ, Lubatti HJ, Luci C, Lucio Alves FL, Lucotte A, Luehring F, Luise I, Luminari L, Lund-Jensen B, Luongo NA, Lutz MS, Lynn D, Lyons H, Lysak R, Lytken E, Lyu F, Lyubushkin V, Lyubushkina T, Ma H, Ma LL, Ma Y, Mac Donell DM, Maccarrone G, Macdonald CM, MacDonald JC, Machado Miguens J, Madar R, Mader WF, Madugoda Ralalage Don M, Madysa N, Maeda J, Maeno T, Maerker M, Magerl V, Magro J, Mahon DJ, Maidantchik C, Maio A, Maj K, Majersky O, Majewski S, Makovec N, Malaescu B, Malecki P, Maleev VP, Malek F, Malito D, Mallik U, Malone C, Maltezos S, Malyukov S, Mamuzic J, Mancini G, Mandalia JP, Mandić I, Manhaes de Andrade Filho L, Maniatis IM, Manjarres Ramos J, Mankinen KH, Mann A, Manousos A, Mansoulie B, Manthos I, Manzoni S, Marantis A, Marchese L, Marchiori G, Marcisovsky M, Marcoccia L, Marcon C, Marjanovic M, Marshall Z, Martensson MUF, Marti-Garcia S, Martin TA, Martin VJ, Martin Dit Latour B, Martinelli L, Martinez M, Martinez Agullo P, Martinez Outschoorn VI, Martin-Haugh S, Martoiu VS, Martyniuk AC, Marzin A, Maschek SR, Masetti L, Mashimo T, Mashinistov R, Masik J, Maslennikov AL, Massa L, Massarotti P, Mastrandrea P, Mastroberardino A, Masubuchi T, Matakias D, Mathisen T, Matic A, Matsuzawa N, Maurer J, Maček B, Maximov DA, Mazini R, Maznas I, Mazza SM, Mc Ginn C, Mc Gowan JP, Mc Kee SP, McCarthy TG, McCormack WP, McDonald EF, McDougall AE, Mcfayden JA, Mchedlidze G, McKay MA, McLean KD, McMahon SJ, McNamara PC, McNicol CJ, McPherson RA, Mdhluli JE, Meadows ZA, Meehan S, Megy T, Mehlhase S, Mehta A, Meirose B, Melini D, Mellado Garcia BR, Meloni F, Melzer A, Mendes Gouveia ED, Mendes Jacques Da Costa AM, Meng HY, Meng L, Menke S, Meoni E, Mergelmeyer S, Merkt SAM, Merlassino C, Mermod P, Merola L, Meroni C, Merz G, Meshkov O, Meshreki JKR, Metcalfe J, Mete AS, Meyer C, Meyer JP, Michetti M, Middleton RP, Mijović L, Mikenberg G, Mikestikova M, Mikuž M, Mildner H, Milic A, Milke CD, Miller DW, Miller LS, Milov A, Milstead DA, Minaenko AA, Minashvili IA, Mince L, Mincer AI, Mindur B, Mineev M, Minegishi Y, Mino Y, Mir LM, Mironova M, Mitani T, Mitrevski J, Mitsou VA, Mittal M, Miu O, Miucci A, Miyagawa PS, Mizukami A, Mjörnmark JU, Mkrtchyan T, Mlynarikova M, Moa T, Mobius S, Mochizuki K, Moder P, Mogg P, Mohapatra S, Mokgatitswane G, Mondal B, Mondal S, Mönig K, Monnier E, Montalbano A, Montejo Berlingen J, Montella M, Monticelli F, Morange N, Moreira De Carvalho AL, Moreno Llácer M, Moreno Martinez C, Morettini P, Morgenstern M, Morgenstern S, Mori D, Morii M, Morinaga M, Morisbak V, Morley AK, Morris AP, Morvaj L, Moschovakos P, Moser B, Mosidze M, Moskalets T, Moskvitina P, Moss J, Moyse EJW, Muanza S, Mueller J, Muenstermann D, Mullier GA, Mullin JJ, Mungo DP, Munoz Martinez JL, Munoz Sanchez FJ, Murin P, Murray WJ, Murrone A, Muse JM, Muškinja M, Mwewa C, Myagkov AG, Myers AA, Myers G, Myers J, Myska M, Nachman BP, Nackenhorst O, Nag AN, Nagai K, Nagano K, Nagle JL, Nagy E, Nairz AM, Nakahama Y, Nakamura K, Nanjo H, Napolitano F, Naranjo Garcia RF, Narayan R, Naryshkin I, Naseri M, Naumann T, Navarro G, Navarro-Gonzalez J, Nechaeva PY, Nechansky F, Neep TJ, Negri A, Negrini M, Nellist C, Nelson C, Nelson ME, Nemecek S, Nessi M, Neubauer MS, Neuhaus F, Neumann M, Newhouse R, Newman PR, Ng CW, Ng YS, Ng YWY, Ngair B, Nguyen HDN, Nguyen Manh T, Nibigira E, Nickerson RB, Nicolaidou R, Nielsen DS, Nielsen J, Niemeyer M, Nikiforou N, Nikolaenko V, Nikolic-Audit I, Nikolopoulos K, Nilsson P, Nindhito HR, Nisati A, Nishu N, Nisius R, Nitsche I, Nitta T, Nobe T, Noel DL, Noguchi Y, Nomidis I, Nomura MA, Norisam RRB, Novak J, Novak T, Novgorodova O, Novotny R, Nozka L, Ntekas K, Nurse E, Oakham FG, Ocariz J, Ochi A, Ochoa I, Ochoa-Ricoux JP, O'Connor K, Oda S, Odaka S, Oerdek S, Ogrodnik A, Oh A, Ohm CC, Oide H, Oishi R, Ojeda ML, Okazaki Y, O'Keefe MW, Okumura Y, Olariu A, Oleiro Seabra LF, Olivares Pino SA, Oliveira Damazio D, Oliver JL, Olsson MJR, Olszewski A, Olszowska J, Öncel ÖO, O'Neil DC, O'neill AP, Onofre A, Onyisi PUE, Oppen H, Oreamuno Madriz RG, Oreglia MJ, Orellana GE, Orestano D, Orlando N, Orr RS, O'Shea V, Ospanov R, Otero Y Garzon G, Otono H, Ott PS, Ottino GJ, Ouchrif M, Ouellette J, Ould-Saada F, Ouraou A, Ouyang Q, Owen M, Owen RE, Ozcan VE, Ozturk N, Pacalt J, Pacey HA, Pachal K, Pacheco Pages A, Padilla Aranda C, Pagan Griso S, Palacino G, Palazzo S, Palestini S, Palka M, Palni P, Panchal DK, Pandini CE, Panduro Vazquez JG, Pani P, Panizzo G, Paolozzi L, Papadatos C, Parajuli S, Paramonov A, Paraskevopoulos C, Paredes Hernandez D, Paredes Saenz SR, Parida B, Park TH, Parker AJ, Parker MA, Parodi F, Parrish EW, Parsons JA, Parzefall U, Pascual Dominguez L, Pascuzzi VR, Pasner JMP, Pasquali F, Pasqualucci E, Passaggio S, Pastore F, Pasuwan P, Pater JR, Pathak A, Patton J, Pauly T, Pearkes J, Pedersen M, Pedraza Diaz L, Pedro R, Peiffer T, Peleganchuk SV, Penc O, Peng C, Peng H, Peralva BS, Perego MM, Pereira Peixoto AP, Pereira Sanchez L, Perepelitsa DV, Perez Codina E, Perini L, Pernegger H, Perrella S, Perrevoort A, Peters K, Peters RFY, Petersen BA, Petersen TC, Petit E, Petousis V, Petridou C, Petroff P, Petrucci F, Pettee M, Pettersson NE, Petukhova K, Peyaud A, Pezoa R, Pezzotti L, Pezzullo G, Pham T, Phillips PW, Phipps MW, Piacquadio G, Pianori E, Picazio A, Piegaia R, Pietreanu D, Pilcher JE, Pilkington AD, Pinamonti M, Pinfold JL, Pitman Donaldson C, Pizzimento L, Pizzini A, Pleier MA, Plesanovs V, Pleskot V, Plotnikova E, Podberezko P, Poettgen R, Poggi R, Poggioli L, Pogrebnyak I, Pohl D, Pokharel I, Polesello G, Poley A, Policicchio A, Polifka R, Polini A, Pollard CS, Polychronakos V, Ponomarenko D, Pontecorvo L, Popa S, Popeneciu GA, Portales L, Portillo Quintero DM, Pospisil S, Postolache P, Potamianos K, Potrap IN, Potter CJ, Potti H, Poulsen T, Poveda J, Powell TD, Pownall G, Pozo Astigarraga ME, Prades Ibanez A, Pralavorio P, Prapa MM, Prell S, Price D, Primavera M, Proffitt ML, Proklova N, Prokofiev K, Prokoshin F, Protopopescu S, Proudfoot J, Przybycien M, Pudzha D, Puri A, Puzo P, Pyatiizbyantseva D, Qian J, Qin Y, Quadt A, Queitsch-Maitland M, Rabanal Bolanos G, Racko M, Ragusa F, Rahal G, Raine JA, Rajagopalan S, Ran K, Rassloff DF, Rauch DM, Rave S, Ravina B, Ravinovich I, Raymond M, Read AL, Readioff NP, Reale M, Rebuzzi DM, Redlinger G, Reeves K, Reikher D, Reiss A, Rej A, Rembser C, Renardi A, Renda M, Rendel MB, Rennie AG, Resconi S, Resseguie ED, Rettie S, Reynolds B, Reynolds E, Rezanova OL, Reznicek P, Ricci E, Richter R, Richter S, Richter-Was E, Ridel M, Rieck P, Rifki O, Rijssenbeek M, Rimoldi A, Rimoldi M, Rinaldi L, Rinn TT, Ripellino G, Riu I, Rivadeneira P, Rivera Vergara JC, Rizatdinova F, Rizvi E, Rizzi C, Robertson SH, Robin M, Robinson D, Robles Gajardo CM, Robles Manzano M, Robson A, Rocchi A, Roda C, Rodriguez Bosca S, Rodriguez Rodriguez A, Rodríguez Vera AM, Roe S, Roggel J, Røhne O, Rojas RA, Roland B, Roland CPA, Roloff J, Romaniouk A, Romano M, Rompotis N, Ronzani M, Roos L, Rosati S, Rosin G, Rosser BJ, Rossi E, Rossi E, Rossi E, Rossi LP, Rossini L, Rosten R, Rotaru M, Rottler B, Rousseau D, Rovelli G, Roy A, Rozanov A, Rozen Y, Ruan X, Ruby AJ, Ruggeri TA, Rühr F, Ruiz-Martinez A, Rummler A, Rurikova Z, Rusakovich NA, Russell HL, Rustige L, Rutherfoord JP, Rüttinger EM, Rybar M, Rye EB, Ryzhov A, Sabater Iglesias JA, Sabatini P, Sabetta L, Sacerdoti S, Sadrozinski HFW, Sadykov R, Safai Tehrani F, Safarzadeh Samani B, Safdari M, Saha P, Saha S, Sahinsoy M, Sahu A, Saimpert M, Saito M, Saito T, Salamani D, Salamanna G, Salnikov A, Salt J, Salvador Salas A, Salvatore D, Salvatore F, Salzburger A, Sammel D, Sampsonidis D, Sampsonidou D, Sánchez J, Sanchez Pineda A, Sandaker H, Sander CO, Sanderswood IG, Sandhoff M, Sandoval C, Sankey DPC, Sannino M, Sano Y, Sansoni A, Santoni C, Santos H, Santpur SN, Santra A, Saoucha KA, Sapronov A, Saraiva JG, Sasaki O, Sato K, Sauerburger F, Sauvan E, Savard P, Sawada R, Sawyer C, Sawyer L, Sayago Galvan I, Sbarra C, Sbrizzi A, Scanlon T, Schaarschmidt J, Schacht P, Schaefer D, Schaefer L, Schäfer U, Schaffer AC, Schaile D, Schamberger RD, Schanet E, Scharf C, Scharmberg N, Schegelsky VA, Scheirich D, Schenck F, Schernau M, Schiavi C, Schildgen LK, Schillaci ZM, Schioppa EJ, Schioppa M, Schleicher KE, Schlenker S, Schmidt-Sommerfeld KR, Schmieden K, Schmitt C, Schmitt S, Schoeffel L, Schoening A, Scholer PG, Schopf E, Schott M, Schouwenberg JFP, Schovancova J, Schramm S, Schroeder F, Schulte A, Schultz-Coulon HC, Schumacher M, Schumm BA, Schune P, Schwartzman A, Schwarz TA, Schwemling P, Schwienhorst R, Sciandra A, Sciolla G, Scuri F, Scutti F, Scyboz LM, Sebastiani CD, Sedlaczek K, Seema P, Seidel SC, Seiden A, Seidlitz BD, Seiss T, Seitz C, Seixas JM, Sekhniaidze G, Sekula SJ, Semprini-Cesari N, Sen S, Serfon C, Serin L, Serkin L, Sessa M, Severini H, Sevova S, Sforza F, Sfyrla A, Shabalina E, Shahinian JD, Shaikh NW, Shaked Renous D, Shan LY, Shapiro M, Sharma A, Sharma AS, Shatalov PB, Shaw K, Shaw SM, Shehade M, Shen Y, Sherwood P, Shi L, Shimmin CO, Shimogama Y, Shimojima M, Shinner JD, Shipsey IPJ, Shirabe S, Shiyakova M, Shlomi J, Shochet MJ, Shojaii J, Shope DR, Shrestha S, Shrif EM, Shroff MJ, Shulga E, Sicho P, Sickles AM, Sideras Haddad E, Sidiropoulou O, Sidoti A, Siegert F, Sijacki D, Silva Oliveira MV, Silverstein SB, Simion S, Simoniello R, Simpson-Allsop CJ, Simsek S, Sinervo P, Sinetckii V, Singh S, Sinha S, Sioli M, Siral I, Sivoklokov SY, Sjölin J, Skaf A, Skorda E, Skubic P, Slawinska M, Sliwa K, Smakhtin V, Smart BH, Smiesko J, Smirnov N, Smirnov SY, Smirnov Y, Smirnova LN, Smirnova O, Smith EA, Smith HA, Smizanska M, Smolek K, Smykiewicz A, Snesarev AA, Snoek HL, Snyder IM, Snyder S, Sobie R, Soffer A, Søgaard A, Sohns F, Solans Sanchez CA, Soldatov EY, Soldevila U, Solodkov AA, Soloshenko A, Solovyanov OV, Solovyev V, Sommer P, Son H, Sonay A, Song WY, Sopczak A, Sopio AL, Sopkova F, Sottocornola S, Soualah R, Soukharev AM, South D, Spagnolo S, Spalla M, Spangenberg M, Spanò F, Sperlich D, Spieker TM, Spigo G, Spina M, Spiteri DP, Spousta M, Stabile A, Stamas BL, Stamen R, Stamenkovic M, Stampekis A, Stanecka E, Stanislaus B, Stanitzki MM, Stankaityte M, Stapf B, Starchenko EA, Stark GH, Stark J, Staroba P, Starovoitov P, Stärz S, Staszewski R, Stavropoulos G, Steinberg P, Steinhebel AL, Stelzer B, Stelzer HJ, Stelzer-Chilton O, Stenzel H, Stevenson TJ, Stewart GA, Stockton MC, Stoicea G, Stolarski M, Stonjek S, Straessner A, Strandberg J, Strandberg S, Strauss M, Strebler T, Strizenec P, Ströhmer R, Strom DM, Stroynowski R, Strubig A, Stucci SA, Stugu B, Stupak J, Styles NA, Su D, Su W, Su X, Suarez NB, Sulin VV, Sullivan MJ, Sultan DMS, Sultansoy S, Sumida T, Sun S, Sun X, Suster CJE, Sutton MR, Svatos M, Swiatlowski M, Swift SP, Swirski T, Sydorenko A, Sykora I, Sykora M, Sykora T, Ta D, Tackmann K, Taenzer J, Taffard A, Tafirout R, Tagiev E, Taibah RHM, Takashima R, Takeda K, Takeshita T, Takeva EP, Takubo Y, Talby M, Talyshev AA, Tam KC, Tamir NM, Tanaka J, Tanaka R, Tapia Araya S, Tapprogge S, Tarek Abouelfadl Mohamed A, Tarem S, Tariq K, Tarna G, Tartarelli GF, Tas P, Tasevsky M, Tassi E, Tateno G, Tayalati Y, Taylor GN, Taylor W, Teagle H, Tee AS, Teixeira De Lima R, Teixeira-Dias P, Ten Kate H, Teoh JJ, Terashi K, Terron J, Terzo S, Testa M, Teuscher RJ, Themistokleous N, Theveneaux-Pelzer T, Thomas DW, Thomas JP, Thompson EA, Thompson PD, Thomson E, Thorpe EJ, Tikhomirov VO, Tikhonov YA, Timoshenko S, Tipton P, Tisserant S, Todome K, Todorova-Nova S, Todt S, Tojo J, Tokár S, Tokushuku K, Tolley E, Tombs R, Tomoto M, Tompkins L, Tornambe P, Torrence E, Torres H, Torró Pastor E, Toscani M, Tosciri C, Toth J, Tovey DR, Traeet A, Treado CJ, Trefzger T, Tresoldi F, Tricoli A, Trigger IM, Trincaz-Duvoid S, Trischuk DA, Trischuk W, Trocmé B, Trofymov A, Troncon C, Trovato F, Truong L, Trzebinski M, Trzupek A, Tsai F, Tsiareshka PV, Tsirigotis A, Tsiskaridze V, Tskhadadze EG, Tsopoulou M, Tsukerman II, Tsulaia V, Tsuno S, Tsybychev D, Tu Y, Tudorache A, Tudorache V, Tuna AN, Turchikhin S, Turgeman D, Turk Cakir I, Turner RJ, Turra R, Tuts PM, Tzamarias S, Tzovara E, Uchida K, Ukegawa F, Unal G, Unal M, Undrus A, Unel G, Ungaro FC, Uno K, Urban J, Urquijo P, Usai G, Uysal Z, Vacek V, Vachon B, Vadla KOH, Vafeiadis T, Vaidya A, Valderanis C, Valdes Santurio E, Valente M, Valentinetti S, Valero A, Valéry L, Vallance RA, Vallier A, Valls Ferrer JA, Van Daalen TR, Van Gemmeren P, Van Stroud S, Van Vulpen I, Vanadia M, Vandelli W, Vandenbroucke M, Vandewall ER, Vannicola D, Vari R, Varnes EW, Varni C, Varol T, Varouchas D, Varvell KE, Vasile ME, Vasquez GA, Vazeille F, Vazquez Furelos D, Vazquez Schroeder T, Veatch J, Vecchio V, Veen MJ, Veloce LM, Veloso F, Veneziano S, Ventura A, Verbytskyi A, Verducci M, Vergis C, Verkerke W, Vermeulen AT, Vermeulen JC, Vernieri C, Verschuuren PJ, Vetterli MC, Viaux Maira N, Vickey T, Vickey Boeriu OE, Viehhauser GHA, Vigani L, Villa M, Villaplana Perez M, Villhauer EM, Vilucchi E, Vincter MG, Virdee GS, Vishwakarma A, Vittori C, Vivarelli I, Vogel M, Vokac P, Von Ahnen J, von Buddenbrock SE, Von Toerne E, Vorobel V, Vorobev K, Vos M, Vossebeld JH, Vozak M, Vranjes N, Vranjes Milosavljevic M, Vrba V, Vreeswijk M, Vu NK, Vuillermet R, Vukotic I, Wada S, Wagner C, Wagner P, Wagner W, Wahdan S, Wahlberg H, Wakasa R, Walbrecht VM, Walder J, Walker R, Walker SD, Walkowiak W, Wallangen V, Wang AM, Wang AZ, Wang C, Wang C, Wang H, Wang J, Wang P, Wang RJ, Wang R, Wang R, Wang SM, Wang S, Wang T, Wang WT, Wang WX, Wang Y, Wang Z, Wanotayaroj C, Warburton A, Ward CP, Ward RJ, Warrack N, Watson AT, Watson MF, Watts G, Waugh BM, Webb AF, Weber C, Weber MS, Weber SA, Weber SM, Wei Y, Weidberg AR, Weingarten J, Weirich M, Weiser C, Wells PS, Wenaus T, Wendland B, Wengler T, Wenig S, Wermes N, Wessels M, Weston TD, Whalen K, Wharton AM, White AS, White A, White MJ, Whiteson D, Whitmore BW, Wiedenmann W, Wiel C, Wielers M, Wieseotte N, Wiglesworth C, Wiik-Fuchs LAM, Wilkens HG, Wilkins LJ, Williams DM, Williams HH, Williams S, Willocq S, Windischhofer PJ, Wingerter-Seez I, Winkels E, Winklmeier F, Winter BT, Wittgen M, Wobisch M, Wolf A, Wölker R, Wollrath J, Wolter MW, Wolters H, Wong VWS, Wongel AF, Woods NL, Worm SD, Wosiek BK, Woźniak KW, Wraight K, Wu SL, Wu X, Wu Y, Wuerzinger J, Wyatt TR, Wynne BM, Xella S, Xiang J, Xiao X, Xie X, Xiotidis I, Xu D, Xu H, Xu H, Xu L, Xu R, Xu T, Xu W, Xu Y, Xu Z, Xu Z, Yabsley B, Yacoob S, Yallup DP, Yamaguchi N, Yamaguchi Y, Yamatani M, Yamauchi H, Yamazaki T, Yamazaki Y, Yan J, Yan Z, Yang HJ, Yang HT, Yang S, Yang T, Yang X, Yang X, Yang Y, Yang Z, Yao WM, Yap YC, Ye H, Ye J, Ye S, Yeletskikh I, Yexley MR, Yin P, Yorita K, Yoshihara K, Young CJS, Young C, Yuan R, Yue X, Zaazoua M, Zabinski B, Zacharis G, Zaffaroni E, Zahreddine J, Zaitsev AM, Zakareishvili T, Zakharchuk N, Zambito S, Zanzi D, Zeißner SV, Zeitnitz C, Zemaityte G, Zeng JC, Zenin O, Ženiš T, Zenz S, Zerradi S, Zerwas D, Zgubič M, Zhang B, Zhang DF, Zhang G, Zhang J, Zhang K, Zhang L, Zhang L, Zhang M, Zhang R, Zhang S, Zhang X, Zhang X, Zhang Y, Zhang Z, Zhao P, Zhao Y, Zhao Z, Zhemchugov A, Zheng Z, Zhong D, Zhou B, Zhou C, Zhou H, Zhou M, Zhou N, Zhou Y, Zhu CG, Zhu C, Zhu HL, Zhu H, Zhu J, Zhu Y, Zhuang X, Zhukov K, Zhulanov V, Zieminska D, Zimine NI, Zimmermann S, Zinonos Z, Ziolkowski M, Živković L, Zoccoli A, Zoch K, Zorbas TG, Zou R, Zwalinski L. Search for Displaced Leptons in sqrt[s]=13 TeV pp Collisions with the ATLAS Detector. PHYSICAL REVIEW LETTERS 2021; 127:051802. [PMID: 34397238 DOI: 10.1103/physrevlett.127.051802] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Revised: 03/03/2021] [Accepted: 06/11/2021] [Indexed: 06/13/2023]
Abstract
A search for charged leptons with large impact parameters using 139 fb^{-1} of sqrt[s]=13 TeV pp collision data from the ATLAS detector at the LHC is presented, addressing a long-standing gap in coverage of possible new physics signatures. Results are consistent with the background prediction. This search provides unique sensitivity to long-lived scalar supersymmetric lepton partners (sleptons). For lifetimes of 0.1 ns, selectron, smuon, and stau masses up to 720, 680, and 340 GeV, respectively, are excluded at 95% confidence level, drastically improving on the previous best limits from LEP.
Collapse
|
206
|
Ablikim M, Achasov M, Adlarson P, Ahmed S, Albrecht M, Amoroso A, An Q, Anita, Bai Y, Bakina O, Baldini Ferroli R, Balossino I, Ban Y, Begzsuren K, Bennett J, Berger N, Bertani M, Bettoni D, Bianchi F, Biernat J, Bloms J, Bortone A, Boyko I, Briere R, Cai H, Cai X, Calcaterra A, Cao G, Cao N, Cetin S, Chang J, Chang W, Chelkov G, Chen D, Chen G, Chen H, Chen M, Chen S, Chen X, Chen Y, Cheng W, Cibinetto G, Cossio F, Cui X, Dai H, Dai J, Dai X, Dbeyssi A, de Boer R, Dedovich D, Deng Z, Denig A, Denysenko I, Destefanis M, De Mori F, Ding Y, Dong C, Dong J, Dong L, Dong M, Du S, Fang J, Fang S, Fang Y, Farinelli R, Fava L, Feldbauer F, Felici G, Feng C, Fritsch M, Fu C, Fu Y, Gao X, Gao Y, Gao Y, Gao Y, Garzia I, Gersabeck E, Gilman A, Goetzen K, Gong L, Gong W, Gradl W, Greco M, Gu L, Gu M, Gu S, Gu Y, Guan C, Guo A, Guo L, Guo R, Guo Y, Guo Y, Guskov A, Han S, Han T, Han T, Hao X, Harris F, He K, Heinsius F, Held T, Heng Y, Himmelreich M, Holtmann T, Hou Y, Hou Z, Hu H, Hu J, Hu T, Hu Y, Huang G, Huang L, Huang X, Huang Z, Huesken N, Hussain T, Ikegami Andersson W, Imoehl W, Irshad M, Jaeger S, Janchiv S, Ji Q, Ji Q, Ji X, Ji X, Jiang H, Jiang X, Jiang X, Jiao J, Jiao Z, Jin S, Jin Y, Johansson T, Kalantar-Nayestanaki N, Kang X, Kappert R, Kavatsyuk M, Ke B, Keshk I, Khoukaz A, Kiese P, Kiuchi R, Kliemt R, Koch L, Kolcu O, Kopf B, Kuemmel M, Kuessner M, Kupsc A, Kurth M, Kühn W, Lane J, Lange J, Larin P, Lavezzi L, Leithoff H, Lellmann M, Lenz T, Li C, Li C, Li C, Li D, Li F, Li G, Li H, Li H, Li J, Li J, Li K, Li L, Li L, Li P, Li P, Li S, Li W, Li W, Li X, Li X, Li Z, Li Z, Liang H, Liang H, Liang Y, Liang Y, Liao L, Libby J, Lin C, Liu B, Liu B, Liu C, Liu D, Liu D, Liu F, Liu F, Liu F, Liu H, Liu H, Liu H, Liu H, Liu J, Liu J, Liu K, Liu K, Liu K, Liu L, Liu Q, Liu S, Liu S, Liu T, Liu X, Liu Y, Liu Z, Liu Z, Long Y, Lou X, Lu F, Lu H, Lu J, Lu J, Lu X, Lu Y, Lu Y, Luo C, Luo M, Luo P, Luo T, Luo X, Lusso S, Lyu X, Ma F, Ma H, Ma L, Ma M, Ma Q, Ma R, Ma R, Ma X, Ma X, Ma X, Ma Y, Maas F, Maggiora M, Maldaner S, Malde S, Malik Q, Mangoni A, Mao Y, Mao Z, Marcello S, Meng Z, Messchendorp J, Mezzadri G, Min T, Mitchell R, Mo X, Mo Y, Muchnoi N, Muramatsu H, Nakhoul S, Nefedov Y, Nerling F, Nikolaev I, Ning Z, Nisar S, Olsen S, Ouyang Q, Pacetti S, Pan X, Pan Y, Pathak A, Patteri P, Pelizaeus M, Peng H, Peters K, Pettersson J, Ping J, Ping R, Pitka A, Poling R, Prasad V, Qi H, Qi H, Qi M, Qi T, Qian S, Qian WB, Qian Z, Qiao C, Qin L, Qin X, Qin X, Qin Z, Qiu J, Qu S, Rashid K, Ravindran K, Redmer C, Rivetti A, Rodin V, Rolo M, Rong G, Rosner C, Rump M, Sarantsev A, Schelhaas Y, Schnier C, Schoenning K, Shan D, Shan W, Shan X, Shao M, Shen C, Shen P, Shen X, Shi H, Shi R, Shi X, Shi X, Song J, Song Q, Song W, Song Y, Sosio S, Spataro S, Sui F, Sun G, Sun J, Sun L, Sun S, Sun T, Sun W, Sun X, Sun Y, Sun Y, Sun Y, Sun Z, Tan Y, Tan Y, Tang C, Tang G, Tang J, Thoren V, Tsednee B, Uman I, Wang B, Wang B, Wang C, Wang D, Wang H, Wang K, Wang L, Wang M, Wang M, Wang M, Wang W, Wang W, Wang X, Wang X, Wang X, Wang Y, Wang Y, Wang Y, Wang Y, Wang Y, Wang Z, Wang Z, Wang Z, Wang Z, Wei D, Weidenkaff P, Weidner F, Wen S, White D, Wiedner U, Wilkinson G, Wolke M, Wollenberg L, Wu J, Wu L, Wu L, Wu X, Wu Z, Xia L, Xiao H, Xiao S, Xiao Y, Xiao Z, Xie X, Xie Y, Xie Y, Xing T, Xiong X, Xu G, Xu J, Xu Q, Xu W, Xu X, Yan L, Yan L, Yan W, Yan W, Yan X, Yang H, Yang H, Yang L, Yang R, Yang S, Yang Y, Yang Y, Yang Y, Yang Z, Ye M, Ye M, Yin J, You Z, Yu B, Yu C, Yu G, Yu J, Yu T, Yuan C, Yuan W, Yuan X, Yuan Y, Yuan Z, Yue C, Yuncu A, Zafar A, Zeng Y, Zhang B, Zhang G, Zhang H, Zhang H, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang L, Zhang L, Zhang S, Zhang S, Zhang T, Zhang X, Zhang Y, Zhang Y, Zhang Y, Zhang Y, Zhang Y, Zhang Y, Zhang Z, Zhang Z, Zhao G, Zhao J, Zhao J, Zhao J, Zhao L, Zhao L, Zhao M, Zhao Q, Zhao S, Zhao Y, Zhao Y, Zhao Z, Zhemchugov A, Zheng B, Zheng J, Zheng Y, Zheng Y, Zhong B, Zhong C, Zhou L, Zhou Q, Zhou X, Zhou X, Zhou X, Zhu A, Zhu J, Zhu K, Zhu K, Zhu S, Zhu W, Zhu X, Zhu Y, Zhu Z, Zou B, Zou J. Amplitude analysis and branching fraction measurement of
Ds+→K+K−π+. Int J Clin Exp Med 2021. [DOI: 10.1103/physrevd.104.012016] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
207
|
Mao J, Pan BH, Yin H, Wu JZ, Xia Y, Wang L, Li JY, Xu W. [Prognostic value of activated partial thromboplastin time and D-dimer in chronic lymphocytic leukemia]. ZHONGHUA XUE YE XUE ZA ZHI = ZHONGHUA XUEYEXUE ZAZHI 2021; 42:425-427. [PMID: 34218587 PMCID: PMC8292996 DOI: 10.3760/cma.j.issn.0253-2727.2021.05.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
208
|
Blauvelt A, Ramharter M, Cohen AD, Xu W, Patel H, Schuster C, Riedl E, Puig L. An integrated safety analysis of treatment-emergent fungal infections in patients with psoriasis treated with ixekizumab from 16 clinical studies. J Eur Acad Dermatol Venereol 2021; 35:e828-e831. [PMID: 34310771 DOI: 10.1111/jdv.17554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
209
|
Xie L, Qin J, Rao L, Tang X, Cui D, Chen L, Xu W, Xiao S, Zhang Z, Huang L. Accurate prediction and genome-wide association analysis of digital intramuscular fat content in longissimus muscle of pigs. Anim Genet 2021; 52:633-644. [PMID: 34291482 DOI: 10.1111/age.13121] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/01/2021] [Indexed: 11/30/2022]
Abstract
Intramuscular fat (IMF) content is a critical indicator of pork quality that affects directly the purchasing desire of consumers. However, to measure IMF content is both laborious and costly, preventing our understanding of its genetic determinants and improvement. In the present study, we constructed an accurate and fast image acquisition and analysis system, to extract and calculate the digital IMF content, the proportion of fat areas in the image (PFAI) of the longissimus muscle of 1709 animals from multiple pig populations. PFAI was highly significantly correlated with marbling scores (MS; 0.95, r2 = 0.90), and also with IMF contents chemically defined for 80 samples (0.79, r2 = 0.63; more accurate than direct analysis between IMF contents and MS). The processing time for one image is only 2.31 s. Genome-wide association analysis on PFAI for all 1709 animals identified 14 suggestive significant SNPs and 1 genome-wide significant SNP. On MS, we identified nine suggestive significant SNPs, and seven of them were also identified in PFAI. Furthermore, the significance (-log P) values of the seven common SNPs are higher in PFAI than in MS. Novel candidate genes of biological importance for IMF content were also discovered. Our imaging systems developed for prediction of digital IMF content is closer to IMF measured by Soxhlet extraction and slightly more accurate than MS. It can achieve fast and high-throughput IMF phenotype, which can be used in improvement of pork quality.
Collapse
|
210
|
Ablikim M, Achasov M, Adlarson P, Ahmed S, Albrecht M, Aliberti R, Amoroso A, An M, An Q, Bai X, Bai Y, Bakina O, Ferroli RB, Balossino I, Ban Y, Begzsuren K, Berger N, Bertani M, Bettoni D, Bianchi F, Bloms J, Bortone A, Boyko I, Briere R, Cai H, Cai X, Calcaterra A, Cao G, Cao N, Cetin S, Chang J, Chang W, Chelkov G, Chen D, Chen G, Chen H, Chen M, Chen S, Chen X, Chen Y, Chen Z, Cheng W, Cibinetto G, Cossio F, Cui X, Dai H, Dai X, Dbeyssi A, de Boer R, Dedovich D, Deng Z, Denig A, Denysenko I, Destefanis M, De Mori F, Ding Y, Dong C, Dong J, Dong L, Dong M, Dong X, Du S, Fan Y, Fang J, Fang S, Fang Y, Farinelli R, Fava L, Feldbauer F, Felici G, Feng C, Feng J, Fritsch M, Fu C, Gao Y, Gao Y, Gao Y, Gao Y, Garzia I, Ge P, Geng C, Gersabeck E, Gilman A, Goetzen K, Gong L, Gong W, Gradl W, Greco M, Gu L, Gu M, Gu S, Gu Y, Guan C, Guo A, Guo L, Guo R, Guo Y, Guskov A, Han T, Han W, Hao X, Harris F, Hüsken N, He K, Heinsius F, Heinz C, Held T, Heng Y, Herold C, Himmelreich M, Holtmann T, Hou G, Hou Y, Hou Z, Hu H, Hu J, Hu T, Hu Y, Huang G, Huang L, Huang X, Huang Y, Huang Z, Hussain T, Andersson WI, Imoehl W, Irshad M, Jaeger S, Janchiv S, Ji Q, Ji Q, Ji X, Ji X, Ji Y, Jiang H, Jiang X, Jiao J, Jiao Z, Jin S, Jin Y, Jing M, Johansson T, Kalantar-Nayestanaki N, Kang X, Kappert R, Kavatsyuk M, Ke B, Keshk I, Khoukaz A, Kiese P, Kiuchi R, Kliemt R, Koch L, Kolcu O, Kopf B, Kuemmel M, Kuessner M, Kupsc A, Kurth M, Kühn W, Lane J, Lange J, Larin P, Lavania A, Lavezzi L, Lei Z, Leithoff H, Lellmann M, Lenz T, Li C, Li C, Li C, Li D, Li F, Li G, Li H, Li H, Li H, Li H, Li J, Li J, Li J, Li K, Li L, Li L, Li P, Li S, Li W, Li W, Li X, Li X, Li X, Li Z, Liang H, Liang H, Liang H, Liang Y, Liang Y, Liao G, Liao L, Libby J, Lin C, Liu B, Liu C, Liu D, Liu F, Liu F, Liu F, Liu H, Liu H, Liu H, Liu H, Liu J, Liu J, Liu J, Liu K, Liu K, Liu L, Liu M, Liu P, Liu Q, Liu Q, Liu S, Liu S, Liu T, Liu W, Liu X, Liu Y, Liu Y, Liu Z, Liu Z, Lou X, Lu F, Lu H, Lu J, Lu J, Lu X, Lu Y, Lu Y, Luo C, Luo M, Luo P, Luo T, Luo X, Lyu X, Ma F, Ma H, Ma L, Ma M, Ma Q, Ma R, Ma R, Ma X, Ma X, Maas F, Maggiora M, Maldaner S, Malde S, Malik Q, Mangoni A, Mao Y, Mao Z, Marcello S, Meng Z, Messchendorp J, Mezzadri G, Min T, Mitchell R, Mo X, Mo Y, Muchnoi N, Muramatsu H, Nakhoul S, Nefedov Y, Nerling F, Nikolaev I, Ning Z, Nisar S, Olsen S, Ouyang Q, Pacetti S, Pan X, Pan Y, Pathak A, Patteri P, Pelizaeus M, Peng H, Peters K, Pettersson J, Ping J, Ping R, Poling R, Prasad V, Qi H, Qi H, Qi K, Qi M, Qi T, Qian S, Qian W, Qian Z, Qiao C, Qin L, Qin X, Qin X, Qin Z, Qiu J, Qu S, Rashid K, Ravindran K, Redmer C, Rivetti A, Rodin V, Rolo M, Rong G, Rosner C, Rump M, Sang H, Sarantsev A, Schelhaas Y, Schnier C, Schoenning K, Scodeggio M, Shan D, Shan W, Shan X, Shangguan J, Shao M, Shen C, Shen H, Shen P, Shen X, Shi H, Shi R, Shi X, Shi X, Song J, Song W, Song Y, Sosio S, Spataro S, Su K, Su P, Sui F, Sun G, Sun H, Sun J, Sun L, Sun S, Sun T, Sun W, Sun W, Sun X, Sun Y, Sun Y, Sun Y, Sun Z, Tan Y, Tan Y, Tang C, Tang G, Tang J, Teng J, Thoren V, Tian W, Tian Y, Uman I, Wang B, Wang C, Wang D, Wang H, Wang H, Wang K, Wang L, Wang M, Wang M, Wang M, Wang W, Wang W, Wang W, Wang X, Wang X, Wang X, Wang Y, Wang Y, Wang Y, Wang Y, Wang Y, Wang Y, Wang Z, Wang Z, Wang Z, Wang Z, Wei D, Weidner F, Wen S, White D, Wiedner U, Wilkinson G, Wolke M, Wollenberg L, Wu J, Wu L, Wu L, Wu X, Wu Z, Xia L, Xiao H, Xiao S, Xiao Z, Xie X, Xie Y, Xie Y, Xing T, Xu G, Xu Q, Xu W, Xu X, Xu Y, Yan F, Yan L, Yan W, Yan W, Yan X, Yang H, Yang H, Yang L, Yang S, Yang Y, Yang Y, Yang Z, Ye M, Ye M, Yin J, You Z, Yu B, Yu C, Yu G, Yu J, Yu T, Yuan C, Yuan L, Yuan X, Yuan Y, Yuan Z, Yue C, Yuncu A, Zafar A, Zeng X, Zeng Y, Zhang A, Zhang B, Zhang G, Zhang H, Zhang H, Zhang H, Zhang H, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang L, Zhang L, Zhang L, Zhang S, Zhang S, Zhang S, Zhang X, Zhang X, Zhang Y, Zhang Y, Zhang Y, Zhang Y, Zhang Y, Zhang Y, Zhang Z, Zhang Z, Zhao G, Zhao J, Zhao J, Zhao J, Zhao L, Zhao L, Zhao M, Zhao Q, Zhao S, Zhao Y, Zhao Y, Zhao Z, Zhemchugov A, Zheng B, Zheng J, Zheng Y, Zheng Y, Zhong B, Zhong C, Zhou L, Zhou Q, Zhou X, Zhou X, Zhou X, Zhou X, Zhu A, Zhu J, Zhu K, Zhu K, Zhu S, Zhu T, Zhu W, Zhu W, Zhu Y, Zhu Z, Zou B, Zou J. Study of the decay
D+→K*(892)+KS0
in
D+→K+KS0π0. Int J Clin Exp Med 2021. [DOI: 10.1103/physrevd.104.012006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
211
|
Aker M, Altenmüller K, Beglarian A, Behrens J, Berlev A, Besserer U, Bieringer B, Blaum K, Block F, Bornschein B, Bornschein L, Böttcher M, Brunst T, Caldwell T, La Cascio L, Chilingaryan S, Choi W, Díaz Barrero D, Debowski K, Deffert M, Descher M, Doe P, Dragoun O, Drexlin G, Dyba S, Edzards F, Eitel K, Ellinger E, Engel R, Enomoto S, Fedkevych M, Felden A, Formaggio J, Fränkle F, Franklin G, Friedel F, Fulst A, Gauda K, Gil W, Glück F, Grössle R, Gumbsheimer R, Höhn T, Hannen V, Haußmann N, Helbing K, Hickford S, Hiller R, Hillesheimer D, Hinz D, Houdy T, Huber A, Jansen A, Köllenberger L, Karl C, Kellerer J, Kippenbrock L, Klein M, Kopmann A, Korzeczek M, Kovalík A, Krasch B, Krause H, Lasserre T, Le T, Lebeda O, Lehnert B, Lokhov A, Lopez Poyato J, Müller K, Machatschek M, Malcherek E, Mark M, Marsteller A, Martin E, Melzer C, Mertens S, Niemes S, Oelpmann P, Osipowicz A, Parno D, Poon A, Priester F, Röllig M, Röttele C, Rest O, Robertson R, Rodenbeck C, Ryšavý M, Sack R, Saenz A, Schaller (née Pollithy) A, Schäfer P, Schimpf L, Schlösser K, Schlösser M, Schlüter L, Schrank M, Schulz B, Šefčík M, Seitz-Moskaliuk H, Sibille V, Siegmann D, Slezák M, Spanier F, Steidl M, Sturm M, Sun M, Telle H, Thümmler T, Thorne L, Titov N, Tkachev I, Trost N, Vénos D, Valerius K, Vizcaya Hernández A, Wüstling S, Weber M, Weinheimer C, Weiss C, Welte S, Wendel J, Wilkerson J, Wolf J, Xu W, Yen YR, Zadoroghny S, Zeller G. Analysis methods for the first KATRIN neutrino-mass measurement. Int J Clin Exp Med 2021. [DOI: 10.1103/physrevd.104.012005] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
212
|
Chiu K, Hosni A, Huang SH, Tong L, Xu W, Lu L, Bayley A, Bratman S, Cho J, Giuliani M, Kim J, Ringash J, Waldron J, Spreafico A, Irish J, Gilbert R, Gullane P, Goldstein D, O'Sullivan B, Hope A. The Potential Impact and Usability of the Eighth Edition TNM Staging Classification in Oral Cavity Cancer. Clin Oncol (R Coll Radiol) 2021; 33:e442-e449. [PMID: 34261594 DOI: 10.1016/j.clon.2021.05.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2020] [Revised: 04/15/2021] [Accepted: 05/18/2021] [Indexed: 11/29/2022]
Abstract
AIMS In the current eighth edition head and neck TNM staging, extranodal extension (ENE) is an adverse feature in oral cavity squamous cell cancer (OSCC). The previous seventh edition N1 with ENE is now staged as N2a. Seventh edition N2+ with ENE is staged as N3b in the eighth edition. We evaluated its potential impact on patients treated with surgery and postoperative intensity-modulated radiotherapy (IMRT). MATERIALS AND METHODS OSCC patients treated with primary surgery and adjuvant (chemo)radiotherapy between January 2005 and December 2014 were reviewed. Cohorts with pathological node-negative (pN-), pathological node-positive without ENE (pN+_pENE-) and pathological node-positive with ENE (pN+_pENE+) diseases were compared for local control, regional control, distant control and overall survival. The pN+ cohorts were further stratified into seventh edition N-staging subgroups for outcomes comparison. RESULTS In total, 478 patients were evaluated: 173 pN-; 159 pN+_pENE-; 146 pN+_pENE+. Outcomes at 5 years were: local control was identical (78%) in all cohorts (P = 0.892), whereas regional control was 91%, 80% and 68%, respectively (P < 0.001). Distant control was 97%, 87%, 68% (P < 0.001) and overall survival was 75%, 53% and 39% (P < 0.001), respectively. Overall survival for N1 and N2a subgroups was not significantly different. In the seventh edition N2b subgroup of pENE- (n = 79) and pENE+ (n = 79) cohorts, overall survival was 67% and 37%, respectively. In the seventh edition N2c subgroups, overall survival for pENE- (n = 17) and pENE+ (n = 38) cohorts was 65% and 35% (P = 0.08), respectively. Overall, an additional 128 patients (42% pN+) were upstaged as N3b. CONCLUSIONS When eighth edition staging was applied, stage migration across the N2-3 categories resulted in expected larger separations of overall survival by stage. Patients treated with primary radiation without surgical staging should have outcomes carefully monitored. Strategies to predict ENE preoperatively and trials to improve the outcomes of pENE+ patients should be explored.
Collapse
|
213
|
Aguilar M, Cavasonza LA, Alpat B, Ambrosi G, Arruda L, Attig N, Barao F, Barrin L, Bartoloni A, Başeğmez-du Pree S, Battiston R, Behlmann M, Beranek B, Berdugo J, Bertucci B, Bindi V, Bollweg K, Borgia B, Boschini MJ, Bourquin M, Bueno EF, Burger J, Burger WJ, Burmeister S, Cai XD, Capell M, Casaus J, Castellini G, Cervelli F, Chang YH, Chen GM, Chen GR, Chen HS, Chen Y, Cheng L, Chou HY, Chouridou S, Choutko V, Chung CH, Clark C, Coignet G, Consolandi C, Contin A, Corti C, Cui Z, Dadzie K, Delgado C, Della Torre S, Demirköz MB, Derome L, Di Falco S, Di Felice V, Díaz C, Dimiccoli F, von Doetinchem P, Dong F, Donnini F, Duranti M, Egorov A, Eline A, Feng J, Fiandrini E, Fisher P, Formato V, Freeman C, Gámez C, García-López RJ, Gargiulo C, Gast H, Gervasi M, Giovacchini F, Gómez-Coral DM, Gong J, Goy C, Grabski V, Grandi D, Graziani M, Haino S, Han KC, Hashmani RK, He ZH, Heber B, Hsieh TH, Hu JY, Incagli M, Jang WY, Jia Y, Jinchi H, Khiali B, Kim GN, Kirn T, Konyushikhin M, Kounina O, Kounine A, Koutsenko V, Krasnopevtsev D, Kuhlman A, Kulemzin A, La Vacca G, Laudi E, Laurenti G, Lazzizzera I, Lebedev A, Lee HT, Lee SC, Li JQ, Li M, Li Q, Li S, Li JH, Li ZH, Liang J, Light C, Lin CH, Lippert T, Liu JH, Liu Z, Lu SQ, Lu YS, Luebelsmeyer K, Luo JZ, Luo X, Machate F, Mañá C, Marín J, Marquardt J, Martin T, Martínez G, Masi N, Maurin D, Medvedeva T, Menchaca-Rocha A, Meng Q, Mikhailov VV, Molero M, Mott P, Mussolin L, Negrete J, Nikonov N, Nozzoli F, Oliva A, Orcinha M, Palermo M, Palmonari F, Paniccia M, Pashnin A, Pauluzzi M, Pensotti S, Phan HD, Plyaskin V, Pohl M, Poluianov S, Qin X, Qu ZY, Quadrani L, Rancoita PG, Rapin D, Conde AR, Robyn E, Rosier-Lees S, Rozhkov A, Rozza D, Sagdeev R, Schael S, von Dratzig AS, Schwering G, Seo ES, Shakfa Z, Shan BS, Siedenburg T, Solano C, Song JW, Song XJ, Sonnabend R, Strigari L, Su T, Sun Q, Sun ZT, Tacconi M, Tang XW, Tang ZC, Tian J, Ting SCC, Ting SM, Tomassetti N, Torsti J, Tüysüz C, Urban T, Usoskin I, Vagelli V, Vainio R, Valencia-Otero M, Valente E, Valtonen E, Vázquez Acosta M, Vecchi M, Velasco M, Vialle JP, Wang CX, Wang L, Wang LQ, Wang NH, Wang QL, Wang S, Wang X, Wang Y, Wang ZM, Wei J, Weng ZL, Wu H, Xiong RQ, Xu W, Yan Q, Yang Y, Yashin II, Yi H, Yu YM, Yu ZQ, Zannoni M, Zhang C, Zhang F, Zhang FZ, Zhang JH, Zhang Z, Zhao F, Zheng C, Zheng ZM, Zhuang HL, Zhukov V, Zichichi A, Zuccon P. Properties of a New Group of Cosmic Nuclei: Results from the Alpha Magnetic Spectrometer on Sodium, Aluminum, and Nitrogen. PHYSICAL REVIEW LETTERS 2021; 127:021101. [PMID: 34296911 DOI: 10.1103/physrevlett.127.021101] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/03/2021] [Revised: 04/30/2021] [Accepted: 06/01/2021] [Indexed: 06/13/2023]
Abstract
We report the properties of sodium (Na) and aluminum (Al) cosmic rays in the rigidity range 2.15 GV to 3.0 TV based on 0.46 million sodium and 0.51 million aluminum nuclei collected by the Alpha Magnetic Spectrometer experiment on the International Space Station. We found that Na and Al, together with nitrogen (N), belong to a distinct cosmic ray group. In this group, we observe that, similar to the N flux, both the Na flux and Al flux are well described by the sums of a primary cosmic ray component (proportional to the silicon flux) and a secondary cosmic ray component (proportional to the fluorine flux). The fraction of the primary component increases with rigidity for the N, Na, and Al fluxes and becomes dominant at the highest rigidities. The Na/Si and Al/Si abundance ratios at the source, 0.036±0.003 for Na/Si and 0.103±0.004 for Al/Si, are determined independent of cosmic ray propagation.
Collapse
|
214
|
Ablikim M, Achasov M, Adlarson P, Ahmed S, Albrecht M, Aliberti R, Amoroso A, An M, An Q, Bai X, Bai Y, Bakina O, Baldini Ferroli R, Balossino I, Ban Y, Begzsuren K, Berger N, Bertani M, Bettoni D, Bianchi F, Bloms J, Bortone A, Boyko I, Briere R, Cai H, Cai X, Calcaterra A, Cao G, Cao N, Cetin S, Chang J, Chang W, Chelkov G, Chen D, Chen G, Chen H, Chen M, Chen S, Chen X, Chen Y, Chen Z, Cheng W, Cibinetto G, Cossio F, Cui X, Dai H, Dai X, Dbeyssi A, de Boer R, Dedovich D, Deng Z, Denig A, Denysenko I, Destefanis M, De Mori F, Ding Y, Dong C, Dong J, Dong L, Dong M, Dong X, Du S, Fan Y, Fang J, Fang S, Fang Y, Farinelli R, Fava L, Feldbauer F, Felici G, Feng C, Feng J, Fritsch M, Fu C, Gao Y, Gao Y, Gao Y, Gao Y, Garzia I, Ge P, Geng C, Gersabeck E, Gilman A, Goetzen K, Gong L, Gong W, Gradl W, Greco M, Gu L, Gu M, Gu Y, Guan C, Guo A, Guo L, Guo R, Guo Y, Guskov A, Han T, Han W, Hao X, Harris F, He K, Heinsius F, Heinz C, Held T, Heng Y, Herold C, Himmelreich M, Holtmann T, Hou G, Hou Y, Hou Z, Hu H, Hu J, Hu T, Hu Y, Huang G, Huang L, Huang X, Huang Y, Huang Z, Hussain T, Hüsken N, Ikegami Andersson W, Imoehl W, Irshad M, Jaeger S, Janchiv S, Ji Q, Ji Q, Ji X, Ji X, Ji Y, Jiang H, Jiang X, Jiao J, Jiao Z, Jin S, Jin Y, Jing M, Johansson T, Kalantar-Nayestanaki N, Kang X, Kappert R, Kavatsyuk M, Ke B, Keshk I, Khoukaz A, Kiese P, Kiuchi R, Kliemt R, Koch L, Kolcu O, Kopf B, Kuemmel M, Kuessner M, Kupsc A, Kurth M, Kühn W, Lane J, Lange J, Larin P, Lavania A, Lavezzi L, Lei Z, Leithoff H, Lellmann M, Lenz T, Li C, Li C, Li C, Li D, Li F, Li G, Li H, Li H, Li H, Li H, Li J, Li J, Li J, Li K, Li L, Li L, Li P, Li S, Li W, Li W, Li X, Li X, Li X, Li Z, Liang H, Liang H, Liang H, Liang Y, Liang Y, Liao G, Liao L, Libby J, Lin C, Liu B, Liu C, Liu D, Liu F, Liu F, Liu F, Liu H, Liu H, Liu H, Liu H, Liu J, Liu J, Liu J, Liu K, Liu K, Liu L, Liu M, Liu P, Liu Q, Liu Q, Liu S, Liu S, Liu T, Liu W, Liu X, Liu Y, Liu Y, Liu Z, Liu Z, Lou X, Lu F, Lu H, Lu J, Lu J, Lu X, Lu Y, Lu Y, Luo C, Luo M, Luo P, Luo T, Luo X, Lyu X, Ma F, Ma H, Ma L, Ma M, Ma Q, Ma R, Ma R, Ma X, Ma X, Maas F, Maggiora M, Maldaner S, Malde S, Malik Q, Mangoni A, Mao Y, Mao Z, Marcello S, Meng Z, Messchendorp J, Mezzadri G, Min T, Mitchell R, Mo X, Mo Y, Muchnoi N, Muramatsu H, Nakhoul S, Nefedov Y, Nerling F, Nikolaev I, Ning Z, Nisar S, Ouyang Q, Pacetti S, Pan X, Pan Y, Pathak A, Pathak A, Patteri P, Pelizaeus M, Peng H, Peters K, Pettersson J, Ping J, Ping R, Pogodin S, Poling R, Prasad V, Qi H, Qi H, Qi K, Qi M, Qi T, Qian S, Qian W, Qian Z, Qiao C, Qin L, Qin X, Qin X, Qin Z, Qiu J, Qu S, Rashid K, Ravindran K, Redmer C, Rivetti A, Rodin V, Rolo M, Rong G, Rosner C, Rump M, Sang H, Sarantsev A, Schelhaas Y, Schnier C, Schoenning K, Scodeggio M, Shan D, Shan W, Shan X, Shangguan J, Shao M, Shen C, Shen H, Shen P, Shen X, Shi H, Shi R, Shi X, Shi X, Song J, Song W, Song Y, Sosio S, Spataro S, Su K, Su P, Sui F, Sun G, Sun H, Sun J, Sun L, Sun S, Sun T, Sun W, Sun W, Sun X, Sun Y, Sun Y, Sun Y, Sun Z, Tan Y, Tan Y, Tang C, Tang G, Tang J, Teng J, Thoren V, Tian W, Tian Y, Uman I, Wang B, Wang C, Wang D, Wang H, Wang H, Wang K, Wang L, Wang M, Wang M, Wang M, Wang W, Wang W, Wang W, Wang X, Wang X, Wang X, Wang Y, Wang Y, Wang Y, Wang Y, Wang Y, Wang Y, Wang Z, Wang Z, Wang Z, Wang Z, Wei D, Weidner F, Wen S, White D, Wiedner U, Wilkinson G, Wolke M, Wollenberg L, Wu J, Wu L, Wu L, Wu X, Wu Z, Xia L, Xiao H, Xiao S, Xiao Z, Xie X, Xie Y, Xie Y, Xing T, Xu G, Xu Q, Xu W, Xu X, Xu Y, Yan F, Yan L, Yan W, Yan W, Yan X, Yang H, Yang H, Yang L, Yang S, Yang Y, Yang Y, Yang Z, Ye M, Ye M, Yin J, You Z, Yu B, Yu C, Yu G, Yu J, Yu T, Yuan C, Yuan L, Yuan X, Yuan Y, Yuan Z, Yue C, Zafar A, Zeng XZ, Zeng Y, Zhang A, Zhang B, Zhang G, Zhang H, Zhang H, Zhang H, Zhang H, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang L, Zhang L, Zhang L, Zhang S, Zhang S, Zhang S, Zhang X, Zhang X, Zhang Y, Zhang Y, Zhang Y, Zhang Y, Zhang Y, Zhang Z, Zhang Z, Zhao G, Zhao J, Zhao J, Zhao J, Zhao L, Zhao L, Zhao M, Zhao Q, Zhao S, Zhao Y, Zhao Y, Zhao Z, Zhemchugov A, Zheng B, Zheng J, Zheng Y, Zheng Y, Zhong B, Zhong C, Zhou L, Zhou Q, Zhou X, Zhou X, Zhou X, Zhou X, Zhu A, Zhu J, Zhu K, Zhu K, Zhu S, Zhu T, Zhu W, Zhu W, Zhu Y, Zhu Z, Zou B, Zou J. Measurement of the absolute branching fraction of inclusive semielectronic
Ds+
decays. Int J Clin Exp Med 2021. [DOI: 10.1103/physrevd.104.012003] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
215
|
Yang J, Wang H, Xu W, Chen Z, Yan ZY, Zhang LJ. Inhibition of miR-133b indicates poor prognosis and promotes progression of OSCC via SOX4. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2021; 24:12717-12726. [PMID: 33378019 DOI: 10.26355/eurrev_202012_24170] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Oral squamous cell carcinoma (OSCC) accounts for the first largest proportion of oral and maxillofacial malignancies worldwide. Increasing studies have indicated that miRNAs are involved in the regulation of various tumors, including OSCC. However, the exact role of miR-133b in OSCC has not been fully elucidated. Here, we aimed to explore the effects of miR-133b on the development and progression of OSCC and its related mechanisms. PATIENTS AND METHODS Expression of miR-133b in 44 paired OSCC tissues and adjacent normal tissues were detected using quantitative real-time polymerase chain reaction (qRT-PCR). Clinicopathological characteristics were collected from OSCC patients, and the relationship between miR-133b expression and the prognosis of patients was analyzed. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) and colony formation assays were employed to measure the proliferation of OSCC cells transfected with miR-133b inhibitors or mimics. Cell invasion and migration were detected using transwell and Matrigel experiments, respectively. Bioinformatics and Western blot were applied to investigate the possible underlying mechanism of miR-133b in OSCC. RESULTS MiR-133b was lowly expressed in OSCC tissues compared to adjacent normal tissues (p<0.05). Lower expression miR-133b indicated a significantly worse prognosis of OSCC patients (p<0.05). Over-expression of miR-133b reduced the growth and metastasis of SCC9 cells (p<0.05). Transfection of miR-133b inhibitors obviously enhanced the proliferation, migration and invasion of TSC-15 cells (p<0.05). SRY-Box Transcription Factor 4 (SOX4) was verified as a specific target for miR-133b. Up- or down-regulation of miR-133b decreased or increased the protein expression level of SOX4 in OSCC, respectively (p<0.05). CONCLUSIONS MiR-133b was lowly expressed in OSCC tissues and cell lines. Down-regulation of miR-133b reduced the proliferation, invasion and migration of OSCC cells via regulating SOX4. All our findings suggested that miR-133b could be used as a potential target for the treatment of OSCC.
Collapse
|
216
|
Chen Z, Huang Q, Xu W, Wang H, Yang J, Zhang LJ. PRKD3 promotes malignant progression of OSCC by downregulating KLF16 expression. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2021; 24:12709-12716. [PMID: 33378018 DOI: 10.26355/eurrev_202012_24169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE We aimed to clarify the molecular mechanism of how PRKD3 promotes the malignant progression of oral squamous cell carcinoma (OSCC). PATIENTS AND METHODS 62 cases of OSCC tissues and normal adjacent ones which were further confirmed by a qualified pathologist were collected from patients in the Department of Pathology and Stomatology of our hospital. PRKD3 expression in the above tissue samples was studied by quantitative real-time polymerase chain reaction (qRT-PCR) analysis, and its relationship with clinicopathological characteristics of these OSCC patients was analyzed. Meanwhile, a PRKD3 knockdown expression model was constructed in OSCC cell lines for cell functional experiments. The relationship between PRKD3 and KLF16 was elucidated through bioinformatics and Luciferase reporter gene experiments. RESULTS Our data showed that PRKD3 expression in OSCC specimens was remarkably higher than that in adjacent ones. PRKD3 expression showed positive association with the incidence of distant metastasis, but not with other clinical indicators such as gender, age, tumor stage or lymph node metastasis incidence. Patients with high PRKD3 expression had lower overall survival compared to those with low expression. In addition, OSCC cells migration ability and invasiveness were remarkably attenuated after PRKD3 was knocked down. Bioinformatics and Luciferase assay revealed that PRKD3 could directly bind to KLF16 and Western blot suggested that KLF16 was upregulated after PRKD3 was knocked down. In addition, knocking down KLF16 reversed the inhibitory effect of PRKD3 knockdown on invasiveness and metastasis of OSCC cells. CONCLUSIONS The highly-expressed PRKD3, remarkably associated with metastasis incidence and poor prognosis of OSCC patients, may accelerate the malignant progression of OSCC through modulating KLF16 expression.
Collapse
|
217
|
Xu W, Song Y, Wang T, Yang S, Liu L, Hu Y, Zhang W, Zhou J, Gao S, Ding K, Zhang H, Zhu Z, Wang S, Xu B, Hu J, Liu T, Ji C, Xia Z, Li Y, Wang X, Zhao R, Zhang B, Li J. UPDATED EFFICACY AND SAFETY RESULTS OF ORELABRUTINIB IN THE TREATMENT OF RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL CELL LEUKEMIA. Hematol Oncol 2021. [DOI: 10.1002/hon.43_2880] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
218
|
Huang H, Gao Y, Wang X, Bai B, Zhang L, Xiao Y, Liu X, Li W, Cai Q, Li Z, Chen Y, Xu W, Feng R, Wu H, Li J, Wu X. SINTILIMAB PLUS CHIDAMIDE FOR RELAPSED/REFRACTORY (R/R) EXTRANODAL NK/T CELL LYMPHOMA (ENKTL): A PROSPECTIVE, MULTICENTER, SINGLE‐ARM, PHASE IB/II TRIAL (SCENT). Hematol Oncol 2021. [DOI: 10.1002/hon.127_2880] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
219
|
Wang XT, Wang ZT, Hu HY, Qu Y, Wang M, Shen XN, Xu W, Dong Q, Tan L, Yu JT. Association of Subjective Cognitive Decline with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Longitudinal Studies. JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE 2021; 8:277-285. [PMID: 34101784 DOI: 10.14283/jpad.2021.27] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
BACKGROUND Subjective cognitive decline (SCD) as an early pathological manifestation of brain aging has become more prevalent among older adults. OBJECTIVES We aimed to investigate the associations of subjective cognitive decline (SCD) with the combined risk of cognitive impairment and dementia. DESIGN We performed a systematic review and meta-analysis via searching Embase, PubMed and Cochrane electronic databases from January 1 st 1970 to June 4th, 2020. SETTING Prospective cohort studies Participants: Healthy individuals were recruited from community, clinics and population. MEASUREMENTS Healthy individuals with SCD were classified into exposure groups, while those without were considered as the reference group. Adjusted relative risks (RR) were estimated in a random-effects model. Both primary and subgroup analyses were conducted. RESULTS Of 28,895 identified studies, 21 studies containing 22 cohorts were eligible for inclusion in the meta-analysis. SCD increased the risk of subsequent cognitive disorders (RR=2.12, 95% confidence intervals [CI] =1.75-2.58, I2=87%, P<0.01). To be specific, SCD conferred a 2.29-fold excess risk for cognitive impairment (RR=2.29, 95% CI=1.66-3.17, I2=83%, P<0.01) and a 2.16-fold excess risk for dementia (RR=2.16, 95% CI=1.63-2.86, I2=81%, P<0.01). In subgroup analyses, participants with SCD in the subgroup of 65-75 years old, long-education (>15 years) subgroup and subgroup of clinics showed a higher risk of developing objective cognitive disorders. CONCLUSIONS SCD is associated with an increased combined risk of cognitive impairment and incident dementia and should be considered a risk factor for objective cognitive disorders.
Collapse
|
220
|
Brunner PM, Conrad C, Vender R, Grond S, Schuster C, Patel H, Xu W, Carrascosa Carrillo JM. Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab. Br J Dermatol 2021; 185:865-867. [PMID: 34076896 PMCID: PMC8518506 DOI: 10.1111/bjd.20527] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2021] [Revised: 04/06/2021] [Accepted: 05/30/2021] [Indexed: 01/18/2023]
|
221
|
Zhu H, Sha Y, Wu W, Chen R, Yang Y, Qiu J, Mi H, Peng C, Ding C, Wang Z, Fan L, Xu W, Li J. ZANUBRUTINIB, LENALIDOMIDE PLUS R‐CHOP (ZR
2
‐CHOP) AS THE TREATMENT FOR DIFFUSED LARGE B‐CELL LYMPHOMA (DLBCL). Hematol Oncol 2021. [DOI: 10.1002/hon.49_2881] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
222
|
Ali O, Wang L, Xu W, Falleroni D, Falloon J, Illei G. OP0120 DURATION OF CLINICAL EFFICACY FOLLOWING TREATMENT WITH VIB4920 IN SUBJECTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.2544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:VIB4920 binds CD40 ligand and functionally neutralizes its engagement with CD401. We reported results through Day 85 of a Phase 1b, randomized, double-blind, placebo-controlled study (NCT02780388) in subjects with moderate to severe rheumatoid arthritis (RA) who had an inadequate response to methotrexate (MTX) or other disease modifying anti-rheumatic drugs (DMARDs) or tumor necrosis factor (TNF)-inhibitors1. We showed that at the end of the 12-week treatment period (Day 85), subjects treated with 1000 or 1500 mg VIB4920 (once every 2 weeks) had a clinically meaningful and statistically significant greater reduction in disease activity compared to placebo.Objectives:To assess the duration of clinical efficacy following the last dose of VIB4920 in subjects with moderate to severe RA.Methods:Subjects in the Phase 1b study (Ph1b) continued to have monthly safety and efficacy assessments between Days 85 and 169, the end of a 12-week follow-up. To estimate the subsequent duration of meaningful clinical improvement, we conducted an observational one-visit study (OS) (EudraCT 2019-002351-42) with the primary endpoint of time from last dose of VIB4920 to start of a new DMARD or biologic therapy or increase in dose of DMARD that was ongoing at Day 169 (ie, rescue therapy).Results:At Day 169 of the Ph1b (3 months after the last dose), clinical responses achieved at Day 85 were maintained in the 1000 and 1500 mg cohorts (Figure). Of 24 subjects, 16 (6/12 treated with 1000 mg and 10/12 with 1500 mg) participated in the OS. The median (range) time from Day 169 (last visit) in the Ph1b to the OS was 21.8 (21.2 to 23.1) months in the 1000 mg group and 33.7 (32.3 to 34.8) months in the 1500 mg group. All subjects had taken DMARDs (primarily methotrexate [MTX]) for at least part of this time (Table). Rescue therapy was started in 1/6 (16.7%) subject in the 1000 mg group and 3/10 (30.0%) subjects in the 1500 mg group (Table); median time to rescue could not be estimated due to the limited number of rescues. Two subjects were on no DMARDs at the OS. All subjects, except for 1 in the 1000 mg group, who was rescued with adalimumab, and 2 in the 1500 mg group (no rescue), had active disease (DAS28-CRP ≥ 2.6) at the OS. The median DAS28-CRP at the OS was higher than at Day 169 of the Ph1b but lower than at the Ph1b baseline visit (Table). Two subjects who received 1500 mg and met DAS28-CRP criteria for low disease activity (< 3.2) at Day 169 also met these criteria at the OS without receiving any rescue therapy after a median of nearly 37 months after last treatment. Results from the Patient and Physician Global Assessment VAS showed trends similar to the DAS28-CRP.Conclusion:Blocking CD40L with VIB4920 led to prolonged clinical benefit in patients with RA when added to stable background DMARD therapy. The exact duration of benefit could not be defined in this study, but most patients did not require rescue therapy during a prolonged follow-up period, and some patients maintained low disease activity or discontinued DMARDs, suggesting a possible long-term benefit of VIB4920. Interpretation of these data is limited because the OS did not include placebo-treated subjects from the Ph1b. The duration of clinical response needs to be confirmed in prospective, double-blind, placebo-controlled studies.References:[1]Karnell JL et al. Sci Transl Med. 2019 Apr 24;11(489).Summary of ResultsVIB4920 1000 mg N = 6VIB4920 1500 mg N = 10Subjects who received ≥ 1 DMARD at any time between Day 169 of Ph1b and OS6 (100%)10 (100%)Hydroxychloroquine (HCQ)1 (16.7%)0MTX5 (83.3%)9 (90.0%)Leflunomide1 (16.7%)2 (20.0%)Adalimumab1 (16.7%)0Etanercept01 (10.0%)Rescue therapyHCQ, Adalimumab1 (16.7%)0MTX02 (20%)MTX, Leflunomide, Etanercept01 (10%)DAS28-CRP [median (min, max)]Ph1b Baseline5.4 (4.7 – 6.3)4.7 (4.3 - 5.7)Ph1b Day 1692.9 (1.1 – 4.2)2.3 (1.1 - 3.4)OS3.7 (1.1 – 5.5)3.9 (2.3 – 5.6)Acknowledgements:The authors thank the study participants and investigators.Disclosure of Interests:Omar Ali Shareholder of: I own shares of Viela Bio., Employee of: I am an employee of Viela Bio., Liangwei Wang Shareholder of: I own shares of Viela Bio., Employee of: I am an employee of Viela Bio., Wenjing Xu Shareholder of: I own shares of Viela Bio., Employee of: I am an employee of Viela Bio., Dan Falleroni Shareholder of: I own shares of Viela Bio., Employee of: I am an employee of Viela Bio., Judith Falloon Shareholder of: I own shares of Viela Bio., Employee of: I am an employee of Viela Bio., Gabor Illei Shareholder of: I own shares of Viela Bio., Employee of: I am an employee of Viela Bio.
Collapse
|
223
|
Sesin C, Gallo G, Gellett A, Kronbergs A, Sprabery AT, Xu W, Patel H, Deodhar A, Combe B, Burmester GR. POS1033 SAFETY OF IXEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS: AN INTEGRATED ANALYSIS OF 4 CLINICAL TRIALS. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.567] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Patients with psoriatic arthritis (PsA) require long-term treatment, which may lead to adverse events (AEs). Ixekizumab, an interleukin-17A antagonist, is approved for the treatment of adults with active PsA.Objectives:We report a summary of safety outcomes for patients enrolled in 4 PsA studies with up to 3 years of exposure to ixekizumab.Methods:This integrated safety analysis included all patients with PsA who received at least 1 dose of ixekizumab (80 mg every 2 or 4 weeks) in 4 clinical trials (NCT01695239, NCT02349295, NCT02584855, NCT03151551). Safety outcomes included treatment-emergent adverse events (TEAEs), serious AEs (SAEs), discontinuations due to AEs, deaths, and AEs of special interest.Results:A total of 1401 patients were included in this safety analysis (51.5% female; mean age 49 years), with 2247.6 patient-years of exposure (Table 1). In all, 1131 patients (80.7%) reported ≥1 TEAE (exposure-adjusted incidence rate per 100 patient-years [IR] 50.3, 95% CI 47.5–53.3), mostly mild (32.9%) or moderate (39.7%) in severity. The most common TEAEs were nasopharyngitis (n=202, IR 9.0), upper respiratory infections (n=186, IR 8.3), and injection site reaction (n=156, IR 6.9). SAEs were reported by 134 patients (IR 6.0, 95% CI 5.0–7.1). 115 (8.2%) patients discontinued due to AEs (IR 5.1, 95% CI 4.3–6.1). Six deaths were reported (IR 0.3, 95% CI 0.1–0.6). Allergic reactions/hypersensitivity were reported in 102 patients (IR 4.5, 95% CI 3.7–5.5). Three cases were adjudicated as de novo inflammatory bowel disease (IR 0.13, 95% CI 0.04–0.41); 1 was ulcerative colitis (IR 0.04, 95% CI 0.01–0.32), 2 were Crohn’s disease (IR 0.09, 95% CI 0.02–0.36). Major adverse cardiac events occurred in 12 patients (IR 0.5) and malignancies in 15 (IR 0.7), 9 of which were non-melanoma skin cancer. Opportunistic infections occurred in 40 (2.9%) patients (IR 1.8, 95% CI 1.3–2.4). Candidiasis occurred in 24 patients (oral: IR 0.7, 95% CI 0.4–1.2; oral fungal infection: IR 0.3, 95% CI 0.1–0.6; esophageal infection: IR 0.1, 95% CI 0.0–0.4). No active or reactive cases of tuberculosis were reported. Other opportunistic infections included hepatitis B (IR 0.0, 95% CI 0.0–0.3), herpes simplex (IR 1.8, 95% CI 1.3–2.5), and herpes zoster (IR 0.7, 95% CI 0.4–1.2).Conclusion:The safety profile of ixekizumab across 4 clinical trials and up to 3 years of continuous treatment in patients with active PsA was consistent with the known safety profile reported in previous studies for psoriasis and PsA. No new safety events were found in this analysis.Pooled Ixekizumab(N=1401; Total Patient-Years=2247.6)n (IR)95% CIYear 0–1(n=1401)n (IR)95% CIYear 1–2(n=946)n (IR)95% CIYear 2–3(n=510)n (IR)95% CIYear ≥3(n=89)n (IR)95% CITotal Patient-Years2247.71207.3689.8347.72.9Patients with ≥1 TEAE1131 (50.3)1050 (87.0)496 (71.9)234 (67.3)6 (206.2)47.5–53.381.9–92.465.9–78.559.2–76.592.6–458.9SAEs134 (6.0)72 (6.0)53 (7.7)19 (5.5)1 (34.4)5.0–7.14.7–7.55.9–10.13.5–8.64.8–243.9Discontinuations due to AEs115 (5.1)61 (5.1)37 (5.4)17 (4.9)0 (0)4.3–6.13.9–6.53.9–7.43.0–7.90.0–274.7Hepatic reactions112 (5.0)80 (6.6)32 (4.6)14 (4.0)0 (0)4.1–6.05.3–8.33.3–6.62.4–6.80.0–274.7Allergic reaction/hypersensitivity102 (4.5)83 (6.9)23 (3.3)5 (1.4)0 (0)3.7–5.55.5–8.52.2–5.00.6–3.50.0–274.7Serious infection28 (1.2)18 (1.5)9 (1.3)3 (0.9)0 (0)0.9–1.80.9–2.40.7–2.50.3–2.70.0–274.7Malignancies15 (0.7)4 (0.3)8 (1.2)4 (1.2)0 (0)0.4–1.10.1–0.90.6–2.30.4–3.10.0–274.7Major adverse cardiac events12 (0.5)3 (0.2)8 (1.2)1 (0.3)0 (0)0.3–0.90.1–0.80.6–2.30.0–2.00.0–274.7Inflammatory bowel disease3 (0.1)3 (0.2)1 (0.1)0 (0.0)0 (0.0)0.0–0.40.1–0.80.0–1.00.0–2.30.0–274.7 Ulcerative colitis1 (0.0)1 (0.1)1 (0.1)0 (0.0)0 (0.0)0.0–0.30.0–0.60.0–1.00.0–2.30.0–274.7 Crohn’s disease2 (0.1)2 (0.2)0 (0.0)0 (0.0)0 (0.0)0.0–0.40.0–0.70.0–1.20.0–2.30.0–274.7AE, adverse event; CI, confidence interval; IR, exposure-adjusted incidence rate per 100 patient-years; SAE, serious adverse event; TEAE, treatment-emergent adverse event.Disclosure of Interests:Carlos Sesin Speakers bureau: Amgen, AbbVie, Sanofi, Radius, Pfizer, Eli Lilly and Company, Novartis, Gaia Gallo Shareholder of: Eli Lilly and Company, Employee of: Eli Lilly and Company, Amanda Gellett Shareholder of: Eli Lilly and Company, Employee of: Eli Lilly and Company, Andris Kronbergs Shareholder of: Eli Lilly and Company, Employee of: Eli Lilly and Company, Aubrey Trevelin Sprabery Shareholder of: Eli Lilly and Company, Employee of: Eli Lilly and Company, Wen Xu Shareholder of: Eli Lilly and Company, Employee of: Eli Lilly and Company, Himanshu Patel Shareholder of: Eli Lilly and Company, Employee of: Eli Lilly and Company, Atul Deodhar Consultant of: AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli Lilly and Company, Galapagos, Glaxo Smith & Kline, Janssen, Novartis, Pfizer, UCB, Grant/research support from: AbbVie, Eli Lilly and Company, Glaxo Smith & Kline, Novartis, Pfizer, UCB, Bernard Combe Speakers bureau: AbbVie, BMS, Gilead-Galapagos, Eli Lilly and Company, MSD, Pfizer, Roche Chugai, Consultant of: AbbVie, Bayer, Gilead-Galapagos, Janssen, Eli Lilly and Company, Novartis, Roche Chugai, Grant/research support from: AbbVie, Eli Lilly and Company, Pfizer, Roche Chugai, Gerd Rüdiger Burmester Speakers bureau: AbbVie, Janssen, Novartis, Eli Lilly and Company, MSD, Pfizer, Consultant of: AbbVie, Janssen, Novartis, Eli Lilly and Company, MSD, Pfizer.
Collapse
|
224
|
Zhu W, Su Z, Xu W, Sun HX, Gao JF, Tu DF, Ren CH, Zhang ZJ, Cao HG. Garlic skin induces shifts in the rumen microbiome and metabolome of fattening lambs. Animal 2021; 15:100216. [PMID: 34051409 DOI: 10.1016/j.animal.2021.100216] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Revised: 02/25/2021] [Accepted: 02/26/2021] [Indexed: 12/16/2022] Open
Abstract
Garlic (Allium sativum L.) and its constituents have been shown to modify rumen fermentation and improve growth performance. Garlic skin, a by-product of garlic processing, contains similar bioactive components as garlic bulb. This study aimed to investigate the effects of garlic skin supplementation on growth performance, ruminal microbes, and metabolites in ruminants. Twelve Hu lambs were randomly assigned to receive a basal diet (CON) or a basal diet supplemented with 80 g/kg DM of garlic skin (GAS). The experiment lasted for 10 weeks, with the first 2 weeks serving as the adaptation period. The results revealed that the average daily gain and volatile fatty acid concentration were higher (P < 0.05) in lambs fed GAS than those in the CON group. Garlic skin supplementation did not significantly (P > 0.10) affect the α-diversity indices, including the Chao1 index, the abundance-based coverage estimator value, and the Shannon and Simpson indices. At the genus level, garlic skin supplementation altered the ruminal bacterial composition by increasing (P < 0.05) the relative abundances of Prevotella, Bulleidia, Howardella, and Methanosphaera and decreasing (P < 0.05) the abundance of Fretibacterium. Concentrations of 139 metabolites significantly differed (P < 0.05) between the GAS and the CON groups. Among them, substrates for rumen microbial protein synthesis were enriched in the GAS group. The pathways of pyrimidine metabolism, purine metabolism, and vitamin B6 metabolism were influenced (P < 0.05) by garlic skin supplementation. Integrated correlation analysis also provided a link between the significantly altered rumen microbiota and metabolites. Thus, supplementation of garlic skin improved the growth performance of lambs by modifying rumen fermentation through shifts in the rumen microbiome and metabolome.
Collapse
|
225
|
Ablikim M, Achasov M, Adlarson P, Ahmed S, Albrecht M, Aliberti R, Amoroso A, An M, An Q, Bai X, Bai Y, Bakina O, Ferroli RB, Balossino I, Ban Y, Begzsuren K, Berger N, Bertani M, Bettoni D, Bianchi F, Bloms J, Bortone A, Boyko I, Briere R, Cai H, Cai X, Calcaterra A, Cao G, Cao N, Cetin S, Chang J, Chang W, Chelkov G, Chen D, Chen G, Chen H, Chen M, Chen S, Chen X, Chen Y, Chen Z, Cheng W, Cibinetto G, Cossio F, Cui X, Dai H, Dai X, Dbeyssi A, de Boer R, Dedovich D, Deng Z, Denig A, Denysenko I, Destefanis M, De Mori F, Ding Y, Dong C, Dong J, Dong L, Dong M, Dong X, Du S, Fan Y, Fang J, Fang S, Fang Y, Farinelli R, Fava L, Feldbauer F, Felici G, Feng C, Feng J, Fritsch M, Fu C, Gao Y, Gao Y, Gao Y, Gao Y, Garzia I, Ge P, Geng C, Gersabeck E, Gilman A, Goetzen K, Gong L, Gong W, Gradl W, Greco M, Gu L, Gu M, Gu S, Gu Y, Guan C, Guo A, Guo L, Guo R, Guo Y, Guskov A, Han T, Han W, Hao X, Harris F, He K, Heinsius F, Heinz C, Held T, Heng Y, Herold C, Himmelreich M, Holtmann T, Hou G, Hou Y, Hou Z, Hu H, Hu J, Hu T, Hu Y, Huang G, Huang L, Huang X, Huang Y, Huang Z, Hussain T, Hüsken N, Andersson WI, Imoehl W, Irshad M, Jaeger S, Janchiv S, Ji Q, Ji Q, Ji X, Ji X, Ji Y, Jiang H, Jiang X, Jiao J, Jiao Z, Jin S, Jin Y, Jing M, Johansson T, Kalantar-Nayestanaki N, Kang X, Kappert R, Kavatsyuk M, Ke B, Keshk I, Khoukaz A, Kiese P, Kiuchi R, Kliemt R, Koch L, Kolcu O, Kopf B, Kuemmel M, Kuessner M, Kupsc A, Kurth M, Kühn W, Lane J, Lange J, Larin P, Lavania A, Lavezzi L, Lei Z, Leithoff H, Lellmann M, Lenz T, Li C, Li C, Li C, Li D, Li F, Li G, Li H, Li H, Li H, Li H, Li J, Li J, Li J, Li K, Li L, Li L, Li P, Li S, Li W, Li W, Li X, Li X, Li X, Li Z, Liang H, Liang H, Liang H, Liang Y, Liang Y, Liao G, Liao L, Libby J, Lin C, Liu B, Liu C, Liu D, Liu F, Liu F, Liu F, Liu H, Liu H, Liu H, Liu H, Liu J, Liu J, Liu J, Liu K, Liu K, Liu L, Liu M, Liu P, Liu Q, Liu Q, Liu S, Liu S, Liu T, Liu W, Liu X, Liu Y, Liu Y, Liu Z, Liu Z, Lou X, Lu F, Lu F, Lu H, Lu J, Lu J, Lu X, Lu Y, Lu Y, Luo C, Luo M, Luo P, Luo T, Luo X, Lusso S, Lyu X, Ma F, Ma H, Ma L, Ma M, Ma Q, Ma R, Ma R, Ma X, Ma X, Maas F, Maggiora M, Maldaner S, Malde S, Malik Q, Mangoni A, Mao Y, Mao Z, Marcello S, Meng Z, Messchendorp J, Mezzadri G, Min T, Mitchell R, Mo X, Mo Y, Muchnoi N, Muramatsu H, Nakhoul S, Nefedov Y, Nerling F, Nikolaev I, Ning Z, Nisar S, Olsen S, Ouyang Q, Pacetti S, Pan X, Pan Y, Pathak A, Patteri P, Pelizaeus M, Peng H, Peters K, Pettersson J, Ping J, Ping R, Poling R, Prasad V, Qi H, Qi H, Qi K, Qi M, Qi T, Qi T, Qian S, Qian W, Qian Z, Qiao C, Qin L, Qin X, Qin X, Qin Z, Qiu J, Qu S, Rashid K, Ravindran K, Redmer C, Rivetti A, Rodin V, Rolo M, Rong G, Rosner C, Rump M, Sang H, Sarantsev A, Schelhaas Y, Schnier C, Schoenning K, Scodeggio M, Shan D, Shan W, Shan X, Shangguan J, Shao M, Shen C, Shen H, Shen P, Shen X, Shi H, Shi R, Shi X, Shi X, Song J, Song W, Song Y, Sosio S, Spataro S, Su K, Su P, Sui F, Sun G, Sun H, Sun J, Sun L, Sun S, Sun T, Sun W, Sun W, Sun X, Sun Y, Sun Y, Sun Y, Sun Z, Tan Y, Tan Y, Tang C, Tang G, Tang J, Teng J, Thoren V, Tian W, Tian Y, Uman I, Wang B, Wang C, Wang D, Wang H, Wang H, Wang K, Wang L, Wang M, Wang M, Wang M, Wang W, Wang W, Wang W, Wang X, Wang X, Wang X, Wang Y, Wang Y, Wang Y, Wang Y, Wang Y, Wang Y, Wang Z, Wang Z, Wang Z, Wang Z, Wei D, Weidenkaff P, Weidner F, Wen S, White D, Wiedner U, Wilkinson G, Wolke M, Wollenberg L, Wu J, Wu L, Wu L, Wu X, Wu Z, Xia L, Xiao H, Xiao S, Xiao Z, Xie X, Xie Y, Xie Y, Xing T, Xu G, Xu Q, Xu W, Xu X, Xu Y, Yan F, Yan L, Yan W, Yan W, Yan X, Yang H, Yang H, Yang L, Yang S, Yang Y, Yang Y, Yang Z, Ye M, Ye M, Yin J, You Z, Yu B, Yu C, Yu G, Yu J, Yu T, Yuan C, Yuan L, Yuan X, Yuan Y, Yuan Z, Yue C, Zafar A, Zeng XZ, Zeng Y, Zhang A, Zhang B, Zhang G, Zhang H, Zhang H, Zhang H, Zhang H, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang J, Zhang L, Zhang L, Zhang L, Zhang S, Zhang S, Zhang S, Zhang X, Zhang X, Zhang Y, Zhang Y, Zhang Y, Zhang Y, Zhang Y, Zhang Z, Zhang Z, Zhao G, Zhao J, Zhao J, Zhao J, Zhao L, Zhao L, Zhao M, Zhao Q, Zhao S, Zhao Y, Zhao Y, Zhao Z, Zhemchugov A, Zheng B, Zheng J, Zheng Y, Zheng Y, Zhong B, Zhong C, Zhou L, Zhou Q, Zhou X, Zhou X, Zhou X, Zhou X, Zhu A, Zhu J, Zhu K, Zhu K, Zhu S, Zhu T, Zhu W, Zhu W, Zhu Y, Zhu Z, Zou B, Zou J. Search for the decay
Ds+→a0(980)0e+νe. Int J Clin Exp Med 2021. [DOI: 10.1103/physrevd.103.092004] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
226
|
Xu W, Xu JQ, Dai D, Zhu JJ, He Q, Xing XY, Chen YJ, Liu ZR. [Estimation of dietary salt intake in adult residents in Anhui province, 2019]. ZHONGHUA LIU XING BING XUE ZA ZHI = ZHONGHUA LIUXINGBINGXUE ZAZHI 2021; 42:823-826. [PMID: 34814473 DOI: 10.3760/cma.j.cn112338-20200703-00913] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Objective: Based on the data of the baseline survey of hypertension and sodium intake monitoring in Anhui province in 2019, the salt intake in adult residents was estimated. Methods: Multi-stage stratified cluster random sampling was used to select participants aged 18-69 years, questionnaire survey and related measurements were conducted. Salt intake in participants with different characteristics were estimated with complex sample and linearization of Taylor series based on design and the correlation between salt intake and blood pressure, waist circumference and BMI were tested by linear regression. Results: A total of 1 500 participants were included. The overall salt intake was 9.14 g/d, which was 9.84 g/d in men and 8.47 g/d in women (P<0.05). The differences in salt intake across different subgroups were significant (P<0.05). Univariate linear regression analysis showed that salt intake was positively correlated with SBP, DBP, waist circumference and BMI (P<0.05), while multivariate linear regression analysis (adjusted for other factors) only showed a positive correlation between salt intake and BMI (β=0.053,95%CI: 0.028-0.078, P<0.05). Conclusion: The dietary salt intake in adult residents in Anhui was higher than WHO recommendation, suggesting that public health education need to be taken to reduce salt intake.
Collapse
|
227
|
Sun P, Xu W, Ye Y, Zhong F, Wan X, Li Y. Neglected Tarlov cysts: a case of a Tarlov cyst with spermatorrhea. Eur J Med Res 2021; 26:44. [PMID: 33964972 PMCID: PMC8106831 DOI: 10.1186/s40001-021-00514-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2020] [Accepted: 04/28/2021] [Indexed: 11/29/2022] Open
Abstract
Background Tarlov cysts are a commonly misdiagnosed condition, which can present with many rare symptoms. We report a case of a Tarlov cyst with spermatorrhea and review the pertinent literature. Case presentation A 42-year-old male patient had a history of spermatorrhea for > 10 years, but was incorrectly diagnosed as the patient and the doctors consistently mistook the symptoms for a genitourinary disease. Magnetic resonance imaging showed that two cysts in the sacral canal. The diagnosis was Tarlov cyst. We performed surgery to remove the cyst and the symptoms of spermatorrhea disappeared after the operation. Conclusions This case demonstrates that orthopedics and urologists should improve their understanding of Tarlov cysts to avoid misdiagnosis and mistreatment.
Collapse
|
228
|
Huang J, Xu W, Zheng Z, Wong MCS. Importance of sustaining non-pharmaceutical interventions for COVID-19 until herd immunity. Hong Kong Med J 2021; 27:95-96. [PMID: 33879626 DOI: 10.12809/hkmj215112] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
229
|
Bi XG, Li ML, Xu W, You JY, Xie D, Yuan XF, Xiang Y. Helix B surface peptide protects against acute lung injury through reducing oxidative stress and endoplasmic reticulum stress via activation of Nrf2/HO-1 signaling pathway. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2021; 24:6919-6930. [PMID: 32633385 DOI: 10.26355/eurrev_202006_21683] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Acute lung injury (ALI) is a clinical problem with poor prognosis and high mortality. The purpose of this study was to explore the effects of helix B position peptide (HBSP) on ALI and its mechanism. MATERIALS AND METHODS C57/BL6 male mice were used to construct ALI models by LPS tracheal injection and detect the effect of HBSP on mouse ALI by subcutaneously injecting HBSP. In addition, normal human lung epithelial cell line (BEAS-2B) were cultured and stimulated with HBSP. Then, the effects of HBSP on oxidative stress and endoplasmic reticulum stress (ERS) in BEAS-2B cells were examined. Finally, the effect of HBSP on the Nrf2/HO-1 signaling pathway was examined, and the mechanism of action of HBSP was verified using the Nrf2/HO-1 signaling pathway inhibitor ML385. RESULTS In vitro, HBSP increased the expression of SOD1/2 and decreased the expression of ERS-related molecules such as CHOP, GRP-78, and caspase-12, indicating that HBSP effectively reduces the level of oxidative stress and ERS in BEAS-2B cells. In addition, HBSP also increased the activity of the Nrf2/HO-1 signaling pathway and ML385 reduced the protective effect of HBSP on BEAS-2B cells. In vivo, HBSP significantly reduced LPS-induced mouse ALI. W/D and inflammatory factors in the BALF of the mouse lung were significantly reduced and the level of oxidative stress was also reduced. CONCLUSIONS HBSP plays an important role in relieving ALI by activating Nrf2/HO-1 signaling pathway, which reduces the level of inflammation in lung tissue and oxidative stress and ERS in lung epithelial cells.
Collapse
|
230
|
Xu W, Ma X, Yao J, Wang D, Li W, Liu L, Shao L, Wang Y. Increasing coenzyme Q 10 yield from Rhodopseudomonas palustris by expressing rate-limiting enzymes and blocking carotenoid and hopanoid pathways. Lett Appl Microbiol 2021; 73:88-95. [PMID: 33783839 DOI: 10.1111/lam.13479] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2020] [Revised: 03/24/2021] [Accepted: 03/25/2021] [Indexed: 11/29/2022]
Abstract
Coenzyme Q10 (CoQ10 ), a strong antioxidant, is used extensively in food, cosmetic and medicine industries. A natural producer, Rhodopseudomonas palustris, was engineered to overproduce CoQ10 . For increasing the CoQ10 content, crtB gene was deleted to block the carotenoid pathway. crtB gene deletion led to 33% improvement of CoQ10 content over the wild type strain. However, it was found that the yield of hopanoids was also increased by competing for the precursors from carotenoid pathway with CoQ10 pathway. To further increase the CoQ10 content, hopanoid pathway was blocked by deleting shc gene, resulting in R. palustris [Δshc, ΔcrtB] to produce 4·7 mg g-1 DCW CoQ10 , which was 1·2 times higher than the CoQ10 content in the wild type strain. The common strategy of co-expression of rate-limiting enzymes (DXS, DPS and UbiA) was combined with the pathway blocking method resulted in 8·2 mg g-1 DCW of CoQ10 , which was 2·9 times higher than that of wild type strain. The results suggested a synergistic effect among different metabolic engineering strategies. This study demonstrates the potential of R. palustris for CoQ10 production and provides viable strategies to increase CoQ10 titer.
Collapse
|
231
|
Xu W, Zhang H, Feng G, Zheng Q, Shang R, Liu X. The value of MRI in identifying pancreatic neuroendocrine tumour G3 and carcinoma G3. Clin Radiol 2021; 76:551.e1-551.e9. [PMID: 33902887 DOI: 10.1016/j.crad.2021.02.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2020] [Accepted: 02/11/2021] [Indexed: 11/17/2022]
Abstract
AIM To explore the magnetic resonance imaging (MRI) differences between pancreatic neuroendocrine tumour grade 3 (pNET-G3) and pancreatic neuroendocrine carcinoma grade 3 (pNEC-G3). MATERIALS AND METHODS Between 2009 and 2019, 31 patients underwent pNEN-G3 resection with preoperative MRI in two local hospitals in China. The 31 patients were assigned to a pNET-G3 group (n=13) or a pNEC-G3 group (n=18). The MRI findings between the groups were compared. RESULTS There was no statistically significant difference between the two groups in lesion size, clinical characteristics, or laboratory indexes. The lesions showed high or slightly higher signal on diffusion-weighted imaging and decreased apparent diffusion coefficient (ADC) values, which differed between the two groups (p=0.013). The difference between the groups regarding positive enhancement integral, arterial phase and portal phase signal enhancement ratio were statistically significant; however, the delayed phase signal enhancement ratio was not significantly different. CONCLUSIONS pNET-G3 and pNEC-G3 showed different characteristics on MRI. In particular, the ADC value and dynamic enhanced imaging could have an important role in distinguishing between the two.
Collapse
|
232
|
Hu Y, Xu YJ, Li MZ, Lan YX, Mao L, Ning QY, Xu W, Yang HL, Zhang YZ. [The prognostic impact of diabetic mellitus and hyperglycemia during DLBCL treatment on patients with diffuse large B-cell lymphoma]. ZHONGHUA XUE YE XUE ZA ZHI = ZHONGHUA XUEYEXUE ZAZHI 2021; 42:151-157. [PMID: 33858047 PMCID: PMC8071671 DOI: 10.3760/cma.j.issn.0253-2727.2021.02.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
目的 探讨弥漫大B细胞淋巴瘤(DLBCL)患者的临床特征和预后因素,评估合并糖尿病(DM)及治疗过程中发生血糖升高对DLBCL预后的影响。 方法 回顾性收集2009年1月1日至2019年12月31日天津医科大学肿瘤医院及中山大学肿瘤防治中心收治的481例初诊DLBCL患者的临床资料,重点关注其治疗前及治疗中的血糖水平,采用Cox回归风险模型进行单因素分析评估预后影响因素,采用Kaplan-Meier法绘制生存曲线分析血糖异常对DLBCL患者总生存(OS)、无进展生存(PFS)的影响。 结果 82例(17.0%)患者在诊断DLBCL前患DM,88例(18.3%)患者在DLBCL治疗过程中至少发生一次血糖升高。单因素分析显示,年龄、Ann-Arbor分期、IPI评分、是否合并DM与OS、PFS相关(P值均<0.05)。组间比较显示,合并DM组与治疗过程中血糖升高组的OS和PFS均较无血糖异常组差(OS:P值分别为0.001、0.003,PFS:P值均<0.001),合并DM组与治疗过程中血糖升高组相比OS和PFS的差异均无统计学意义(P值分别为0.557、0.463)。化疗期间血糖控制良好组的OS和PFS优于血糖控制差组(OS:P=0.037,PFS:P=0.007)。 结论 合并DM是影响DLBCL患者预后的重要因素,治疗过程中血糖升高与DLBCL患者的不良预后相关。
Collapse
|
233
|
Elamir AM, Hutchinson S, Albaba H, Keshavarzi S, Xu W, Moulton CA, McGilvary I, Cleary S, Wei A, Dodd A, Knox J, O'Kane G, Prince RM, Kalimuthu S, Kim J, Ringash J, Dawson LA, Wong R, Barry A, Brierley J, Gallinger S, Hosni A. A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant Therapy. Clin Oncol (R Coll Radiol) 2021; 33:527-535. [PMID: 33875360 DOI: 10.1016/j.clon.2021.03.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2020] [Revised: 01/21/2021] [Accepted: 03/11/2021] [Indexed: 10/21/2022]
Abstract
AIMS The aims of the study were to identify predictors of locoregional failure (LRF) following surgery for pancreatic adenocarcinoma, develop a prediction risk score model of LRF and evaluate the impact of postoperative radiation therapy (PORT) on LRF. MATERIALS AND METHODS A retrospective review was conducted on patients with stages I-III pancreatic adenocarcinoma who underwent surgery at our institution (2005-2016). Univariable and then multivariable analyses were used to evaluate clinicopathological factors associated with LRF for patients who did not receive PORT. The risk score of LRF was calculated based on the sum of coefficients of the predictors of LRF. The model was applied to the entire cohort to evaluate the impact of PORT on the high- and low-risk groups for LRF. RESULTS In total, 467 patients were identified (median follow-up 22 months). Among patients who did not receive PORT (n = 440), predictors of LRF were pN+, involved or close ≤1 mm margin(s), moderately and poorly differentiated tumour grade and lymphovascular invasion. After adding patients who received PORT, the 2-year LRF in the high-risk group was 57% for patients who did not receive PORT (n = 242) and 32% among patients who received PORT (n = 22), with an absolute benefit to LRF of 25% (95% confidence interval 5-52%, P = 0.07). The 2-year overall survival for the high-versus the low-risk group was 36% versus 67% (P < 0.001). CONCLUSION This risk group classification could be used to identify pancreatic adenocarcinoma patients with higher risk of LRF who may benefit from PORT. However, validation and prospective evaluation are warranted.
Collapse
|
234
|
Schneeberger P, Zhang C, Santilli J, Wijesinha Z, Levy L, Chen B, Xu W, Lee Y, Huszti E, Ahmed M, Boonstra K, Moshkelgosha S, Weigt S, Shah P, Budev M, Frankel C, Todd J, Snyder L, Palmer S, Yeung J, Keshavjee S, Singer L, Coburn B, Martinu T. The Pulmonary Microbiome after Lung Transplantation is Associated with Gastroesophageal Reflux Disease, Inflammation, and Allograft Dysfunction. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.1885] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
235
|
Xu W, Xue R, Xia R, Liu WW, Zheng JW, Tang L, Kang LY, Wang W, Wei WT. Sevoflurane impedes the progression of glioma through modulating the circular RNA has_circ_0012129/miR-761/TGIF2 axis. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2021; 24:5534-5548. [PMID: 32495888 DOI: 10.26355/eurrev_202005_21339] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Glioma is a highly aggressive and lethal brain tumor. Anesthetics have been shown to have important effects on the biological characteristics of cancer cells. Nevertheless, the molecular mechanism of anesthetic-mediated glioma cells progression remains unclear. MATERIALS AND METHODS Sevoflurane (sev) was employed to treat glioma cells. The biological characteristics (viability, colony formation, apoptosis, cell cycle, migration, and invasion) of glioma cells were determined via Cell Counting Kit-8 (CCK-8), cell colony formation, flow cytometry, PI cytometry, or transwell assays. The protein levels of Cell Cycle Dependent Kinase (CDK) 2, CDK4, E-cadherin, N-cadherin, Vimentin, and Transforming Growth Factor Beta (TGFB) induced factor homeobox 2 (TGIF2) were assessed through Western blot analysis. Glucose consumption and lactate production were measured using special commercial kits. The expression of circular RNA has_circ_0012129 (circ_0012129) and miR-761 was detected via quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The relationship between circ_0012129 or TGIF2 and miR-761 was verified with Dual-Luciferase reporter assay. Sevoflurane-mediated molecular mechanisms have been confirmed via xenograft assay. RESULTS Sevoflurane suppressed viability, colony formation, cell cycle, migration, and invasion and promoted apoptosis of glioma cells in vitro, and impeded tumor growth in vivo. Circ_0012129 and TGIF2 were downregulated and miR-761 was upregulated in sevoflurane-treated glioma cells. Circ_0012129 elevation abolished sevoflurane-mediated biological characteristics of glioma cells. MiR-761 served as target for circ_0012129 and miR-761 targeted TGIF2. Moreover, both miR-761 overexpression and TGIF2 suppression restored circ_0012129 enhancement-mediated biological characteristics of sevoflurane-treated glioma cells. CONCLUSIONS Sevoflurane mediated the progression of glioma via regulating the circ_0012129/miR-761/TGIF2 axis.
Collapse
|
236
|
Owen CN, Bai X, Quah T, Lo SN, Allayous C, Callaghan S, Martínez-Vila C, Wallace R, Bhave P, Reijers ILM, Thompson N, Vanella V, Gerard CL, Aspeslagh S, Labianca A, Khattak A, Mandala M, Xu W, Neyns B, Michielin O, Blank CU, Welsh SJ, Haydon A, Sandhu S, Mangana J, McQuade JL, Ascierto PA, Zimmer L, Johnson DB, Arance A, Lorigan P, Lebbé C, Carlino MS, Sullivan RJ, Long GV, Menzies AM. Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma. Ann Oncol 2021; 32:917-925. [PMID: 33798657 DOI: 10.1016/j.annonc.2021.03.204] [Citation(s) in RCA: 66] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2020] [Revised: 03/09/2021] [Accepted: 03/28/2021] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND Immune-related adverse events (irAEs) typically occur within 4 months of starting anti-programmed cell death protein 1 (PD-1)-based therapy [anti-PD-1 ± anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4)], but delayed irAEs (onset >12 months after commencement) can also occur. This study describes the incidence, nature and management of delayed irAEs in patients receiving anti-PD-1-based immunotherapy. PATIENTS AND METHODS Patients with delayed irAEs from 20 centres were studied. The incidence of delayed irAEs was estimated as a proportion of melanoma patients treated with anti-PD-1-based therapy and surviving >1 year. Onset, clinical features, management and outcomes of irAEs were examined. RESULTS One hundred and eighteen patients developed a total of 140 delayed irAEs (20 after initial combination with anti-CTLA4), with an estimated incidence of 5.3% (95% confidence interval 4.0-6.9, 53/999 patients at sites with available data). The median onset of delayed irAE was 16 months (range 12-53 months). Eighty-seven patients (74%) were on anti-PD-1 at irAE onset, 15 patients (12%) were <3 months from the last dose and 16 patients (14%) were >3 months from the last dose of anti-PD-1. The most common delayed irAEs were colitis, rash and pneumonitis; 55 of all irAEs (39%) were ≥grade 3. Steroids were required in 80 patients (68%), as well as an additional immunosuppressive agent in 27 patients (23%). There were two irAE-related deaths: encephalitis with onset during anti-PD-1 and a multiple-organ irAE with onset 11 months after ceasing anti-PD-1. Early irAEs (<12 months) had also occurred in 69 patients (58%), affecting a different organ from the delayed irAE in 59 patients (86%). CONCLUSIONS Delayed irAEs occur in a small but relevant subset of patients. Delayed irAEs are often different from previous irAEs, may be high grade and can lead to death. They mostly occur in patients still receiving anti-PD-1. The risk of delayed irAE should be considered when deciding the duration of treatment in responding patients. However, patients who stop treatment may also rarely develop delayed irAE.
Collapse
|
237
|
Aad G, Abbott B, Abbott DC, Abed Abud A, Abeling K, Abhayasinghe DK, Abidi SH, AbouZeid OS, Abraham NL, Abramowicz H, Abreu H, Abulaiti Y, Acharya BS, Achkar B, Adachi S, Adam L, Adam Bourdarios C, Adamczyk L, Adamek L, Adelman J, Adersberger M, Adiguzel A, Adorni S, Adye T, Affolder AA, Afik Y, Agapopoulou C, Agaras MN, Aggarwal A, Agheorghiesei C, Aguilar-Saavedra JA, Ahmadov F, Ahmed WS, Ai X, Aielli G, Akatsuka S, Åkesson TPA, Akilli E, Akimov AV, Al Khoury K, Alberghi GL, Albert J, Alconada Verzini MJ, Alderweireldt S, Aleksa M, Aleksandrov IN, Alexa C, Alexopoulos T, Alfonsi A, Alfonsi F, Alhroob M, Ali B, Aliev M, Alimonti G, Allaire C, Allbrooke BMM, Allen BW, Allport PP, Aloisio A, Alonso F, Alpigiani C, Alshehri AA, Alunno Camelia E, Alvarez Estevez M, Alviggi MG, Amaral Coutinho Y, Ambler A, Ambroz L, Amelung C, Amidei D, Amor Dos Santos SP, Amoroso S, Amrouche CS, An F, Anastopoulos C, Andari N, Andeen T, Anders CF, Anders JK, Andrean SY, Andreazza A, Andrei V, Anelli CR, Angelidakis S, Angerami A, Anisenkov AV, Annovi A, Antel C, Anthony MT, Antipov E, Antonelli M, Antrim DJA, Anulli F, Aoki M, Aparisi Pozo JA, Aparo MA, Aperio Bella L, Araque JP, Araujo Ferraz V, Araujo Pereira R, Arcangeletti C, Arce ATH, Arduh FA, Arguin JF, Argyropoulos S, Arling JH, Armbruster AJ, Armstrong A, Arnaez O, Arnold H, Arrubarrena Tame ZP, Artoni G, Artz S, Asai S, Asawatavonvanich T, Asbah N, Asimakopoulou EM, Asquith L, Assahsah J, Assamagan K, Astalos R, Atkin RJ, Atkinson M, Atlay NB, Atmani H, Augsten K, Avolio G, Ayoub MK, Azuelos G, Bachacou H, Bachas K, Backes M, Backman F, Bagnaia P, Bahmani M, Bahrasemani H, Bailey AJ, Bailey VR, Baines JT, Bakalis C, Baker OK, Bakker PJ, Bakshi Gupta D, Balaji S, Baldin EM, Balek P, Balli F, Balunas WK, Balz J, Banas E, Bandieramonte M, Bandyopadhyay A, Banerjee S, Barak L, Barbe WM, Barberio EL, Barberis D, Barbero M, Barbour G, Barillari T, Barisits MS, Barkeloo J, Barklow T, Barnea R, Barnett BM, Barnett RM, Barnovska-Blenessy Z, Baroncelli A, Barone G, Barr AJ, Barranco Navarro L, Barreiro F, Barreiro Guimarães da Costa J, Barsov S, Bartels F, Bartoldus R, Bartolini G, Barton AE, Bartos P, Basalaev A, Basan A, Bassalat A, Basso MJ, Bates RL, Batlamous S, Batley JR, Batool B, Battaglia M, Bauce M, Bauer F, Bauer KT, Bawa HS, Beacham JB, Beau T, Beauchemin PH, Becherer F, Bechtle P, Beck HC, Beck HP, Becker K, Becot C, Beddall A, Beddall AJ, Bednyakov VA, Bedognetti M, Bee CP, Beermann TA, Begalli M, Begel M, Behera A, Behr JK, Beisiegel F, Bell AS, Bella G, Bellagamba L, Bellerive A, Bellos P, Beloborodov K, Belotskiy K, Belyaev NL, Benchekroun D, Benekos N, Benhammou Y, Benjamin DP, Benoit M, Bensinger JR, Bentvelsen S, Beresford L, Beretta M, Berge D, Bergeaas Kuutmann E, Berger N, Bergmann B, Bergsten LJ, Beringer J, Berlendis S, Bernardi G, Bernius C, Bernlochner FU, Berry T, Berta P, Bertella C, Bertram IA, Bessidskaia Bylund O, Besson N, Bethani A, Bethke S, Betti A, Bevan AJ, Beyer J, Bhattacharya DS, Bhattarai P, Bi R, Bianchi RM, Biebel O, Biedermann D, Bielski R, Bierwagen K, Biesuz NV, Biglietti M, Billoud TRV, Bindi M, Bingul A, Bini C, Biondi S, Birman M, Bisanz T, Biswal JP, Biswas D, Bitadze A, Bittrich C, Bjørke K, Blazek T, Bloch I, Blocker C, Blue A, Blumenschein U, Bobbink GJ, Bobrovnikov VS, Bocchetta SS, Bocci A, Bogavac D, Bogdanchikov AG, Bohm C, Boisvert V, Bokan P, Bold T, Bolz AE, Bomben M, Bona M, Bonilla JS, Boonekamp M, Booth CD, Borecka-Bielska HM, Borgna LS, Borisov A, Borissov G, Bortfeldt J, Bortoletto D, Boscherini D, Bosman M, Bossio Sola JD, Bouaouda K, Boudreau J, Bouhova-Thacker EV, Boumediene D, Boutle SK, Boveia A, Boyd J, Boye D, Boyko IR, Bozson AJ, Bracinik J, Brahimi N, Brandt G, Brandt O, Braren F, Brau B, Brau JE, Breaden Madden WD, Brendlinger K, Brenner L, Brenner R, Bressler S, Brickwedde B, Briglin DL, Britton D, Britzger D, Brock I, Brock R, Brooijmans G, Brooks WK, Brost E, Broughton JH, Bruckman de Renstrom PA, Bruncko D, Bruni A, Bruni G, Bruni LS, Bruno S, Bruschi M, Bruscino N, Bryngemark L, Buanes T, Buat Q, Buchholz P, Buckley AG, Budagov IA, Bugge MK, Bührer F, Bulekov O, Burch TJ, Burdin S, Burgard CD, Burger AM, Burghgrave B, Burr JTP, Burton CD, Burzynski JC, Büscher V, Buschmann E, Bussey PJ, Butler JM, Buttar CM, Butterworth JM, Butti P, Buttinger W, Buxo Vazquez CJ, Buzatu A, Buzykaev AR, Cabras G, Cabrera Urbán S, Caforio D, Cai H, Cairo VMM, Cakir O, Calace N, Calafiura P, Calderini G, Calfayan P, Callea G, Caloba LP, Caltabiano A, Calvente Lopez S, Calvet D, Calvet S, Calvet TP, Calvetti M, Camacho Toro R, Camarda S, Camarero Munoz D, Camarri P, Cameron D, Camincher C, Campana S, Campanelli M, Camplani A, Campoverde A, Canale V, Canesse A, Cano Bret M, Cantero J, Cao T, Cao Y, Capeans Garrido MDM, Capua M, Cardarelli R, Cardillo F, Carducci G, Carli I, Carli T, Carlino G, Carlson BT, Carlson EM, Carminati L, Carney RMD, Caron S, Carquin E, Carrá S, Carter JWS, Casado MP, Casha AF, Castillo FL, Castillo Garcia L, Castillo Gimenez V, Castro NF, Catinaccio A, Catmore JR, Cattai A, Cavaliere V, Cavallaro E, Cavalli-Sforza M, Cavasinni V, Celebi E, Cerda Alberich L, Cerny K, Cerqueira AS, Cerri A, Cerrito L, Cerutti F, Cervelli A, Cetin SA, Chadi Z, Chakraborty D, Chan J, Chan WS, Chan WY, Chapman JD, Chargeishvili B, Charlton DG, Charman TP, Chau CC, Che S, Chekanov S, Chekulaev SV, Chelkov GA, Chen B, Chen C, Chen CH, Chen H, Chen J, Chen J, Chen J, Chen S, Chen SJ, Chen X, Chen YH, Cheng HC, Cheng HJ, Cheplakov A, Cheremushkina E, Cherkaoui El Moursli R, Cheu E, Cheung K, Chevalérias TJA, Chevalier L, Chiarella V, Chiarelli G, Chiodini G, Chisholm AS, Chitan A, Chiu I, Chiu YH, Chizhov MV, Choi K, Chomont AR, Chouridou S, Chow YS, Chu MC, Chu X, Chudoba J, Chwastowski JJ, Chytka L, Cieri D, Ciesla KM, Cinca D, Cindro V, Cioară IA, Ciocio A, Cirotto F, Citron ZH, Citterio M, Ciubotaru DA, Ciungu BM, Clark A, Clark MR, Clark PJ, Clement C, Coadou Y, Cobal M, Coccaro A, Cochran J, Coelho Lopes De Sa R, Cohen H, Coimbra AEC, Cole B, Colijn AP, Collot J, Conde Muiño P, Connell SH, Connelly IA, Constantinescu S, Conventi F, Cooper-Sarkar AM, Cormier F, Cormier KJR, Corpe LD, Corradi M, Corrigan EE, Corriveau F, Costa MJ, Costanza F, Costanzo D, Cowan G, Cowley JW, Crane J, Cranmer K, Crawley SJ, Creager RA, Crépé-Renaudin S, Crescioli F, Cristinziani M, Croft V, Crosetti G, Cueto A, Cuhadar Donszelmann T, Cukierman AR, Cunningham WR, Czekierda S, Czodrowski P, Czurylo MM, Da Cunha Sargedas De Sousa MJ, Da Fonseca Pinto JV, Da Via C, Dabrowski W, Dachs F, Dado T, Dahbi S, Dai T, Dallapiccola C, Dam M, D'amen G, D'Amico V, Damp J, Dandoy JR, Daneri MF, Dann NS, Danninger M, Dao V, Darbo G, Dartsi O, Dattagupta A, Daubney T, D'Auria S, David C, Davidek T, Davis DR, Dawson I, De K, De Asmundis R, De Beurs M, De Castro S, De Cecco S, De Groot N, de Jong P, De la Torre H, De Maria A, De Pedis D, De Salvo A, De Sanctis U, De Santis M, De Santo A, De Vasconcelos Corga K, De Vivie De Regie JB, Debenedetti C, Dedovich DV, Deiana AM, Del Peso J, Delabat Diaz Y, Delgove D, Deliot F, Delitzsch CM, Della Pietra M, Della Volpe D, Dell'Acqua A, Dell'Asta L, Delmastro M, Delporte C, Delsart PA, DeMarco DA, Demers S, Demichev M, Demontigny G, Denisov SP, D'Eramo L, Derendarz D, Derkaoui JE, Derue F, Dervan P, Desch K, Deterre C, Dette K, Deutsch C, Devesa MR, Deviveiros PO, Di Bello FA, Di Ciaccio A, Di Ciaccio L, Di Clemente WK, Di Donato C, Di Girolamo A, Di Gregorio G, Di Micco B, Di Nardo R, Di Petrillo KF, Di Sipio R, Diaconu C, Dias FA, Dias Do Vale T, Diaz MA, Dickinson J, Diehl EB, Dietrich J, Díez Cornell S, Dimitrievska A, Ding W, Dingfelder J, Dittus F, Djama F, Djobava T, Djuvsland JI, Do Vale MAB, Dobre M, Dodsworth D, Doglioni C, Dolejsi J, Dolezal Z, Donadelli M, Dong B, Donini J, D'onofrio A, D'Onofrio M, Dopke J, Doria A, Dova MT, Doyle AT, Drechsler E, Dreyer E, Dreyer T, Drobac AS, Du D, Duan Y, Dubinin F, Dubovsky M, Dubreuil A, Duchovni E, Duckeck G, Ducourthial A, Ducu OA, Duda D, Dudarev A, Dudder AC, Duffield EM, Duflot L, Dührssen M, Dülsen C, Dumancic M, Dumitriu AE, Duncan AK, Dunford M, Duperrin A, Duran Yildiz H, Düren M, Durglishvili A, Duschinger D, Dutta B, Duvnjak D, Dyckes GI, Dyndal M, Dysch S, Dziedzic BS, Ecker KM, Eggleston MG, Eifert T, Eigen G, Einsweiler K, Ekelof T, El Jarrari H, El Kosseifi R, Ellajosyula V, Ellert M, Ellinghaus F, Elliot AA, Ellis N, Elmsheuser J, Elsing M, Emeliyanov D, Emerman A, Enari Y, Epland MB, Erdmann J, Ereditato A, Erland PA, Errenst M, Escalier M, Escobar C, Estrada Pastor O, Etzion E, Evans H, Evans MO, Ezhilov A, Fabbri F, Fabbri L, Fabiani V, Facini G, Faisca Rodrigues Pereira RM, Fakhrutdinov RM, Falciano S, Falke PJ, Falke S, Faltova J, Fang Y, Fang Y, Fanourakis G, Fanti M, Faraj M, Farbin A, Farilla A, Farina EM, Farooque T, Farrington SM, Farthouat P, Fassi F, Fassnacht P, Fassouliotis D, Faucci Giannelli M, Fawcett WJ, Fayard L, Fedin OL, Fedorko W, Fehr A, Feickert M, Feligioni L, Fell A, Feng C, Feng M, Fenton MJ, Fenyuk AB, Ferguson SW, Ferrando J, Ferrante A, Ferrari A, Ferrari P, Ferrari R, Ferreira de Lima DE, Ferrer A, Ferrere D, Ferretti C, Fiedler F, Filipčič A, Filthaut F, Finelli KD, Fiolhais MCN, Fiorini L, Fischer F, Fisher WC, Fleck I, Fleischmann P, Flick T, Flierl BM, Flores L, Flores Castillo LR, Follega FM, Fomin N, Foo JH, Forcolin GT, Formica A, Förster FA, Forti AC, Foster AG, Foti MG, Fournier D, Fox H, Francavilla P, Francescato S, Franchini M, Franchino S, Francis D, Franconi L, Franklin M, Fray AN, Freeman PM, Freund B, Freund WS, Freundlich EM, Frizzell DC, Froidevaux D, Frost JA, Fukunaga C, Fullana Torregrosa E, Fusayasu T, Fuster J, Gabrielli A, Gabrielli A, Gadatsch S, Gadow P, Gagliardi G, Gagnon LG, Galhardo B, Gallardo GE, Gallas EJ, Gallop BJ, Galster G, Gamboa Goni R, Gan KK, Ganguly S, Gao J, Gao Y, Gao YS, García C, García Navarro JE, García Pascual JA, Garcia-Argos C, Garcia-Sciveres M, Gardner RW, Garelli N, Gargiulo S, Garner CA, Garonne V, Gasiorowski SJ, Gaspar P, Gaudiello A, Gaudio G, Gavrilenko IL, Gavrilyuk A, Gay C, Gaycken G, Gazis EN, Geanta AA, Gee CM, Gee CNP, Geisen J, Geisen M, Gemme C, Genest MH, Geng C, Gentile S, George S, Geralis T, Gerlach LO, Gessinger-Befurt P, Gessner G, Ghasemi S, Ghasemi Bostanabad M, Ghneimat M, Ghosh A, Ghosh A, Giacobbe B, Giagu S, Giangiacomi N, Giannetti P, Giannini A, Giannini G, Gibson SM, Gignac M, Gillberg D, Gilles G, Gingrich DM, Giordani MP, Giraud PF, Giugliarelli G, Giugni D, Giuli F, Gkaitatzis S, Gkialas I, Gkougkousis EL, Gkountoumis P, Gladilin LK, Glasman C, Glatzer J, Glaysher PCF, Glazov A, Gledhill GR, Gnesi I, Goblirsch-Kolb M, Godin D, Goldfarb S, Golling T, Golubkov D, Gomes A, Goncalves Gama R, Gonçalo R, Gonella G, Gonella L, Gongadze A, Gonnella F, Gonski JL, González de la Hoz S, Gonzalez Fernandez S, Gonzalez Renteria C, Gonzalez-Sevilla S, Gonzalvo Rodriguez GR, Goossens L, Gorasia NA, Gorbounov PA, Gordon HA, Gorini B, Gorini E, Gorišek A, Goshaw AT, Gostkin MI, Gottardo CA, Gouighri M, Goussiou AG, Govender N, Goy C, Gozani E, Grabowska-Bold I, Graham EC, Gramling J, Gramstad E, Grancagnolo S, Grandi M, Gratchev V, Gravila PM, Gravili FG, Gray C, Gray HM, Grefe C, Gregersen K, Gregor IM, Grenier P, Grevtsov K, Grieco C, Grieser NA, Grillo AA, Grimm K, Grinstein S, Grivaz JF, Groh S, Gross E, Grosse-Knetter J, Grout ZJ, Grud C, Grummer A, Guan L, Guan W, Gubbels C, Guenther J, Guerguichon A, Guerrero Rojas JGR, Guescini F, Guest D, Gugel R, Guillemin T, Guindon S, Gul U, Guo J, Guo W, Guo Y, Guo Z, Gupta R, Gurbuz S, Gustavino G, Guth M, Gutierrez P, Gutschow C, Guyot C, Gwenlan C, Gwilliam CB, Haas A, Haber C, Hadavand HK, Hadef A, Haleem M, Haley J, Halladjian G, Hallewell GD, Hamacher K, Hamal P, Hamano K, Hamdaoui H, Hamer M, Hamity GN, Han K, Han L, Han S, Han YF, Hanagaki K, Hance M, Handl DM, Haney B, Hankache R, Hansen E, Hansen JB, Hansen JD, Hansen MC, Hansen PH, Hanson EC, Hara K, Harenberg T, Harkusha S, Harrison PF, Hartman NM, Hartmann NM, Hasegawa Y, Hasib A, Hassani S, Haug S, Hauser R, Havener LB, Havranek M, Hawkes CM, Hawkings RJ, Hayden D, Hayes C, Hayes RL, Hays CP, Hays JM, Hayward HS, Haywood SJ, He F, Heath MP, Hedberg V, Heer S, Heidegger KK, Heidorn WD, Heilman J, Heim S, Heim T, Heinemann B, Heinrich JJ, Heinrich L, Hejbal J, Helary L, Held A, Hellesund S, Helling CM, Hellman S, Helsens C, Henderson RCW, Heng Y, Henkelmann L, Henriques Correia AM, Herde H, Hernández Jiménez Y, Herr H, Herrmann MG, Herrmann T, Herten G, Hertenberger R, Hervas L, Herwig TC, Hesketh GG, Hessey NP, Hibi H, Higashida A, Higashino S, Higón-Rodriguez E, Hildebrand K, Hill JC, Hill KK, Hiller KH, Hillier SJ, Hils M, Hinchliffe I, Hinterkeuser F, Hirose M, Hirose S, Hirschbuehl D, Hiti B, Hladik O, Hlaluku DR, Hobbs J, Hod N, Hodgkinson MC, Hoecker A, Hohn D, Hohov D, Holm T, Holmes TR, Holzbock M, Hommels LBAH, Honda S, Hong TM, Honig JC, Hönle A, Hooberman BH, Hopkins WH, Horii Y, Horn P, Horyn LA, Hou S, Hoummada A, Howarth J, Hoya J, Hrabovsky M, Hrdinka J, Hristova I, Hrivnac J, Hrynevich A, Hryn'ova T, Hsu PJ, Hsu SC, Hu Q, Hu S, Hu YF, Huang DP, Huang Y, Huang Y, Hubacek Z, Hubaut F, Huebner M, Huegging F, Huffman TB, Huhtinen M, Hunter RFH, Huo P, Huseynov N, Huston J, Huth J, Hyneman R, Hyrych S, Iacobucci G, Iakovidis G, Ibragimov I, Iconomidou-Fayard L, Iengo P, Ignazzi R, Igonkina O, Iguchi R, Iizawa T, Ikegami Y, Ikeno M, Iliadis D, Ilic N, Iltzsche F, Introzzi G, Iodice M, Iordanidou K, Ippolito V, Isacson MF, Ishino M, Islam W, Issever C, Istin S, Ito F, Iturbe Ponce JM, Iuppa R, Ivina A, Iwasaki H, Izen JM, Izzo V, Jacka P, Jackson P, Jacobs RM, Jaeger BP, Jain V, Jäkel G, Jakobi KB, Jakobs K, Jakoubek T, Jamieson J, Janas KW, Jansky R, Janus M, Janus PA, Jarlskog G, Jaspan AE, Javadov N, Javůrek T, Javurkova M, Jeanneau F, Jeanty L, Jejelava J, Jelinskas A, Jenni P, Jeong N, Jézéquel S, Ji H, Jia J, Jiang H, Jiang Y, Jiang Z, Jiggins S, Jimenez Morales FA, Jimenez Pena J, Jin S, Jinaru A, Jinnouchi O, Jivan H, Johansson P, Johns KA, Johnson CA, Jones RWL, Jones SD, Jones S, Jones TJ, Jongmanns J, Jorge PM, Jovicevic J, Ju X, Junggeburth JJ, Juste Rozas A, Kaczmarska A, Kado M, Kagan H, Kagan M, Kahn A, Kahra C, Kaji T, Kajomovitz E, Kalderon CW, Kaluza A, Kamenshchikov A, Kaneda M, Kang NJ, Kang S, Kano Y, Kanzaki J, Kaplan LS, Kar D, Karava K, Kareem MJ, Karkanias I, Karpov SN, Karpova ZM, Kartvelishvili V, Karyukhin AN, Kastanas A, Kato C, Katzy J, Kawade K, Kawagoe K, Kawaguchi T, Kawamoto T, Kawamura G, Kay EF, Kazanin VF, Keeler R, Kehoe R, Keller JS, Kellermann E, Kelsey D, Kempster JJ, Kendrick J, Kennedy KE, Kepka O, Kersten S, Kerševan BP, Ketabchi Haghighat S, Khader M, Khalil-Zada F, Khandoga M, Khanov A, Kharlamov AG, Kharlamova T, Khoda EE, Khodinov A, Khoo TJ, Khramov E, Khubua J, Kido S, Kiehn M, Kilby CR, Kim E, Kim YK, Kimura N, Kind OM, King BT, Kirchmeier D, Kirk J, Kiryunin AE, Kishimoto T, Kisliuk DP, Kitali V, Kivernyk O, Klapdor-Kleingrothaus T, Klassen M, Klein C, Klein MH, Klein M, Klein U, Kleinknecht K, Klimek P, Klimentov A, Klingl T, Klioutchnikova T, Klitzner FF, Kluit P, Kluth S, Kneringer E, Knoops EBFG, Knue A, Kobayashi D, Kobayashi T, Kobel M, Kocian M, Kodama T, Kodys P, Koeck DM, Koenig PT, Koffas T, Köhler NM, Kolb M, Koletsou I, Komarek T, Kondo T, Köneke K, Kong AXY, König AC, Kono T, Konstantinides V, Konstantinidis N, Konya B, Kopeliansky R, Koperny S, Korcyl K, Kordas K, Koren G, Korn A, Korolkov I, Korolkova EV, Korotkova N, Kortner O, Kortner S, Kostyukhin VV, Kotsokechagia A, Kotwal A, Koulouris A, Kourkoumeli-Charalampidi A, Kourkoumelis C, Kourlitis E, Kouskoura V, Kowalewska AB, Kowalewski R, Kozanecki W, Kozhin AS, Kramarenko VA, Kramberger G, Krasnopevtsev D, Krasny MW, Krasznahorkay A, Krauss D, Kremer JA, Kretzschmar J, Krieger P, Krieter F, Krishnan A, Krizka K, Kroeninger K, Kroha H, Kroll J, Kroll J, Krowpman KS, Kruchonak U, Krüger H, Krumnack N, Kruse MC, Krzysiak JA, Kubota T, Kuchinskaia O, Kuday S, Kuechler D, Kuechler JT, Kuehn S, Kugel A, Kuhl T, Kukhtin V, Kukla R, Kulchitsky Y, Kuleshov S, Kulinich YP, Kuna M, Kunigo T, Kupco A, Kupfer T, Kuprash O, Kurashige H, Kurchaninov LL, Kurochkin YA, Kurova A, Kurth MG, Kuwertz ES, Kuze M, Kvam AK, Kvita J, Kwan T, La Rotonda L, La Ruffa F, Lacasta C, Lacava F, Lack DPJ, Lacker H, Lacour D, Ladygin E, Lafaye R, Laforge B, Lagouri T, Lai S, Lakomiec IK, Lammers S, Lampl W, Lampoudis C, Lançon E, Landgraf U, Landon MPJ, Lanfermann MC, Lang VS, Lange JC, Langenberg RJ, Lankford AJ, Lanni F, Lantzsch K, Lanza A, Lapertosa A, Laplace S, Laporte JF, Lari T, Lasagni Manghi F, Lassnig M, Lau TS, Laudrain A, Laurier A, Lavorgna M, Lawlor SD, Lazzaroni M, Le B, Le Guirriec E, Lebedev A, LeBlanc M, LeCompte T, Ledroit-Guillon F, Lee ACA, Lee CA, Lee GR, Lee L, Lee SC, Lee S, Lefebvre B, Lefebvre HP, Lefebvre M, Leggett C, Lehmann K, Lehmann N, Lehmann Miotto G, Leight WA, Leisos A, Leite MAL, Leitgeb CE, Leitner R, Lellouch D, Leney KJC, Lenz T, Leone R, Leone S, Leonidopoulos C, Leopold A, Leroy C, Les R, Lester CG, Levchenko M, Levêque J, Levin D, Levinson LJ, Lewis DJ, Li B, Li B, Li CQ, Li F, Li H, Li H, Li J, Li K, Li L, Li M, Li Q, Li QY, Li S, Li X, Li Y, Li Z, Li Z, Liang Z, Liberti B, Liblong A, Lie K, Lim S, Lin CY, Lin K, Lin TH, Linck RA, Lindley RE, Lindon JH, Lionti AL, Lipeles E, Lipniacka A, Liss TM, Lister A, Little JD, Liu B, Liu BX, Liu HB, Liu H, Liu JB, Liu JKK, Liu K, Liu M, Liu P, Liu Y, Liu Y, Liu YL, Liu YW, Livan M, Lleres A, Llorente Merino J, Lloyd SL, Lo CY, Lobodzinska EM, Loch P, Loffredo S, Lohse T, Lohwasser K, Lokajicek M, Long JD, Long RE, Longo L, Looper KA, Lopez Paz I, Lopez Solis A, Lorenz J, Lorenzo Martinez N, Lory AM, Lösel PJ, Lösle A, Lou X, Lou X, Lounis A, Love J, Love PA, Lozano Bahilo JJ, Lu M, Lu YJ, Lubatti HJ, Luci C, Lucotte A, Luedtke C, Luehring F, Luise I, Luminari L, Lund-Jensen B, Lutz MS, Lynn D, Lyons H, Lysak R, Lytken E, Lyu F, Lyubushkin V, Lyubushkina T, Ma H, Ma LL, Ma Y, Maccarrone G, Macchiolo A, Macdonald CM, Machado Miguens J, Madaffari D, Madar R, Mader WF, Madugoda Ralalage Don M, Madysa N, Maeda J, Maeno T, Maerker M, Magerl V, Magini N, Magro J, Mahon DJ, Maidantchik C, Maier T, Maio A, Maj K, Majersky O, Majewski S, Makida Y, Makovec N, Malaescu B, Malecki P, Maleev VP, Malek F, Mallik U, Malon D, Malone C, Maltezos S, Malyukov S, Mamuzic J, Mancini G, Mandić I, Manhaes de Andrade Filho L, Maniatis IM, Manjarres Ramos J, Mankinen KH, Mann A, Manousos A, Mansoulie B, Manthos I, Manzoni S, Marantis A, Marceca G, Marchese L, Marchiori G, Marcisovsky M, Marcoccia L, Marcon C, Marin Tobon CA, Marjanovic M, Marshall Z, Martensson MUF, Marti-Garcia S, Martin CB, Martin TA, Martin VJ, Martin Dit Latour B, Martinelli L, Martinez M, Martinez Outschoorn VI, Martin-Haugh S, Martoiu VS, Martyniuk AC, Marzin A, Maschek SR, Masetti L, Mashimo T, Mashinistov R, Masik J, Maslennikov AL, Massa L, Massarotti P, Mastrandrea P, Mastroberardino A, Masubuchi T, Matakias D, Matic A, Matsuzawa N, Mättig P, Maurer J, Maček B, Maximov DA, Mazini R, Maznas I, Mazza SM, Mc Kee SP, McCarthy TG, McCormack WP, McDonald EF, Mcfayden JA, Mchedlidze G, McKay MA, McLean KD, McMahon SJ, McNamara PC, McNicol CJ, McPherson RA, Mdhluli JE, Meadows ZA, Meehan S, Megy T, Mehlhase S, Mehta A, Meideck T, Meirose B, Melini D, Mellado Garcia BR, Mellenthin JD, Melo M, Meloni F, Melzer A, Menary SB, Mendes Gouveia ED, Meng L, Meng XT, Menke S, Meoni E, Mergelmeyer S, Merkt SAM, Merlassino C, Mermod P, Merola L, Meroni C, Merz G, Meshkov O, Meshreki JKR, Messina A, Metcalfe J, Mete AS, Meyer C, Meyer JP, Meyer Zu Theenhausen H, Miano F, Michetti M, Middleton RP, Mijović L, Mikenberg G, Mikestikova M, Mikuž M, Mildner H, Milesi M, Milic A, Milke CD, Miller DW, Milov A, Milstead DA, Mina RA, Minaenko AA, Miñano Moya M, Minashvili IA, Mincer AI, Mindur B, Mineev M, Minegishi Y, Mir LM, Mirto A, Mistry KP, Mitani T, Mitrevski J, Mitsou VA, Mittal M, Miu O, Miucci A, Miyagawa PS, Mizukami A, Mjörnmark JU, Mkrtchyan T, Mlynarikova M, Moa T, Mochizuki K, Mogg P, Mohapatra S, Moles-Valls R, Mondragon MC, Mönig K, Monk J, Monnier E, Montalbano A, Montejo Berlingen J, Montella M, Monticelli F, Monzani S, Morange N, Moreno D, Moreno Llácer M, Moreno Martinez C, Morettini P, Morgenstern M, Morgenstern S, Mori D, Morii M, Morinaga M, Morisbak V, Morley AK, Mornacchi G, Morris AP, Morvaj L, Moschovakos P, Moser B, Mosidze M, Moskalets T, Moss HJ, Moss J, Moyse EJW, Muanza S, Mueller J, Mueller RSP, Muenstermann D, Mullier GA, Mungo DP, Munoz Martinez JL, Munoz Sanchez FJ, Murin P, Murray WJ, Murrone A, Muškinja M, Mwewa C, Myagkov AG, Myers AA, Myers J, Myska M, Nachman BP, Nackenhorst O, Nag AN, Nagai K, Nagano K, Nagasaka Y, Nagle JL, Nagy E, Nairz AM, Nakahama Y, Nakamura K, Nakamura T, Nanjo H, Napolitano F, Naranjo Garcia RF, Narayan R, Naryshkin I, Naumann T, Navarro G, Nechaeva PY, Nechansky F, Neep TJ, Negri A, Negrini M, Nellist C, Nelson ME, Nemecek S, Nessi M, Neubauer MS, Neuhaus F, Neumann M, Newhouse R, Newman PR, Ng CW, Ng YS, Ng YWY, Ngair B, Nguyen HDN, Nguyen Manh T, Nibigira E, Nickerson RB, Nicolaidou R, Nielsen DS, Nielsen J, Nikiforou N, Nikolaenko V, Nikolic-Audit I, Nikolopoulos K, Nilsson P, Nindhito HR, Ninomiya Y, Nisati A, Nishu N, Nisius R, Nitsche I, Nitta T, Nobe T, Noguchi Y, Nomidis I, Nomura MA, Nordberg M, Novak T, Novgorodova O, Novotny R, Nozka L, Ntekas K, Nurse E, Oakham FG, Oberlack H, Ocariz J, Ochi A, Ochoa I, Ochoa-Ricoux JP, O'Connor K, Oda S, Odaka S, Oerdek S, Ogrodnik A, Oh A, Oh SH, Ohm CC, Oide H, Ojeda ML, Okawa H, Okazaki Y, O'Keefe MW, Okumura Y, Okuyama T, Olariu A, Oleiro Seabra LF, Olivares Pino SA, Oliveira Damazio D, Oliver JL, Olsson MJR, Olszewski A, Olszowska J, O'Neil DC, O'neill AP, Onofre A, Onyisi PUE, Oppen H, Oreglia MJ, Orellana GE, Orestano D, Orlando N, Orr RS, O'Shea V, Ospanov R, Otero Y Garzon G, Otono H, Ott PS, Ottino GJ, Ouchrif M, Ouellette J, Ould-Saada F, Ouraou A, Ouyang Q, Owen M, Owen RE, Ozcan VE, Ozturk N, Pacalt J, Pacey HA, Pachal K, Pacheco Pages A, Padilla Aranda C, Pagan Griso S, Paganini M, Palacino G, Palazzo S, Palestini S, Palka M, Pallin D, Palni P, Panagoulias I, Pandini CE, Panduro Vazquez JG, Pani P, Panizzo G, Paolozzi L, Papadatos C, Papageorgiou K, Parajuli S, Paramonov A, Paredes Hernandez D, Paredes Saenz SR, Parida B, Park TH, Parker AJ, Parker MA, Parodi F, Parrish EW, Parsons JA, Parzefall U, Pascual Dominguez L, Pascuzzi VR, Pasner JMP, Pasquali F, Pasqualucci E, Passaggio S, Pastore F, Pasuwan P, Pataraia S, Pater JR, Pathak A, Patton J, Pauly T, Pearkes J, Pearson B, Pedersen M, Pedraza Diaz L, Pedro R, Peiffer T, Peleganchuk SV, Penc O, Peng H, Peralva BS, Perego MM, Pereira Peixoto AP, Pereira Sanchez L, Perepelitsa DV, Peri F, Perini L, Pernegger H, Perrella S, Perrevoort A, Peters K, Peters RFY, Petersen BA, Petersen TC, Petit E, Petridis A, Petridou C, Petrucci F, Pettee M, Pettersson NE, Petukhova K, Peyaud A, Pezoa R, Pezzotti L, Pham T, Phillips FH, Phillips PW, Phipps MW, Piacquadio G, Pianori E, Picazio A, Pickles RH, Piegaia R, Pietreanu D, Pilcher JE, Pilkington AD, Pinamonti M, Pinfold JL, Pitman Donaldson C, Pitt M, Pizzimento L, Pleier MA, Pleskot V, Plotnikova E, Podberezko P, Poettgen R, Poggi R, Poggioli L, Pogrebnyak I, Pohl D, Pokharel I, Polesello G, Poley A, Policicchio A, Polifka R, Polini A, Pollard CS, Polychronakos V, Ponomarenko D, Pontecorvo L, Popa S, Popeneciu GA, Portales L, Portillo Quintero DM, Pospisil S, Potamianos K, Potrap IN, Potter CJ, Potti H, Poulsen T, Poveda J, Powell TD, Pownall G, Pozo Astigarraga ME, Pralavorio P, Prell S, Price D, Primavera M, Prince S, Proffitt ML, Proklova N, Prokofiev K, Prokoshin F, Protopopescu S, Proudfoot J, Przybycien M, Pudzha D, Puri A, Puzo P, Qian J, Qin Y, Quadt A, Queitsch-Maitland M, Qureshi A, Racko M, Ragusa F, Rahal G, Raine JA, Rajagopalan S, Ramirez Morales A, Ran K, Rashid T, Raspopov S, Rauch DM, Rauscher F, Rave S, Ravina B, Ravinovich I, Rawling JH, Raymond M, Read AL, Readioff NP, Reale M, Rebuzzi DM, Redlinger G, Reeves K, Rehnisch L, Reichert J, Reikher D, Reiss A, Rej A, Rembser C, Renardi A, Renda M, Rescigno M, Resconi S, Resseguie ED, Rettie S, Reynolds B, Reynolds E, Rezanova OL, Reznicek P, Ricci E, Richter R, Richter S, Richter-Was E, Ricken O, Ridel M, Rieck P, Rifki O, Rijssenbeek M, Rimoldi A, Rimoldi M, Rinaldi L, Ripellino G, Riu I, Rivera Vergara JC, Rizatdinova F, Rizvi E, Rizzi C, Roberts RT, Robertson SH, Robin M, Robinson D, Robles Gajardo CM, Robles Manzano M, Robson A, Rocchi A, Rocco E, Roda C, Rodriguez Bosca S, Rodriguez Perez A, Rodriguez Rodriguez D, Rodríguez Vera AM, Roe S, Røhne O, Röhrig R, Rojas RA, Roland B, Roland CPA, Roloff J, Romaniouk A, Romano M, Rompotis N, Ronzani M, Roos L, Rosati S, Rosin G, Rosser BJ, Rossi E, Rossi E, Rossi E, Rossi LP, Rossini L, Rosten R, Rotaru M, Rottler B, Rousseau D, Rovelli G, Roy A, Roy D, Rozanov A, Rozen Y, Ruan X, Rühr F, Ruiz-Martinez A, Rummler A, Rurikova Z, Rusakovich NA, Russell HL, Rustige L, Rutherfoord JP, Rüttinger EM, Rybar M, Rybkin G, Rye EB, Ryzhov A, Sabater Iglesias JA, Sabatini P, Sacerdoti S, Sadrozinski HFW, Sadykov R, Safai Tehrani F, Safarzadeh Samani B, Safdari M, Saha P, Saha S, Sahinsoy M, Sahu A, Saimpert M, Saito M, Saito T, Sakamoto H, Salamani D, Salamanna G, Salazar Loyola JE, Salnikov A, Salt J, Salvador Salas A, Salvatore D, Salvatore F, Salvucci A, Salzburger A, Samarati J, Sammel D, Sampsonidis D, Sampsonidou D, Sánchez J, Sanchez Pineda A, Sandaker H, Sander CO, Sanderswood IG, Sandhoff M, Sandoval C, Sankey DPC, Sannino M, Sano Y, Sansoni A, Santoni C, Santos H, Santpur SN, Santra A, Sapronov A, Saraiva JG, Sasaki O, Sato K, Sauerburger F, Sauvan E, Savard P, Sawada R, Sawyer C, Sawyer L, Sbarra C, Sbrizzi A, Scanlon T, Schaarschmidt J, Schacht P, Schachtner BM, Schaefer D, Schaefer L, Schaeffer J, Schaepe S, Schäfer U, Schaffer AC, Schaile D, Schamberger RD, Scharmberg N, Schegelsky VA, Scheirich D, Schenck F, Schernau M, Schiavi C, Schildgen LK, Schillaci ZM, Schioppa EJ, Schioppa M, Schleicher KE, Schlenker S, Schmidt-Sommerfeld KR, Schmieden K, Schmitt C, Schmitt S, Schmitz S, Schmoeckel JC, Schoeffel L, Schoening A, Scholer PG, Schopf E, Schott M, Schouwenberg JFP, Schovancova J, Schramm S, Schroeder F, Schulte A, Schultz-Coulon HC, Schumacher M, Schumm BA, Schune P, Schwartzman A, Schwarz TA, Schwemling P, Schwienhorst R, Sciandra A, Sciolla G, Scodeggio M, Scornajenghi M, Scuri F, Scutti F, Scyboz LM, Sebastiani CD, Seema P, Seidel SC, Seiden A, Seidlitz BD, Seiss T, Seitz C, Seixas JM, Sekhniaidze G, Sekula SJ, Semprini-Cesari N, Sen S, Serfon C, Serin L, Serkin L, Sessa M, Severini H, Sevova S, Sforza F, Sfyrla A, Shabalina E, Shahinian JD, Shaikh NW, Shaked Renous D, Shan LY, Shapiro M, Sharma A, Sharma AS, Shatalov PB, Shaw K, Shaw SM, Shehade M, Shen Y, Sherman AD, Sherwood P, Shi L, Shimizu S, Shimmin CO, Shimogama Y, Shimojima M, Shipsey IPJ, Shirabe S, Shiyakova M, Shlomi J, Shmeleva A, Shochet MJ, Shojaii J, Shope DR, Shrestha S, Shrif EM, Shulga E, Sicho P, Sickles AM, Sidebo PE, Sideras Haddad E, Sidiropoulou O, Sidoti A, Siegert F, Sijacki D, Silva M, Silva Oliveira MV, Silverstein SB, Simion S, Simoniello R, Simpson-Allsop CJ, Simsek S, Sinervo P, Sinetckii V, Singh S, Sioli M, Siral I, Sivoklokov SY, Sjölin J, Skorda E, Skubic P, Slawinska M, Sliwa K, Slovak R, Smakhtin V, Smart BH, Smiesko J, Smirnov N, Smirnov SY, Smirnov Y, Smirnova LN, Smirnova O, Smith JW, Smizanska M, Smolek K, Smykiewicz A, Snesarev AA, Snoek HL, Snyder IM, Snyder S, Sobie R, Soffer A, Søgaard A, Sohns F, Solans Sanchez CA, Soldatov EY, Soldevila U, Solodkov AA, Soloshenko A, Solovyanov OV, Solovyev V, Sommer P, Son H, Song W, Song WY, Sopczak A, Sopio AL, Sopkova F, Sotiropoulou CL, Sottocornola S, Soualah R, Soukharev AM, South D, Spagnolo S, Spalla M, Spangenberg M, Spanò F, Sperlich D, Spieker TM, Spigo G, Spina M, Spiteri DP, Spousta M, Stabile A, Stamas BL, Stamen R, Stamenkovic M, Stanecka E, Stanislaus B, Stanitzki MM, Stankaityte M, Stapf B, Starchenko EA, Stark GH, Stark J, Staroba P, Starovoitov P, Stärz S, Staszewski R, Stavropoulos G, Stegler M, Steinberg P, Steinhebel AL, Stelzer B, Stelzer HJ, Stelzer-Chilton O, Stenzel H, Stevenson TJ, Stewart GA, Stockton MC, Stoicea G, Stolarski M, Stonjek S, Straessner A, Strandberg J, Strandberg S, Strauss M, Strizenec P, Ströhmer R, Strom DM, Stroynowski R, Strubig A, Stucci SA, Stugu B, Stupak J, Styles NA, Su D, Su W, Suchek S, Sulin VV, Sullivan MJ, Sultan DMS, Sultansoy S, Sumida T, Sun S, Sun X, Suruliz K, Suster CJE, Sutton MR, Suzuki S, Svatos M, Swiatlowski M, Swift SP, Swirski T, Sydorenko A, Sykora I, Sykora M, Sykora T, Ta D, Tackmann K, Taenzer J, Taffard A, Tafirout R, Takashima R, Takeda K, Takeshita T, Takeva EP, Takubo Y, Talby M, Talyshev AA, Tamir NM, Tanaka J, Tanaka R, Tapia Araya S, Tapprogge S, Tarek Abouelfadl Mohamed A, Tarem S, Tariq K, Tarna G, Tartarelli GF, Tas P, Tasevsky M, Tashiro T, Tassi E, Tavares Delgado A, Tayalati Y, Taylor AJ, Taylor GN, Taylor W, Teagle H, Tee AS, Teixeira De Lima R, Teixeira-Dias P, Ten Kate H, Teoh JJ, Terada S, Terashi K, Terron J, Terzo S, Testa M, Teuscher RJ, Thais SJ, Themistokleous N, Theveneaux-Pelzer T, Thiele F, Thomas DW, Thomas JO, Thomas JP, Thompson PD, Thomsen LA, Thomson E, Thorpe EJ, Ticse Torres RE, Tikhomirov VO, Tikhonov YA, Timoshenko S, Tipton P, Tisserant S, Todome K, Todorova-Nova S, Todt S, Tojo J, Tokár S, Tokushuku K, Tolley E, Tomiwa KG, Tomoto M, Tompkins L, Tornambe P, Torrence E, Torres H, Torró Pastor E, Tosciri C, Toth J, Tovey DR, Traeet A, Treado CJ, Trefzger T, Tresoldi F, Tricoli A, Trigger IM, Trincaz-Duvoid S, Trischuk DA, Trischuk W, Trocmé B, Trofymov A, Troncon C, Trovato F, Truong L, Trzebinski M, Trzupek A, Tsai F, Tseng JCL, Tsiareshka PV, Tsirigotis A, Tsiskaridze V, Tskhadadze EG, Tsopoulou M, Tsukerman II, Tsulaia V, Tsuno S, Tsybychev D, Tu Y, Tudorache A, Tudorache V, Tulbure TT, Tuna AN, Turchikhin S, Turgeman D, Turk Cakir I, Turner RJ, Turra R, Tuts PM, Tzamarias S, Tzovara E, Ucchielli G, Uchida K, Ukegawa F, Unal G, Undrus A, Unel G, Ungaro FC, Unno Y, Uno K, Urban J, Urquijo P, Usai G, Uysal Z, Vacek V, Vachon B, Vadla KOH, Vaidya A, Valderanis C, Valdes Santurio E, Valente M, Valentinetti S, Valero A, Valéry L, Vallance RA, Vallier A, Valls Ferrer JA, Van Daalen TR, Van Gemmeren P, Van Vulpen I, Vanadia M, Vandelli W, Vandenbroucke M, Vandewall ER, Vaniachine A, Vannicola D, Vari R, Varnes EW, Varni C, Varol T, Varouchas D, Varvell KE, Vasile ME, Vasquez GA, Vazeille F, Vazquez Furelos D, Vazquez Schroeder T, Veatch J, Vecchio V, Veen MJ, Veloce LM, Veloso F, Veneziano S, Ventura A, Venturi N, Verbytskyi A, Vercesi V, Verducci M, Vergel Infante CM, Vergis C, Verkerke W, Vermeulen AT, Vermeulen JC, Vernieri C, Vetterli MC, Viaux Maira N, Vickey T, Vickey Boeriu OE, Viehhauser GHA, Vigani L, Villa M, Villaplana Perez M, Vilucchi E, Vincter MG, Virdee GS, Vishwakarma A, Vittori C, Vivarelli I, Vogel M, Vokac P, von Buddenbrock SE, Von Toerne E, Vorobel V, Vorobev K, Vos M, Vossebeld JH, Vozak M, Vranjes N, Vranjes Milosavljevic M, Vrba V, Vreeswijk M, Vuillermet R, Vukotic I, Wada S, Wagner P, Wagner W, Wagner-Kuhr J, Wahdan S, Wahlberg H, Wakasa R, Walbrecht VM, Walder J, Walker R, Walker SD, Walkowiak W, Wallangen V, Wang AM, Wang AZ, Wang C, Wang F, Wang H, Wang H, Wang J, Wang J, Wang P, Wang Q, Wang RJ, Wang R, Wang R, Wang SM, Wang WT, Wang W, Wang WX, Wang Y, Wang Z, Wanotayaroj C, Warburton A, Ward CP, Wardrope DR, Warrack N, Washbrook A, Watson AT, Watson MF, Watts G, Waugh BM, Webb AF, Weber C, Weber MS, Weber SA, Weber SM, Weidberg AR, Weingarten J, Weirich M, Weiser C, Wells PS, Wenaus T, Wengler T, Wenig S, Wermes N, Werner MD, Wessels M, Weston TD, Whalen K, Whallon NL, Wharton AM, White AS, White A, White MJ, Whiteson D, Whitmore BW, Wiedenmann W, Wiel C, Wielers M, Wieseotte N, Wiglesworth C, Wiik-Fuchs LAM, Wilkens HG, Wilkins LJ, Williams HH, Williams S, Willis C, Willocq S, Wingerter-Seez I, Winkels E, Winklmeier F, Winter BT, Wittgen M, Wobisch M, Wolf A, Wolf TMH, Wolff R, Wölker R, Wollrath J, Wolter MW, Wolters H, Wong VWS, Woods NL, Worm SD, Wosiek BK, Woźniak KW, Wraight K, Wu SL, Wu X, Wu Y, Wyatt TR, Wynne BM, Xella S, Xi Z, Xia L, Xiao X, Xiotidis I, Xu D, Xu H, Xu H, Xu L, Xu T, Xu W, Xu Z, Xu Z, Yabsley B, Yacoob S, Yajima K, Yallup DP, Yamaguchi N, Yamaguchi Y, Yamamoto A, Yamatani M, Yamazaki T, Yamazaki Y, Yan J, Yan Z, Yang HJ, Yang HT, Yang S, Yang T, Yang X, Yang Y, Yang Z, Yao WM, Yap YC, Yasu Y, Yatsenko E, Ye H, Ye J, Ye S, Yeletskikh I, Yexley MR, Yigitbasi E, Yorita K, Yoshihara K, Young CJS, Young C, Yu J, Yuan R, Yue X, Zaazoua M, Zabinski B, Zacharis G, Zaffaroni E, Zahreddine J, Zaitsev AM, Zakareishvili T, Zakharchuk N, Zambito S, Zanzi D, Zaripovas DR, Zeißner SV, Zeitnitz C, Zemaityte G, Zeng JC, Zenin O, Ženiš T, Zerwas D, Zgubič M, Zhang B, Zhang DF, Zhang G, Zhang H, Zhang J, Zhang K, Zhang L, Zhang L, Zhang M, Zhang R, Zhang S, Zhang X, Zhang X, Zhang Y, Zhang Z, Zhang Z, Zhao P, Zhao Z, Zhemchugov A, Zheng Z, Zhong D, Zhou B, Zhou C, Zhou H, Zhou MS, Zhou M, Zhou N, Zhou Y, Zhu CG, Zhu C, Zhu HL, Zhu H, Zhu J, Zhu Y, Zhuang X, Zhukov K, Zhulanov V, Zieminska D, Zimine NI, Zimmermann S, Zinonos Z, Ziolkowski M, Živković L, Zobernig G, Zoccoli A, Zoch K, Zorbas TG, Zou R, Zwalinski L. Longitudinal Flow Decorrelations in Xe+Xe Collisions at sqrt[s_{NN}]=5.44 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS 2021; 126:122301. [PMID: 33834811 DOI: 10.1103/physrevlett.126.122301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/14/2020] [Revised: 06/16/2020] [Accepted: 02/12/2021] [Indexed: 06/12/2023]
Abstract
The first measurement of longitudinal decorrelations of harmonic flow amplitudes v_{n} for n=2-4 in Xe+Xe collisions at sqrt[s_{NN}]=5.44 TeV is obtained using 3 μb^{-1} of data with the ATLAS detector at the LHC. The decorrelation signal for v_{3} and v_{4} is found to be nearly independent of collision centrality and transverse momentum (p_{T}) requirements on final-state particles, but for v_{2} a strong centrality and p_{T} dependence is seen. When compared with the results from Pb+Pb collisions at sqrt[s_{NN}]=5.02 TeV, the longitudinal decorrelation signal in midcentral Xe+Xe collisions is found to be larger for v_{2}, but smaller for v_{3}. Current hydrodynamic models reproduce the ratios of the v_{n} measured in Xe+Xe collisions to those in Pb+Pb collisions but fail to describe the magnitudes and trends of the ratios of longitudinal flow decorrelations between Xe+Xe and Pb+Pb. The results on the system-size dependence provide new insights and an important lever arm to separate effects of the longitudinal structure of the initial state from other early and late time effects in heavy-ion collisions.
Collapse
|
238
|
Aad G, Abbott B, Abbott DC, Abed Abud A, Abeling K, Abhayasinghe DK, Abidi SH, AbouZeid OS, Abraham NL, Abramowicz H, Abreu H, Abulaiti Y, Acharya BS, Achkar B, Adam L, Adam Bourdarios C, Adamczyk L, Adamek L, Adelman J, Adiguzel A, Adorni S, Adye T, Affolder AA, Afik Y, Agapopoulou C, Agaras MN, Aggarwal A, Agheorghiesei C, Aguilar-Saavedra JA, Ahmad A, Ahmadov F, Ahmed WS, Ai X, Aielli G, Akatsuka S, Akbiyik M, Åkesson TPA, Akilli E, Akimov AV, Al Khoury K, Alberghi GL, Albert J, Alconada Verzini MJ, Alderweireldt S, Aleksa M, Aleksandrov IN, Alexa C, Alexopoulos T, Alfonsi A, Alfonsi F, Alhroob M, Ali B, Ali S, Aliev M, Alimonti G, Allaire C, Allbrooke BMM, Allen BW, Allport PP, Aloisio A, Alonso F, Alpigiani C, Alunno Camelia E, Alvarez Estevez M, Alviggi MG, Amaral Coutinho Y, Ambler A, Ambroz L, Amelung C, Amidei D, Amor Dos Santos SP, Amoroso S, Amrouche CS, An F, Anastopoulos C, Andari N, Andeen T, Anders JK, Andrean SY, Andreazza A, Andrei V, Anelli CR, Angelidakis S, Angerami A, Anisenkov AV, Annovi A, Antel C, Anthony MT, Antipov E, Antonelli M, Antrim DJA, Anulli F, Aoki M, Aparisi Pozo JA, Aparo MA, Aperio Bella L, Aranzabal N, Araujo Ferraz V, Araujo Pereira R, Arcangeletti C, Arce ATH, Arguin JF, Argyropoulos S, Arling JH, Armbruster AJ, Armstrong A, Arnaez O, Arnold H, Arrubarrena Tame ZP, Artoni G, Asada H, Asai K, Asai S, Asawatavonvanich T, Asbah N, Asimakopoulou EM, Asquith L, Assahsah J, Assamagan K, Astalos R, Atkin RJ, Atkinson M, Atlay NB, Atmani H, Atmasiddha PA, Augsten K, Austrup VA, Avolio G, Ayoub MK, Azuelos G, Babal D, Bachacou H, Bachas K, Backman F, Bagnaia P, Bahmani M, Bahrasemani H, Bailey AJ, Bailey VR, Baines JT, Bakalis C, Baker OK, Bakker PJ, Bakos E, Bakshi Gupta D, Balaji S, Balasubramanian R, Baldin EM, Balek P, Balli F, Balunas WK, Balz J, Banas E, Bandieramonte M, Bandyopadhyay A, Banerjee S, Barak L, Barbe WM, Barberio EL, Barberis D, Barbero M, Barbour G, Barillari T, Barisits MS, Barkeloo J, Barklow T, Barnea R, Barnett BM, Barnett RM, Barnovska-Blenessy Z, Baroncelli A, Barone G, Barr AJ, Barranco Navarro L, Barreiro F, Barreiro Guimarães da Costa J, Barron U, Barsov S, Bartels F, Bartoldus R, Bartolini G, Barton AE, Bartos P, Basalaev A, Basan A, Bassalat A, Basso MJ, Bates RL, Batlamous S, Batley JR, Batool B, Battaglia M, Bauce M, Bauer F, Bauer P, Bawa HS, Bayirli A, Beacham JB, Beau T, Beauchemin PH, Becherer F, Bechtle P, Beck HC, Beck HP, Becker K, Becot C, Beddall A, Beddall AJ, Bednyakov VA, Bedognetti M, Bee CP, Beermann TA, Begalli M, Begel M, Behera A, Behr JK, Beisiegel F, Belfkir M, Bell AS, Bella G, Bellagamba L, Bellerive A, Bellos P, Beloborodov K, Belotskiy K, Belyaev NL, Benchekroun D, Benekos N, Benhammou Y, Benjamin DP, Benoit M, Bensinger JR, Bentvelsen S, Beresford L, Beretta M, Berge D, Bergeaas Kuutmann E, Berger N, Bergmann B, Bergsten LJ, Beringer J, Berlendis S, Bernardi G, Bernius C, Bernlochner FU, Berry T, Berta P, Berthold A, Bertram IA, Bessidskaia Bylund O, Besson N, Bethke S, Betti A, Bevan AJ, Beyer J, Bhatta S, Bhattacharya DS, Bhattarai P, Bhopatkar VS, Bi R, Bianchi RM, Biebel O, Biedermann D, Bielski R, Bierwagen K, Biesuz NV, Biglietti M, Billoud TRV, Bindi M, Bingul A, Bini C, Biondi S, Birch-Sykes CJ, Birman M, Bisanz T, Biswal JP, Biswas D, Bitadze A, Bittrich C, Bjørke K, Blazek T, Bloch I, Blocker C, Blue A, Blumenschein U, Bobbink GJ, Bobrovnikov VS, Bocchetta SS, Bogavac D, Bogdanchikov AG, Bohm C, Boisvert V, Bokan P, Bold T, Bolz AE, Bomben M, Bona M, Bonilla JS, Boonekamp M, Booth CD, Borbély AG, Borecka-Bielska HM, Borgna LS, Borisov A, Borissov G, Bortoletto D, Boscherini D, Bosman M, Bossio Sola JD, Bouaouda K, Boudreau J, Bouhova-Thacker EV, Boumediene D, Boveia A, Boyd J, Boye D, Boyko IR, Bozson AJ, Bracinik J, Brahimi N, Brandt G, Brandt O, Braren F, Brau B, Brau JE, Breaden Madden WD, Brendlinger K, Brener R, Brenner L, Brenner R, Bressler S, Brickwedde B, Briglin DL, Britton D, Britzger D, Brock I, Brock R, Brooijmans G, Brooks WK, Brost E, Bruckman de Renstrom PA, Brüers B, Bruncko D, Bruni A, Bruni G, Bruschi M, Bruscino N, Bryngemark L, Buanes T, Buat Q, Buchholz P, Buckley AG, Budagov IA, Bugge MK, Bulekov O, Bullard BA, Burch TJ, Burdin S, Burgard CD, Burger AM, Burghgrave B, Burr JTP, Burton CD, Burzynski JC, Büscher V, Buschmann E, Bussey PJ, Butler JM, Buttar CM, Butterworth JM, Butti P, Buttinger W, Buxo Vazquez CJ, Buzatu A, Buzykaev AR, Cabras G, Cabrera Urbán S, Caforio D, Cai H, Cairo VMM, Cakir O, Calace N, Calafiura P, Calderini G, Calfayan P, Callea G, Caloba LP, Caltabiano A, Calvente Lopez S, Calvet D, Calvet S, Calvet TP, Calvetti M, Camacho Toro R, Camarda S, Camarero Munoz D, Camarri P, Camerlingo MT, Cameron D, Camincher C, Campana S, Campanelli M, Camplani A, Canale V, Canesse A, Cano Bret M, Cantero J, Cao T, Cao Y, Capua M, Cardarelli R, Cardillo F, Carducci G, Carli I, Carli T, Carlino G, Carlson BT, Carlson EM, Carminati L, Carney RMD, Caron S, Carquin E, Carrá S, Carratta G, Carter JWS, Carter TM, Casado MP, Casha AF, Castiglia EG, Castillo FL, Castillo Garcia L, Castillo Gimenez V, Castro NF, Catinaccio A, Catmore JR, Cattai A, Cavaliere V, Cavasinni V, Celebi E, Celli F, Cerny K, Cerqueira AS, Cerri A, Cerrito L, Cerutti F, Cervelli A, Cetin SA, Chadi Z, Chakraborty D, Chan J, Chan WS, Chan WY, Chapman JD, Chargeishvili B, Charlton DG, Charman TP, Chatterjee M, Chau CC, Che S, Chekanov S, Chekulaev SV, Chelkov GA, Chen B, Chen C, Chen CH, Chen H, Chen H, Chen J, Chen J, Chen J, Chen S, Chen SJ, Chen X, Chen Y, Chen YH, Cheng HC, Cheng HJ, Cheplakov A, Cheremushkina E, Cherkaoui El Moursli R, Cheu E, Cheung K, Chevalérias TJA, Chevalier L, Chiarella V, Chiarelli G, Chiodini G, Chisholm AS, Chitan A, Chiu I, Chiu YH, Chizhov MV, Choi K, Chomont AR, Chou Y, Chow YS, Christopher LD, Chu MC, Chu X, Chudoba J, Chwastowski JJ, Chytka L, Cieri D, Ciesla KM, Cindro V, Cioară IA, Ciocio A, Cirotto F, Citron ZH, Citterio M, Ciubotaru DA, Ciungu BM, Clark A, Clark PJ, Clawson SE, Clement C, Coadou Y, Cobal M, Coccaro A, Cochran J, Coelho Lopes De Sa R, Cohen H, Coimbra AEC, Cole B, Colijn AP, Collot J, Conde Muiño P, Connell SH, Connelly IA, Constantinescu S, Conventi F, Cooper-Sarkar AM, Cormier F, Cormier KJR, Corpe LD, Corradi M, Corrigan EE, Corriveau F, Costa MJ, Costanza F, Costanzo D, Cowan G, Cowley JW, Crane J, Cranmer K, Creager RA, Crépé-Renaudin S, Crescioli F, Cristinziani M, Croft V, Crosetti G, Cueto A, Cuhadar Donszelmann T, Cui H, Cukierman AR, Cunningham WR, Czekierda S, Czodrowski P, Czurylo MM, Da Cunha Sargedas De Sousa MJ, Da Fonseca Pinto JV, Da Via C, Dabrowski W, Dachs F, Dado T, Dahbi S, Dai T, Dallapiccola C, Dam M, D'amen G, D'Amico V, Damp J, Dandoy JR, Daneri MF, Danninger M, Dao V, Darbo G, Dartsi O, Dattagupta A, Daubney T, D'Auria S, David C, Davidek T, Davis DR, Dawson I, De K, De Asmundis R, De Beurs M, De Castro S, De Groot N, de Jong P, De la Torre H, De Maria A, De Pedis D, De Salvo A, De Sanctis U, De Santis M, De Santo A, De Vivie De Regie JB, Dedovich DV, Deiana AM, Del Peso J, Delabat Diaz Y, Delgove D, Deliot F, Delitzsch CM, Della Pietra M, Della Volpe D, Dell'Acqua A, Dell'Asta L, Delmastro M, Delporte C, Delsart PA, Demers S, Demichev M, Demontigny G, Denisov SP, D'Eramo L, Derendarz D, Derkaoui JE, Derue F, Dervan P, Desch K, Dette K, Deutsch C, Devesa MR, Deviveiros PO, Di Bello FA, Di Ciaccio A, Di Ciaccio L, Di Clemente WK, Di Donato C, Di Girolamo A, Di Gregorio G, Di Luca A, Di Micco B, Di Nardo R, Di Petrillo KF, Di Sipio R, Diaconu C, Dias FA, Dias Do Vale T, Diaz MA, Diaz Capriles FG, Dickinson J, Didenko M, Diehl EB, Dietrich J, Díez Cornell S, Diez Pardos C, Dimitrievska A, Ding W, Dingfelder J, Dittmeier SJ, Dittus F, Djama F, Djobava T, Djuvsland JI, Do Vale MAB, Dobre M, Dodsworth D, Doglioni C, Dolejsi J, Dolezal Z, Donadelli M, Dong B, Donini J, D'onofrio A, D'Onofrio M, Dopke J, Doria A, Dova MT, Doyle AT, Drechsler E, Dreyer E, Dreyer T, Drobac AS, Du D, du Pree TA, Duan Y, Dubinin F, Dubovsky M, Dubreuil A, Duchovni E, Duckeck G, Ducu OA, Duda D, Dudarev A, Dudder AC, Duffield EM, D'uffizi M, Duflot L, Dührssen M, Dülsen C, Dumancic M, Dumitriu AE, Dunford M, Dungs S, Duperrin A, Duran Yildiz H, Düren M, Durglishvili A, Duschinger D, Dutta B, Duvnjak D, Dyckes GI, Dyndal M, Dysch S, Dziedzic BS, Eggleston MG, Eifert T, Eigen G, Einsweiler K, Ekelof T, El Jarrari H, Ellajosyula V, Ellert M, Ellinghaus F, Elliot AA, Ellis N, Elmsheuser J, Elsing M, Emeliyanov D, Emerman A, Enari Y, Epland MB, Erdmann J, Ereditato A, Erland PA, Errenst M, Escalier M, Escobar C, Estrada Pastor O, Etzion E, Evans GE, Evans H, Evans MO, Ezhilov A, Fabbri F, Fabbri L, Fabiani V, Facini G, Fakhrutdinov RM, Falciano S, Falke PJ, Falke S, Faltova J, Fang Y, Fang Y, Fanourakis G, Fanti M, Faraj M, Farbin A, Farilla A, Farina EM, Farooque T, Farrington SM, Farthouat P, Fassi F, Fassnacht P, Fassouliotis D, Faucci Giannelli M, Fawcett WJ, Fayard L, Fedin OL, Fedorko W, Fehr A, Feickert M, Feligioni L, Fell A, Feng C, Feng M, Fenton MJ, Fenyuk AB, Ferguson SW, Ferrando J, Ferrari A, Ferrari P, Ferrari R, Ferreira de Lima DE, Ferrer A, Ferrere D, Ferretti C, Fiedler F, Filipčič A, Filthaut F, Finelli KD, Fiolhais MCN, Fiorini L, Fischer F, Fischer J, Fisher WC, Fitschen T, Fleck I, Fleischmann P, Flick T, Flierl BM, Flores L, Flores Castillo LR, Follega FM, Fomin N, Foo JH, Forcolin GT, Forland BC, Formica A, Förster FA, Forti AC, Fortin E, Foti MG, Fournier D, Fox H, Francavilla P, Francescato S, Franchini M, Franchino S, Francis D, Franco L, Franconi L, Franklin M, Frattari G, Fray AN, Freeman PM, Freund B, Freund WS, Freundlich EM, Frizzell DC, Froidevaux D, Frost JA, Fujimoto M, Fukunaga C, Fullana Torregrosa E, Fusayasu T, Fuster J, Gabrielli A, Gabrielli A, Gadatsch S, Gadow P, Gagliardi G, Gagnon LG, Gallardo GE, Gallas EJ, Gallop BJ, Gamboa Goni R, Gan KK, Ganguly S, Gao J, Gao Y, Gao YS, Garay Walls FM, García C, García Navarro JE, García Pascual JA, Garcia-Argos C, Garcia-Sciveres M, Gardner RW, Garelli N, Gargiulo S, Garner CA, Garonne V, Gasiorowski SJ, Gaspar P, Gaudiello A, Gaudio G, Gauzzi P, Gavrilenko IL, Gavrilyuk A, Gay C, Gaycken G, Gazis EN, Geanta AA, Gee CM, Gee CNP, Geisen J, Geisen M, Gemme C, Genest MH, Geng C, Gentile S, George S, Geralis T, Gerlach LO, Gessinger-Befurt P, Gessner G, Ghasemi Bostanabad M, Ghneimat M, Ghosh A, Ghosh A, Giacobbe B, Giagu S, Giangiacomi N, Giannetti P, Giannini A, Giannini G, Gibson SM, Gignac M, Gil DT, Gilbert BJ, Gillberg D, Gilles G, Gillwald NEK, Gingrich DM, Giordani MP, Giraud PF, Giugliarelli G, Giugni D, Giuli F, Gkaitatzis S, Gkialas I, Gkougkousis EL, Gkountoumis P, Gladilin LK, Glasman C, Glatzer J, Glaysher PCF, Glazov A, Gledhill GR, Gnesi I, Goblirsch-Kolb M, Godin D, Goldfarb S, Golling T, Golubkov D, Gomes A, Goncalves Gama R, Gonçalo R, Gonella G, Gonella L, Gongadze A, Gonnella F, Gonski JL, González de la Hoz S, Gonzalez Fernandez S, Gonzalez Lopez R, Gonzalez Renteria C, Gonzalez Suarez R, Gonzalez-Sevilla S, Gonzalvo Rodriguez GR, Goossens L, Gorasia NA, Gorbounov PA, Gordon HA, Gorini B, Gorini E, Gorišek A, Goshaw AT, Gostkin MI, Gottardo CA, Gouighri M, Goussiou AG, Govender N, Goy C, Grabowska-Bold I, Graham EC, Gramling J, Gramstad E, Grancagnolo S, Grandi M, Gratchev V, Gravila PM, Gravili FG, Gray C, Gray HM, Grefe C, Gregersen K, Gregor IM, Grenier P, Grevtsov K, Grieco C, Grieser NA, Grillo AA, Grimm K, Grinstein S, Grivaz JF, Groh S, Gross E, Grosse-Knetter J, Grout ZJ, Grud C, Grummer A, Grundy JC, Guan L, Guan W, Gubbels C, Guenther J, Guerguichon A, Guerrero Rojas JGR, Guescini F, Guest D, Gugel R, Guida A, Guillemin T, Guindon S, Guo J, Guo W, Guo Y, Guo Z, Gupta R, Gurbuz S, Gustavino G, Guth M, Gutierrez P, Gutschow C, Guyot C, Gwenlan C, Gwilliam CB, Haaland ES, Haas A, Haber C, Hadavand HK, Hadef A, Haleem M, Haley J, Hall JJ, Halladjian G, Hallewell GD, Hamano K, Hamdaoui H, Hamer M, Hamity GN, Han K, Han L, Han L, Han S, Han YF, Hanagaki K, Hance M, Handl DM, Hank MD, Hankache R, Hansen E, Hansen JB, Hansen JD, Hansen MC, Hansen PH, Hanson EC, Hara K, Harenberg T, Harkusha S, Harrison PF, Hartman NM, Hartmann NM, Hasegawa Y, Hasib A, Hassani S, Haug S, Hauser R, Havranek M, Hawkes CM, Hawkings RJ, Hayashida S, Hayden D, Hayes C, Hayes RL, Hays CP, Hays JM, Hayward HS, Haywood SJ, He F, He Y, Heath MP, Hedberg V, Heggelund AL, Hehir ND, Heidegger C, Heidegger KK, Heidorn WD, Heilman J, Heim S, Heim T, Heinemann B, Heinlein JG, Heinrich JJ, Heinrich L, Hejbal J, Helary L, Held A, Hellesund S, Helling CM, Hellman S, Helsens C, Henderson RCW, Henkelmann L, Henriques Correia AM, Herde H, Hernández Jiménez Y, Herr H, Herrmann MG, Herrmann T, Herten G, Hertenberger R, Hervas L, Hesketh GG, Hessey NP, Hibi H, Higashino S, Higón-Rodriguez E, Hildebrand K, Hill JC, Hill KK, Hiller KH, Hillier SJ, Hils M, Hinchliffe I, Hinterkeuser F, Hirose M, Hirose S, Hirschbuehl D, Hiti B, Hladik O, Hobbs J, Hobincu R, Hod N, Hodgkinson MC, Hoecker A, Hohn D, Hohov D, Holm T, Holmes TR, Holzbock M, Hommels LBAH, Hong TM, Honig JC, Hönle A, Hooberman BH, Hopkins WH, Horii Y, Horn P, Horyn LA, Hou S, Hoummada A, Howarth J, Hoya J, Hrabovsky M, Hrivnac J, Hrynevich A, Hryn'ova T, Hsu PJ, Hsu SC, Hu Q, Hu S, Hu YF, Huang DP, Huang X, Huang Y, Huang Y, Hubacek Z, Hubaut F, Huebner M, Huegging F, Huffman TB, Huhtinen M, Hulsken R, Hunter RFH, Huseynov N, Huston J, Huth J, Hyneman R, Hyrych S, Iacobucci G, Iakovidis G, Ibragimov I, Iconomidou-Fayard L, Iengo P, Ignazzi R, Iguchi R, Iizawa T, Ikegami Y, Ikeno M, Ilic N, Iltzsche F, Imam H, Introzzi G, Iodice M, Iordanidou K, Ippolito V, Isacson MF, Ishino M, Islam W, Issever C, Istin S, Iturbe Ponce JM, Iuppa R, Ivina A, Izen JM, Izzo V, Jacka P, Jackson P, Jacobs RM, Jaeger BP, Jain V, Jäkel G, Jakobi KB, Jakobs K, Jakoubek T, Jamieson J, Janas KW, Jansky R, Janus M, Janus PA, Jarlskog G, Jaspan AE, Javadov N, Javůrek T, Javurkova M, Jeanneau F, Jeanty L, Jejelava J, Jenni P, Jeong N, Jézéquel S, Jia J, Jia Z, Jiang H, Jiang Y, Jiang Z, Jiggins S, Jimenez Morales FA, Jimenez Pena J, Jin S, Jinaru A, Jinnouchi O, Jivan H, Johansson P, Johns KA, Johnson CA, Jones E, Jones RWL, Jones SD, Jones TJ, Jovicevic J, Ju X, Junggeburth JJ, Juste Rozas A, Kaczmarska A, Kado M, Kagan H, Kagan M, Kahn A, Kahra C, Kaji T, Kajomovitz E, Kalderon CW, Kaluza A, Kamenshchikov A, Kaneda M, Kang NJ, Kang S, Kano Y, Kanzaki J, Kaplan LS, Kar D, Karava K, Kareem MJ, Karkanias I, Karpov SN, Karpova ZM, Kartvelishvili V, Karyukhin AN, Kasimi E, Kastanas A, Kato C, Katzy J, Kawade K, Kawagoe K, Kawaguchi T, Kawamoto T, Kawamura G, Kay EF, Kaya FI, Kazakos S, Kazanin VF, Keaveney JM, Keeler R, Keller JS, Kellermann E, Kelsey D, Kempster JJ, Kendrick J, Kennedy KE, Kepka O, Kersten S, Kerševan BP, Ketabchi Haghighat S, Khalil-Zada F, Khandoga M, Khanov A, Kharlamov AG, Kharlamova T, Khoda EE, Khoo TJ, Khoriauli G, Khramov E, Khubua J, Kido S, Kiehn M, Kim E, Kim YK, Kimura N, Kirchhoff A, Kirchmeier D, Kirk J, Kiryunin AE, Kishimoto T, Kisliuk DP, Kitali V, Kitsaki C, Kivernyk O, Klapdor-Kleingrothaus T, Klassen M, Klein C, Klein MH, Klein M, Klein U, Kleinknecht K, Klimek P, Klimentov A, Klimpel F, Klingl T, Klioutchnikova T, Klitzner FF, Kluit P, Kluth S, Kneringer E, Knoops EBFG, Knue A, Kobayashi D, Kobel M, Kocian M, Kodama T, Kodys P, Koeck DM, Koenig PT, Koffas T, Köhler NM, Kolb M, Koletsou I, Komarek T, Kondo T, Köneke K, Kong AXY, König AC, Kono T, Konstantinides V, Konstantinidis N, Konya B, Kopeliansky R, Koperny S, Korcyl K, Kordas K, Koren G, Korn A, Korolkov I, Korolkova EV, Korotkova N, Kortner O, Kortner S, Kostyukhin VV, Kotsokechagia A, Kotwal A, Koulouris A, Kourkoumeli-Charalampidi A, Kourkoumelis C, Kourlitis E, Kouskoura V, Kowalewski R, Kozanecki W, Kozhin AS, Kramarenko VA, Kramberger G, Krasnopevtsev D, Krasny MW, Krasznahorkay A, Krauss D, Kremer JA, Kretzschmar J, Kreul K, Krieger P, Krieter F, Krishnamurthy S, Krishnan A, Krivos M, Krizka K, Kroeninger K, Kroha H, Kroll J, Kroll J, Krowpman KS, Kruchonak U, Krüger H, Krumnack N, Kruse MC, Krzysiak JA, Kubota A, Kuchinskaia O, Kuday S, Kuechler D, Kuechler JT, Kuehn S, Kuhl T, Kukhtin V, Kulchitsky Y, Kuleshov S, Kulinich YP, Kuna M, Kupco A, Kupfer T, Kuprash O, Kurashige H, Kurchaninov LL, Kurochkin YA, Kurova A, Kurth MG, Kuwertz ES, Kuze M, Kvam AK, Kvita J, Kwan T, Lacasta C, Lacava F, Lack DPJ, Lacker H, Lacour D, Ladygin E, Lafaye R, Laforge B, Lagouri T, Lai S, Lakomiec IK, Lambert JE, Lammers S, Lampl W, Lampoudis C, Lançon E, Landgraf U, Landon MPJ, Lang VS, Lange JC, Langenberg RJ, Lankford AJ, Lanni F, Lantzsch K, Lanza A, Lapertosa A, Laporte JF, Lari T, Lasagni Manghi F, Lassnig M, Latonova V, Lau TS, Laudrain A, Laurier A, Lavorgna M, Lawlor SD, Lazzaroni M, Le B, Le Guirriec E, Lebedev A, LeBlanc M, LeCompte T, Ledroit-Guillon F, Lee ACA, Lee CA, Lee GR, Lee L, Lee SC, Lee S, Lefebvre B, Lefebvre HP, Lefebvre M, Leggett C, Lehmann K, Lehmann N, Lehmann Miotto G, Leight WA, Leisos A, Leite MAL, Leitgeb CE, Leitner R, Leney KJC, Lenz T, Leone S, Leonidopoulos C, Leopold A, Leroy C, Les R, Lester CG, Levchenko M, Levêque J, Levin D, Levinson LJ, Lewis DJ, Li B, Li B, Li CQ, Li F, Li H, Li H, Li J, Li K, Li L, Li M, Li QY, Li S, Li X, Li Y, Li Z, Li Z, Li Z, Li Z, Liang Z, Liberatore M, Liberti B, Lie K, Lim S, Lin CY, Lin K, Linck RA, Lindley RE, Lindon JH, Linss A, Lionti AL, Lipeles E, Lipniacka A, Liss TM, Lister A, Little JD, Liu B, Liu BL, Liu HB, Liu JB, Liu JKK, Liu K, Liu M, Liu MY, Liu P, Liu X, Liu Y, Liu Y, Liu YL, Liu YW, Livan M, Lleres A, Llorente Merino J, Lloyd SL, Lo CY, Lobodzinska EM, Loch P, Loffredo S, Lohse T, Lohwasser K, Lokajicek M, Long JD, Long RE, Longarini I, Longo L, Lopez Paz I, Lopez Solis A, Lorenz J, Lorenzo Martinez N, Lory AM, Lösle A, Lou X, Lou X, Lounis A, Love J, Love PA, Lozano Bahilo JJ, Lu M, Lu YJ, Lubatti HJ, Luci C, Lucio Alves FL, Lucotte A, Luehring F, Luise I, Luminari L, Lund-Jensen B, Luongo NA, Lutz MS, Lynn D, Lyons H, Lysak R, Lytken E, Lyu F, Lyubushkin V, Lyubushkina T, Ma H, Ma LL, Ma Y, Mac Donell DM, Maccarrone G, Macdonald CM, MacDonald JC, Machado Miguens J, Madar R, Mader WF, Madugoda Ralalage Don M, Madysa N, Maeda J, Maeno T, Maerker M, Magerl V, Magini N, Magro J, Mahon DJ, Maidantchik C, Maio A, Maj K, Majersky O, Majewski S, Makida Y, Makovec N, Malaescu B, Malecki P, Maleev VP, Malek F, Malito D, Mallik U, Malone C, Maltezos S, Malyukov S, Mamuzic J, Mancini G, Mandalia JP, Mandić I, Manhaes de Andrade Filho L, Maniatis IM, Manjarres Ramos J, Mankinen KH, Mann A, Manousos A, Mansoulie B, Manthos I, Manzoni S, Marantis A, Marceca G, Marchese L, Marchiori G, Marcisovsky M, Marcoccia L, Marcon C, Marjanovic M, Marshall Z, Martensson MUF, Marti-Garcia S, Martin CB, Martin TA, Martin VJ, Martin Dit Latour B, Martinelli L, Martinez M, Martinez Agullo P, Martinez Outschoorn VI, Martin-Haugh S, Martoiu VS, Martyniuk AC, Marzin A, Maschek SR, Masetti L, Mashimo T, Mashinistov R, Masik J, Maslennikov AL, Massa L, Massarotti P, Mastrandrea P, Mastroberardino A, Masubuchi T, Matakias D, Matic A, Matsuzawa N, Mättig P, Maurer J, Maček B, Maximov DA, Mazini R, Maznas I, Mazza SM, Mc Gowan JP, Mc Kee SP, McCarthy TG, McCormack WP, McDonald EF, McDougall AE, Mcfayden JA, Mchedlidze G, McKay MA, McLean KD, McMahon SJ, McNamara PC, McNicol CJ, McPherson RA, Mdhluli JE, Meadows ZA, Meehan S, Megy T, Mehlhase S, Mehta A, Meirose B, Melini D, Mellado Garcia BR, Mellenthin JD, Melo M, Meloni F, Melzer A, Mendes Gouveia ED, Mendes Jacques Da Costa AM, Meng HY, Meng L, Meng XT, Menke S, Meoni E, Mergelmeyer S, Merkt SAM, Merlassino C, Mermod P, Merola L, Meroni C, Merz G, Meshkov O, Meshreki JKR, Metcalfe J, Mete AS, Meyer C, Meyer JP, Michetti M, Middleton RP, Mijović L, Mikenberg G, Mikestikova M, Mikuž M, Mildner H, Milic A, Milke CD, Miller DW, Miller LS, Milov A, Milstead DA, Minaenko AA, Minashvili IA, Mince L, Mincer AI, Mindur B, Mineev M, Minegishi Y, Mino Y, Mir LM, Mironova M, Mitani T, Mitrevski J, Mitsou VA, Mittal M, Miu O, Miucci A, Miyagawa PS, Mizukami A, Mjörnmark JU, Mkrtchyan T, Mlynarikova M, Moa T, Mobius S, Mochizuki K, Moder P, Mogg P, Mohapatra S, Moles-Valls R, Mönig K, Monnier E, Montalbano A, Montejo Berlingen J, Montella M, Monticelli F, Monzani S, Morange N, Moreira De Carvalho AL, Moreno D, Moreno Llácer M, Moreno Martinez C, Morettini P, Morgenstern M, Morgenstern S, Mori D, Morii M, Morinaga M, Morisbak V, Morley AK, Mornacchi G, Morris AP, Morvaj L, Moschovakos P, Moser B, Mosidze M, Moskalets T, Moskvitina P, Moss J, Moyse EJW, Muanza S, Mueller J, Mueller RSP, Muenstermann D, Mullier GA, Mungo DP, Munoz Martinez JL, Munoz Sanchez FJ, Murin P, Murray WJ, Murrone A, Muse JM, Muškinja M, Mwewa C, Myagkov AG, Myers AA, Myers G, Myers J, Myska M, Nachman BP, Nackenhorst O, Nag AN, Nagai K, Nagano K, Nagasaka Y, Nagle JL, Nagy E, Nairz AM, Nakahama Y, Nakamura K, Nakamura T, Nanjo H, Napolitano F, Naranjo Garcia RF, Narayan R, Naryshkin I, Naseri M, Naumann T, Navarro G, Nechaeva PY, Nechansky F, Neep TJ, Negri A, Negrini M, Nellist C, Nelson C, Nelson ME, Nemecek S, Nessi M, Neubauer MS, Neuhaus F, Neumann M, Newhouse R, Newman PR, Ng CW, Ng YS, Ng YWY, Ngair B, Nguyen HDN, Nguyen Manh T, Nibigira E, Nickerson RB, Nicolaidou R, Nielsen DS, Nielsen J, Niemeyer M, Nikiforou N, Nikolaenko V, Nikolic-Audit I, Nikolopoulos K, Nilsson P, Nindhito HR, Nisati A, Nishu N, Nisius R, Nitsche I, Nitta T, Nobe T, Noel DL, Noguchi Y, Nomidis I, Nomura MA, Nordberg M, Novak J, Novak T, Novgorodova O, Novotny R, Nozka L, Ntekas K, Nurse E, Oakham FG, Ocariz J, Ochi A, Ochoa I, Ochoa-Ricoux JP, O'Connor K, Oda S, Odaka S, Oerdek S, Ogrodnik A, Oh A, Ohm CC, Oide H, Oishi R, Ojeda ML, Okawa H, Okazaki Y, O'Keefe MW, Okumura Y, Olariu A, Oleiro Seabra LF, Olivares Pino SA, Oliveira Damazio D, Oliver JL, Olsson MJR, Olszewski A, Olszowska J, Öncel ÖO, O'Neil DC, O'neill AP, Onofre A, Onyisi PUE, Oppen H, Oreamuno Madriz RG, Oreglia MJ, Orellana GE, Orestano D, Orlando N, Orr RS, O'Shea V, Ospanov R, Otero Y Garzon G, Otono H, Ott PS, Ottino GJ, Ouchrif M, Ouellette J, Ould-Saada F, Ouraou A, Ouyang Q, Owen M, Owen RE, Ozcan VE, Ozturk N, Pacalt J, Pacey HA, Pachal K, Pacheco Pages A, Padilla Aranda C, Pagan Griso S, Palacino G, Palazzo S, Palestini S, Palka M, Palni P, Pandini CE, Panduro Vazquez JG, Pani P, Panizzo G, Paolozzi L, Papadatos C, Papageorgiou K, Parajuli S, Paramonov A, Paraskevopoulos C, Paredes Hernandez D, Paredes Saenz SR, Parida B, Park TH, Parker AJ, Parker MA, Parodi F, Parrish EW, Parsons JA, Parzefall U, Pascual Dominguez L, Pascuzzi VR, Pasner JMP, Pasquali F, Pasqualucci E, Passaggio S, Pastore F, Pasuwan P, Pataraia S, Pater JR, Pathak A, Patton J, Pauly T, Pearkes J, Pedersen M, Pedraza Diaz L, Pedro R, Peiffer T, Peleganchuk SV, Penc O, Peng C, Peng H, Peralva BS, Perego MM, Pereira Peixoto AP, Pereira Sanchez L, Perepelitsa DV, Perez Codina E, Perini L, Pernegger H, Perrella S, Perrevoort A, Peters K, Peters RFY, Petersen BA, Petersen TC, Petit E, Petousis V, Petridou C, Petrucci F, Pettee M, Pettersson NE, Petukhova K, Peyaud A, Pezoa R, Pezzotti L, Pham T, Phillips PW, Phipps MW, Piacquadio G, Pianori E, Picazio A, Pickles RH, Piegaia R, Pietreanu D, Pilcher JE, Pilkington AD, Pinamonti M, Pinfold JL, Pitman Donaldson C, Pitt M, Pizzimento L, Pizzini A, Pleier MA, Plesanovs V, Pleskot V, Plotnikova E, Podberezko P, Poettgen R, Poggi R, Poggioli L, Pogrebnyak I, Pohl D, Pokharel I, Polesello G, Poley A, Policicchio A, Polifka R, Polini A, Pollard CS, Polychronakos V, Ponomarenko D, Pontecorvo L, Popa S, Popeneciu GA, Portales L, Portillo Quintero DM, Pospisil S, Potamianos K, Potrap IN, Potter CJ, Potti H, Poulsen T, Poveda J, Powell TD, Pownall G, Pozo Astigarraga ME, Prades Ibanez A, Pralavorio P, Prapa MM, Prell S, Price D, Primavera M, Proffitt ML, Proklova N, Prokofiev K, Prokoshin F, Protopopescu S, Proudfoot J, Przybycien M, Pudzha D, Puri A, Puzo P, Pyatiizbyantseva D, Qian J, Qin Y, Quadt A, Queitsch-Maitland M, Rabanal Bolanos G, Racko M, Ragusa F, Rahal G, Raine JA, Rajagopalan S, Ramirez Morales A, Ran K, Rassloff DF, Rauch DM, Rauscher F, Rave S, Ravina B, Ravinovich I, Rawling JH, Raymond M, Read AL, Readioff NP, Reale M, Rebuzzi DM, Redlinger G, Reeves K, Reikher D, Reiss A, Rej A, Rembser C, Renardi A, Renda M, Rendel MB, Rennie AG, Resconi S, Resseguie ED, Rettie S, Reynolds B, Reynolds E, Rezanova OL, Reznicek P, Ricci E, Richter R, Richter S, Richter-Was E, Ridel M, Rieck P, Rifki O, Rijssenbeek M, Rimoldi A, Rimoldi M, Rinaldi L, Rinn TT, Ripellino G, Riu I, Rivadeneira P, Rivera Vergara JC, Rizatdinova F, Rizvi E, Rizzi C, Robertson SH, Robin M, Robinson D, Robles Gajardo CM, Robles Manzano M, Robson A, Rocchi A, Roda C, Rodriguez Bosca S, Rodriguez Rodriguez A, Rodríguez Vera AM, Roe S, Roggel J, Røhne O, Röhrig R, Rojas RA, Roland B, Roland CPA, Roloff J, Romaniouk A, Romano M, Rompotis N, Ronzani M, Roos L, Rosati S, Rosin G, Rosser BJ, Rossi E, Rossi E, Rossi E, Rossi LP, Rossini L, Rosten R, Rotaru M, Rottler B, Rousseau D, Rovelli G, Roy A, Roy D, Rozanov A, Rozen Y, Ruan X, Ruggeri TA, Rühr F, Ruiz-Martinez A, Rummler A, Rurikova Z, Rusakovich NA, Russell HL, Rustige L, Rutherfoord JP, Rüttinger EM, Rybar M, Rybkin G, Rye EB, Ryzhov A, Sabater Iglesias JA, Sabatini P, Sabetta L, Sacerdoti S, Sadrozinski HFW, Sadykov R, Safai Tehrani F, Safarzadeh Samani B, Safdari M, Saha P, Saha S, Sahinsoy M, Sahu A, Saimpert M, Saito M, Saito T, Sakamoto H, Salamani D, Salamanna G, Salnikov A, Salt J, Salvador Salas A, Salvatore D, Salvatore F, Salvucci A, Salzburger A, Samarati J, Sammel D, Sampsonidis D, Sampsonidou D, Sánchez J, Sanchez Pineda A, Sandaker H, Sander CO, Sanderswood IG, Sandhoff M, Sandoval C, Sankey DPC, Sannino M, Sano Y, Sansoni A, Santoni C, Santos H, Santpur SN, Santra A, Saoucha KA, Sapronov A, Saraiva JG, Sasaki O, Sato K, Sauerburger F, Sauvan E, Savard P, Sawada R, Sawyer C, Sawyer L, Sayago Galvan I, Sbarra C, Sbrizzi A, Scanlon T, Schaarschmidt J, Schacht P, Schaefer D, Schaefer L, Schäfer U, Schaffer AC, Schaile D, Schamberger RD, Schanet E, Scharf C, Scharmberg N, Schegelsky VA, Scheirich D, Schenck F, Schernau M, Schiavi C, Schildgen LK, Schillaci ZM, Schioppa EJ, Schioppa M, Schleicher KE, Schlenker S, Schmidt-Sommerfeld KR, Schmieden K, Schmitt C, Schmitt S, Schoeffel L, Schoening A, Scholer PG, Schopf E, Schott M, Schouwenberg JFP, Schovancova J, Schramm S, Schroeder F, Schulte A, Schultz-Coulon HC, Schumacher M, Schumm BA, Schune P, Schwartzman A, Schwarz TA, Schwemling P, Schwienhorst R, Sciandra A, Sciolla G, Scuri F, Scutti F, Scyboz LM, Sebastiani CD, Sedlaczek K, Seema P, Seidel SC, Seiden A, Seidlitz BD, Seiss T, Seitz C, Seixas JM, Sekhniaidze G, Sekula SJ, Semprini-Cesari N, Sen S, Serfon C, Serin L, Serkin L, Sessa M, Severini H, Sevova S, Sforza F, Sfyrla A, Shabalina E, Shahinian JD, Shaikh NW, Shaked Renous D, Shan LY, Shapiro M, Sharma A, Sharma AS, Shatalov PB, Shaw K, Shaw SM, Shehade M, Shen Y, Sherman AD, Sherwood P, Shi L, Shimmin CO, Shimogama Y, Shimojima M, Shinner JD, Shipsey IPJ, Shirabe S, Shiyakova M, Shlomi J, Shmeleva A, Shochet MJ, Shojaii J, Shope DR, Shrestha S, Shrif EM, Shroff MJ, Shulga E, Sicho P, Sickles AM, Sideras Haddad E, Sidiropoulou O, Sidoti A, Siegert F, Sijacki D, Silva M, Silva Oliveira MV, Silverstein SB, Simion S, Simoniello R, Simpson-Allsop CJ, Simsek S, Sinervo P, Sinetckii V, Singh S, Sinha S, Sioli M, Siral I, Sivoklokov SY, Sjölin J, Skaf A, Skorda E, Skubic P, Slawinska M, Sliwa K, Smakhtin V, Smart BH, Smiesko J, Smirnov N, Smirnov SY, Smirnov Y, Smirnova LN, Smirnova O, Smith EA, Smith HA, Smizanska M, Smolek K, Smykiewicz A, Snesarev AA, Snoek HL, Snyder IM, Snyder S, Sobie R, Soffer A, Søgaard A, Sohns F, Solans Sanchez CA, Soldatov EY, Soldevila U, Solodkov AA, Soloshenko A, Solovyanov OV, Solovyev V, Sommer P, Son H, Sonay A, Song W, Song WY, Sopczak A, Sopio AL, Sopkova F, Sottocornola S, Soualah R, Soukharev AM, South D, Spagnolo S, Spalla M, Spangenberg M, Spanò F, Sperlich D, Spieker TM, Spigo G, Spina M, Spiteri DP, Spousta M, Stabile A, Stamas BL, Stamen R, Stamenkovic M, Stampekis A, Stanecka E, Stanislaus B, Stanitzki MM, Stankaityte M, Stapf B, Starchenko EA, Stark GH, Stark J, Staroba P, Starovoitov P, Stärz S, Staszewski R, Stavropoulos G, Stegler M, Steinberg P, Steinhebel AL, Stelzer B, Stelzer HJ, Stelzer-Chilton O, Stenzel H, Stevenson TJ, Stewart GA, Stockton MC, Stoicea G, Stolarski M, Stonjek S, Straessner A, Strandberg J, Strandberg S, Strauss M, Strebler T, Strizenec P, Ströhmer R, Strom DM, Stroynowski R, Strubig A, Stucci SA, Stugu B, Stupak J, Styles NA, Su D, Su W, Su X, Suarez NB, Sulin VV, Sullivan MJ, Sultan DMS, Sultansoy S, Sumida T, Sun S, Sun X, Suster CJE, Sutton MR, Suzuki S, Svatos M, Swiatlowski M, Swift SP, Swirski T, Sydorenko A, Sykora I, Sykora M, Sykora T, Ta D, Tackmann K, Taenzer J, Taffard A, Tafirout R, Tagiev E, Taibah RHM, Takashima R, Takeda K, Takeshita T, Takeva EP, Takubo Y, Talby M, Talyshev AA, Tam KC, Tamir NM, Tanaka J, Tanaka R, Tapia Araya S, Tapprogge S, Tarek Abouelfadl Mohamed A, Tarem S, Tariq K, Tarna G, Tartarelli GF, Tas P, Tasevsky M, Tassi E, Tateno G, Tavares Delgado A, Tayalati Y, Taylor AJ, Taylor GN, Taylor W, Teagle H, Tee AS, Teixeira De Lima R, Teixeira-Dias P, Ten Kate H, Teoh JJ, Terashi K, Terron J, Terzo S, Testa M, Teuscher RJ, Themistokleous N, Theveneaux-Pelzer T, Thomas DW, Thomas JP, Thompson EA, Thompson PD, Thomson E, Thorpe EJ, Tikhomirov VO, Tikhonov YA, Timoshenko S, Tipton P, Tisserant S, Todome K, Todorova-Nova S, Todt S, Tojo J, Tokár S, Tokushuku K, Tolley E, Tombs R, Tomiwa KG, Tomoto M, Tompkins L, Tornambe P, Torrence E, Torres H, Torró Pastor E, Toscani M, Tosciri C, Toth J, Tovey DR, Traeet A, Treado CJ, Trefzger T, Tresoldi F, Tricoli A, Trigger IM, Trincaz-Duvoid S, Trischuk DA, Trischuk W, Trocmé B, Trofymov A, Troncon C, Trovato F, Truong L, Trzebinski M, Trzupek A, Tsai F, Tsiareshka PV, Tsirigotis A, Tsiskaridze V, Tskhadadze EG, Tsopoulou M, Tsukerman II, Tsulaia V, Tsuno S, Tsybychev D, Tu Y, Tudorache A, Tudorache V, Tuna AN, Turchikhin S, Turgeman D, Turk Cakir I, Turner RJ, Turra R, Tuts PM, Tzamarias S, Tzovara E, Uchida K, Ukegawa F, Unal G, Unal M, Undrus A, Unel G, Ungaro FC, Unno Y, Uno K, Urban J, Urquijo P, Usai G, Uysal Z, Vacek V, Vachon B, Vadla KOH, Vafeiadis T, Vaidya A, Valderanis C, Valdes Santurio E, Valente M, Valentinetti S, Valero A, Valéry L, Vallance RA, Vallier A, Valls Ferrer JA, Van Daalen TR, Van Gemmeren P, Van Stroud S, Van Vulpen I, Vanadia M, Vandelli W, Vandenbroucke M, Vandewall ER, Vannicola D, Vari R, Varnes EW, Varni C, Varol T, Varouchas D, Varvell KE, Vasile ME, Vasquez GA, Vazeille F, Vazquez Furelos D, Vazquez Schroeder T, Veatch J, Vecchio V, Veen MJ, Veloce LM, Veloso F, Veneziano S, Ventura A, Verbytskyi A, Vercesi V, Verducci M, Vergel Infante CM, Vergis C, Verkerke W, Vermeulen AT, Vermeulen JC, Vernieri C, Verschuuren PJ, Vetterli MC, Viaux Maira N, Vickey T, Vickey Boeriu OE, Viehhauser GHA, Vigani L, Villa M, Villaplana Perez M, Villhauer EM, Vilucchi E, Vincter MG, Virdee GS, Vishwakarma A, Vittori C, Vivarelli I, Vogel M, Vokac P, Von Ahnen J, von Buddenbrock SE, Von Toerne E, Vorobel V, Vorobev K, Vos M, Vossebeld JH, Vozak M, Vranjes N, Vranjes Milosavljevic M, Vrba V, Vreeswijk M, Vu NK, Vuillermet R, Vukotic I, Wada S, Wagner P, Wagner W, Wagner-Kuhr J, Wahdan S, Wahlberg H, Wakasa R, Walbrecht VM, Walder J, Walker R, Walker SD, Walkowiak W, Wallangen V, Wang AM, Wang AZ, Wang C, Wang C, Wang H, Wang H, Wang J, Wang P, Wang Q, Wang RJ, Wang R, Wang R, Wang SM, Wang WT, Wang W, Wang WX, Wang Y, Wang Z, Wanotayaroj C, Warburton A, Ward CP, Ward RJ, Warrack N, Watson AT, Watson MF, Watts G, Waugh BM, Webb AF, Weber C, Weber MS, Weber SA, Weber SM, Wei Y, Weidberg AR, Weingarten J, Weirich M, Weiser C, Wells PS, Wenaus T, Wendland B, Wengler T, Wenig S, Wermes N, Wessels M, Weston TD, Whalen K, Wharton AM, White AS, White A, White MJ, Whiteson D, Whitmore BW, Wiedenmann W, Wiel C, Wielers M, Wieseotte N, Wiglesworth C, Wiik-Fuchs LAM, Wilkens HG, Wilkins LJ, Williams DM, Williams HH, Williams S, Willocq S, Windischhofer PJ, Wingerter-Seez I, Winkels E, Winklmeier F, Winter BT, Wittgen M, Wobisch M, Wolf A, Wölker R, Wollrath J, Wolter MW, Wolters H, Wong VWS, Wongel AF, Woods NL, Worm SD, Wosiek BK, Woźniak KW, Wraight K, Wu SL, Wu X, Wu Y, Wuerzinger J, Wyatt TR, Wynne BM, Xella S, Xia L, Xiang J, Xiao X, Xie X, Xiotidis I, Xu D, Xu H, Xu H, Xu L, Xu R, Xu T, Xu W, Xu Y, Xu Z, Xu Z, Yabsley B, Yacoob S, Yallup DP, Yamaguchi N, Yamaguchi Y, Yamamoto A, Yamatani M, Yamazaki T, Yamazaki Y, Yan J, Yan Z, Yang HJ, Yang HT, Yang S, Yang T, Yang X, Yang X, Yang Y, Yang Z, Yao WM, Yap YC, Ye H, Ye J, Ye S, Yeletskikh I, Yexley MR, Yigitbasi E, Yin P, Yorita K, Yoshihara K, Young CJS, Young C, Yu J, Yuan R, Yue X, Zaazoua M, Zabinski B, Zacharis G, Zaffaroni E, Zahreddine J, Zaitsev AM, Zakareishvili T, Zakharchuk N, Zambito S, Zanzi D, Zeißner SV, Zeitnitz C, Zemaityte G, Zeng JC, Zenin O, Ženiš T, Zerwas D, Zgubič M, Zhang B, Zhang DF, Zhang G, Zhang J, Zhang K, Zhang L, Zhang L, Zhang M, Zhang R, Zhang S, Zhang X, Zhang X, Zhang Y, Zhang Z, Zhang Z, Zhao P, Zhao Y, Zhao Z, Zhemchugov A, Zheng Z, Zhong D, Zhou B, Zhou C, Zhou H, Zhou M, Zhou N, Zhou Y, Zhu CG, Zhu C, Zhu HL, Zhu H, Zhu J, Zhu Y, Zhuang X, Zhukov K, Zhulanov V, Zieminska D, Zimine NI, Zimmermann S, Zinonos Z, Ziolkowski M, Živković L, Zobernig G, Zoccoli A, Zoch K, Zorbas TG, Zou R, Zwalinski L. Search for Dark Matter Produced in Association with a Dark Higgs Boson Decaying into W^{±}W^{∓} or ZZ in Fully Hadronic Final States from sqrt[s]=13 TeV pp Collisions Recorded with the ATLAS Detector. PHYSICAL REVIEW LETTERS 2021; 126:121802. [PMID: 33834820 DOI: 10.1103/physrevlett.126.121802] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Accepted: 01/19/2021] [Indexed: 06/12/2023]
Abstract
Several extensions of the Standard Model predict the production of dark matter particles at the LHC. An uncharted signature of dark matter particles produced in association with VV=W^{±}W^{∓} or ZZ pairs from a decay of a dark Higgs boson s is searched for using 139 fb^{-1} of pp collisions recorded by the ATLAS detector at a center-of-mass energy of 13 TeV. The s→V(qq[over ¯])V(qq[over ¯]) decays are reconstructed with a novel technique aimed at resolving the dense topology from boosted VV pairs using jets in the calorimeter and tracking information. Dark Higgs scenarios with m_{s}>160 GeV are excluded.
Collapse
|
239
|
Hu R, Xu W, Yang QW, Cheng LY. [Diagnosis and endoscopic treatment of blunt laryngeal trauma with arytenoid injury]. ZHONGHUA ER BI YAN HOU TOU JING WAI KE ZA ZHI = CHINESE JOURNAL OF OTORHINOLARYNGOLOGY HEAD AND NECK SURGERY 2021; 56:256-262. [PMID: 33730809 DOI: 10.3760/cma.j.cn115330-20200509-00392] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the clinical characteristics, diagnosis, endoscopic surgical procedures, and therapeutic effect of blunt laryngeal trauma with arytenoid injury. Methods: We retrospectively reviewed 12 patients who suffered blunt laryngeal trauma with laryngeal mucosa avulsion and arytenoid region injury at the Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital from April 2007 to December 2018. Among the 12 patients, 10 were males, 2 were females, aged from 7 to 48 years old, with a median age of 21 years old. All patients were performed with transoral endoscopic laryngeal microsurgery under general anesthesia. Clinical characteristics, laryngoscopic signs, laryngeal CT, endoscopic surgical findings and procedures, and therapeutic effect were analyzed. The subjective and objective parameters of the voice quality of patients before and after surgery were compared using SPSS 22.0 statistical software by paired T test. Results: All patients had a history of obvious dysphonia immediately after trauma, accompanied by throat pain and hemoptysis without obvious dyspnea and dysphagia. Slight subcutaneous emphysema was found in 3 patients by physical examination. Laryngoscope revealed that 14 sides of vocal folds immobilized, arytenoid and/or ventricular region and posterior glottis mucosa were avulsed in 4 patients within 48 h of injury, and arytenoid cartilage was exposed in 4 sides. The arytenoid and ventricular regions were covered with thick pseudo-membrane or granulation, with abnormal structure in 8 patients with damage of more than 48 h. Intraoperative exploration revealed that there were 17 sides of arytenoid region (bilateral 5 cases, unilateral 7 cases) with varying degrees of injury. There was only limited laceration on three sides of the vocal folds. The lateral ventricular and vocal fold mucosae were avulsed vertically from the arytenoid region and arytenoid cartilage was exposed in 14 sides, among which 6 sides had abnormal arytenoid cartilage morphology and 8 sides had fracture displacement. Laryngeal CT showed irregular thickening of lateral glottis and/or supratroglottic structures in patients with vocal folds immobility, among which asymmetry of arytenoid cartilage structure on both sides in 3 cases and displacement in 2 cases were found. Restoration and microsuture of the fractured arytenoid, perichondrium and avulsion laryngeal mucosa under the direct laryngoscope were performed. The degree of dysphonia was significantly improved immediately after laryngeal microsurgery, the voice significantly improved in G, R, B, A, jitter, shimmer, NHR, and MPT three months after surgery(t=12.792, 12.792, 10.340, 3.276, 2.865, 3.781, 3.173, 3.090, respectively, P<0.05). Except for 1 patient with scar on vocal fold, all the other patients had normal laryngeal morphology and normal vocal fold movement. No laryngeal stenosis was found during the follow-up period. Conclusions: For patients with blunt laryngeal trauma, the injury of arytenoid region and arytenoid cartilage should be evaluated if there is obvious hoarseness, vocal fold immobility, avulsion of ventricular/vocal folds mucosa, or structural abnormality of arytenoid region under laryngoscopic examination. For highly suspected cases, microrphonosurgery under the direct laryngoscope should be performed as soon as possible, which can effectively reduce the occurrence of vocal fold movement disorders and laryngeal scar/stenosis, reconstruct the normal laryngeal structure, and restore the vocal function.
Collapse
|
240
|
Ablikim M, Achasov MN, Adlarson P, Ahmed S, Albrecht M, Aliberti R, Amoroso A, An Q, Bai XH, Bai Y, Bakina O, Baldini Ferroli R, Balossino I, Ban Y, Begzsuren K, Berger N, Bertani M, Bettoni D, Bianchi F, Biernat J, Bloms J, Bortone A, Boyko I, Briere RA, Cai H, Cai X, Calcaterra A, Cao GF, Cao N, Cetin SA, Chang JF, Chang WL, Chelkov G, Chen DY, Chen G, Chen HS, Chen ML, Chen SJ, Chen XR, Chen YB, Chen ZJ, Cheng WS, Cibinetto G, Cossio F, Cui XF, Dai HL, Dai XC, Dbeyssi A, de Boer RB, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding Y, Dong C, Dong J, Dong LY, Dong MY, Dong X, Du SX, Fang J, Fang SS, Fang Y, Farinelli R, Fava L, Feldbauer F, Felici G, Feng CQ, Fritsch M, Fu CD, Fu Y, Gao Y, Gao Y, Gao Y, Gao YG, Garzia I, Gersabeck EM, Gilman A, Goetzen K, Gong L, Gong WX, Gradl W, Greco M, Gu LM, Gu MH, Gu S, Gu YT, Guan CY, Guo AQ, Guo LB, Guo RP, Guo YP, Guo YP, Guskov A, Han TT, Hao XQ, Harris FA, He KL, Heinsius FH, Heinz CH, Held T, Heng YK, Herold C, Himmelreich M, Holtmann T, Hou YR, Hou ZL, Hu HM, Hu JF, Hu T, Hu Y, Huang GS, Huang LQ, Huang XT, Huang YP, Huang Z, Huesken N, Hussain T, Ikegami Andersson W, Imoehl W, Irshad M, Jaeger S, Janchiv S, Ji Q, Ji QP, Ji XB, Ji XL, Jiang HB, Jiang XS, Jiang XY, Jiang Y, Jiao JB, Jiao Z, Jin S, Jin Y, Johansson T, Kalantar-Nayestanaki N, Kang XS, Kappert R, Kavatsyuk M, Ke BC, Keshk IK, Khoukaz A, Kiese P, Kiuchi R, Kliemt R, Koch L, Kolcu OB, Kopf B, Kuemmel M, Kuessner M, Kupsc A, Kurth MG, Kühn W, Lane JJ, Lange JS, Larin P, Lavezzi L, Lei ZH, Leithoff H, Lellmann M, Lenz T, Li C, Li CH, Li C, Li DM, Li F, Li G, Li H, Li H, Li HB, Li HJ, Li JL, Li JQ, Li K, Li LK, Li L, Li PL, Li PR, Li SY, Li WD, Li WG, Li XH, Li XL, Li ZY, Liang H, Liang H, Liang YF, Liang YT, Liao LZ, Libby J, Lin CX, Liu BJ, Liu CX, Liu D, Liu FH, Liu F, Liu F, Liu HB, Liu HM, Liu H, Liu H, Liu JB, Liu JY, Liu K, Liu KY, Liu K, Liu L, Liu MH, Liu Q, Liu SB, Liu S, Liu T, Liu WM, Liu X, Liu Y, Liu YB, Liu ZA, Liu ZQ, Lou XC, Lu FX, Lu HJ, Lu JD, Lu JG, Lu XL, Lu Y, Lu YP, Luo CL, Luo MX, Luo PW, Luo T, Luo XL, Lusso S, Lyu XR, Ma FC, Ma HL, Ma LL, Ma MM, Ma QM, Ma RQ, Ma RT, Ma XN, Ma XX, Ma XY, Maas FE, Maggiora M, Maldaner S, Malde S, Malik QA, Mangoni A, Mao YJ, Mao ZP, Marcello S, Meng ZX, Messchendorp JG, Mezzadri G, Min TJ, Mitchell RE, Mo XH, Mo YJ, Muchnoi NY, Muramatsu H, Nakhoul S, Nefedov Y, Nerling F, Nikolaev IB, Ning Z, Nisar S, Olsen SL, Ouyang Q, Pacetti S, Pan X, Pan Y, Pathak A, Patteri P, Pelizaeus M, Peng HP, Peters K, Pettersson J, Ping JL, Ping RG, Pitka A, Poling R, Prasad V, Qi H, Qi HR, Qi KH, Qi M, Qi TY, Qi TY, Qian S, Qian WB, Qian Z, Qiao CF, Qin LQ, Qin XS, Qin ZH, Qiu JF, Qu SQ, Rashid KH, Ravindran K, Redmer CF, Rivetti A, Rodin V, Rolo M, Rong G, Rosner C, Rump M, Sang HS, Sarantsev A, Schelhaas Y, Schnier C, Schoenning K, Scodeggio M, Shan DC, Shan W, Shan XY, Shao M, Shen CP, Shen PX, Shen XY, Shi BA, Shi HC, Shi RS, Shi X, Shi XD, Song WM, Song YX, Sosio S, Spataro S, Su KX, Sui FF, Sun GX, Sun HK, Sun JF, Sun L, Sun SS, Sun T, Sun WY, Sun X, Sun YJ, Sun YK, Sun YZ, Sun ZT, Tan YH, Tan YX, Tang CJ, Tang GY, Tang J, Teng JX, Thoren V, Uman I, Wang CW, Wang DY, Wang HJ, Wang HP, Wang K, Wang LL, Wang M, Wang MZ, Wang M, Wang WH, Wang WP, Wang X, Wang XF, Wang XL, Wang Y, Wang Y, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZY, Wang Z, Wang Z, Wei DH, Weidenkaff P, Weidner F, Wen SP, White DJ, Wiedner U, Wilkinson G, Wolke M, Wollenberg L, Wu JF, Wu LH, Wu LJ, Wu X, Wu Z, Xia L, Xiao H, Xiao SY, Xiao YJ, Xiao ZJ, Xie XH, Xie YG, Xie YH, Xing TY, Xu GF, Xu JJ, Xu QJ, Xu W, Xu XP, Xu YC, Yan F, Yan L, Yan L, Yan WB, Yan WC, Yan X, Yang HJ, Yang HX, Yang L, Yang RX, Yang SL, Yang SL, Yang YH, Yang YX, Yang Y, Yang Z, Ye M, Ye MH, Yin JH, You ZY, Yu BX, Yu CX, Yu G, Yu JS, Yu T, Yuan CZ, Yuan L, Yuan W, Yuan XQ, Yuan Y, Yuan ZY, Yue CX, Yuncu A, Zafar AA, Zeng Y, Zhang BX, Zhang G, Zhang H, Zhang HH, Zhang HY, Zhang JJ, Zhang JL, Zhang JQ, Zhang JW, Zhang JY, Zhang JZ, Zhang J, Zhang J, Zhang L, Zhang S, Zhang SF, Zhang S, Zhang XD, Zhang XY, Zhang Y, Zhang YH, Zhang YT, Zhang Y, Zhang Y, Zhang Y, Zhang ZH, Zhang ZY, Zhao G, Zhao J, Zhao JY, Zhao JZ, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao SJ, Zhao YB, Zhao YX, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng Y, Zheng YH, Zhong B, Zhong C, Zhou LP, Zhou Q, Zhou X, Zhou XK, Zhou XR, Zhu AN, Zhu J, Zhu K, Zhu KJ, Zhu SH, Zhu TJ, Zhu WJ, Zhu XL, Zhu YC, Zhu ZA, Zou BS, Zou JH. Observation of a Near-Threshold Structure in the K^{+} Recoil-Mass Spectra in e^{+}e^{-}→K^{+}(D_{s}^{-}D^{*0}+D_{s}^{*-}D^{0}). PHYSICAL REVIEW LETTERS 2021; 126:102001. [PMID: 33784133 DOI: 10.1103/physrevlett.126.102001] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/16/2020] [Accepted: 02/05/2021] [Indexed: 06/12/2023]
Abstract
We report a study of the processes of e^{+}e^{-}→K^{+}D_{s}^{-}D^{*0} and K^{+}D_{s}^{*-}D^{0} based on e^{+}e^{-} annihilation samples collected with the BESIII detector operating at BEPCII at five center-of-mass energies ranging from 4.628 to 4.698 GeV with a total integrated luminosity of 3.7 fb^{-1}. An excess of events over the known contributions of the conventional charmed mesons is observed near the D_{s}^{-}D^{*0} and D_{s}^{*-}D^{0} mass thresholds in the K^{+} recoil-mass spectrum for events collected at sqrt[s]=4.681 GeV. The structure matches a mass-dependent-width Breit-Wigner line shape, whose pole mass and width are determined as (3982.5_{-2.6}^{+1.8}±2.1) MeV/c^{2} and (12.8_{-4.4}^{+5.3}±3.0) MeV, respectively. The first uncertainties are statistical and the second are systematic. The significance of the resonance hypothesis is estimated to be 5.3 σ over the contributions only from the conventional charmed mesons. This is the first candidate for a charged hidden-charm tetraquark with strangeness, decaying into D_{s}^{-}D^{*0} and D_{s}^{*-}D^{0}. However, the properties of the excess need further exploration with more statistics.
Collapse
|
241
|
Li WX, Xu W, Huang CL, Fei L, Xie XD, Li Q, Chen L. Acute cardiac injury and acute kidney injury associated with severity and mortality in patients with COVID-19. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2021; 25:2114-2122. [PMID: 33660831 DOI: 10.26355/eurrev_202102_25117] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE To determine the incidence and risk factors for acute cardiac injury (ACI) and acute kidney injury (AKI), and then investigate their effect on severity and mortality in patients with COVID-19. PATIENTS AND METHODS A total of 1249 patients with COVID-19 were included in this retrospective study. Predictors of ACI and AKI were investigated. Multivariable-logistic regression models were used to determine the association of ACI (or AKI) with severity and mortality. RESULTS Median age of patients was 36 years and 61.9% were male. ACI and AKI were observed in 53 (4.2%) and 91 (7.3%) of patients, respectively. Patients with age > 60 years, chronic heart disease, decreased lymphocyte and increased CRP, PCT, and ESR on hospital admission, and Lopinavir/Ritonavir use showed higher odds of ACI. Patients with age > 60 years, male, obesity, hypertension, chronic kidney disease, decreased lymphocyte and increased CRP, PCT, and ESR on hospital admission showed higher odds of AKI. Increased Hs-cTnI (> 300 ng/L), Pro-BNP (> 2500 pg/ml) and decreased e-GFR (< 60 ml/min) revealed higher adjusted mortality. CONCLUSIONS ACI and AKI were not common in COVID-19 patients in Shanghai, China. However, patients with ACI/AKI had higher severity-rate and mortality-rate when compared to those without ACI/AKI.
Collapse
|
242
|
Yang S, Xu W, Yang TY, Dai XX, Cui HX, Zhang YS, Cao ZF. [Clinicopathological and genetic features of metastatic lung cancer to the adrenal glands: report of four cases]. ZHONGHUA BING LI XUE ZA ZHI = CHINESE JOURNAL OF PATHOLOGY 2021; 50:248-250. [PMID: 33677891 DOI: 10.3760/cma.j.cn112151-20200615-00473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
243
|
Luo H, Brito LF, Li X, Su G, Dou J, Xu W, Yan X, Zhang H, Guo G, Liu L, Wang Y. Genetic parameters for rectal temperature, respiration rate, and drooling score in Holstein cattle and their relationships with various fertility, production, body conformation, and health traits. J Dairy Sci 2021; 104:4390-4403. [PMID: 33685707 DOI: 10.3168/jds.2020-19192] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2020] [Accepted: 11/03/2020] [Indexed: 12/12/2022]
Abstract
Genetic selection for improved climatic resilience is paramount to increase the long-term sustainability of high-producing dairy cattle, especially in face of climate change. Various physiological indicators, such as rectal temperature (RT), respiration rate score (RR), and drooling score (DS), can be used to genetically identify animals with more effective coping mechanisms in response to heat stress events. In this study, we investigated genetic parameters for RT, RR (score from 1-3), and DS (score from 1-3). Furthermore, we assessed the genetic relationship among these indicators and other economically important traits for the dairy cattle industry. After data editing, 59,265 (RT), 30,290 (RR), and 30,421 (DS) records from 13,592 lactating Holstein cows were used for the analyses. Variance components were estimated based on a multiple-trait repeatability animal model. The heritability ± standard error estimate for RT, RR, and DS was 0.06 ± 0.01, 0.04 ± 0.01, and 0.02 ± 0.01, respectively, whereas their repeatability was 0.19, 0.14, and 0.14, respectively. Moderate genetic correlations of RR with RT and DS (0.26 ± 0.11 and 0.25 ± 0.16) and nonsignificant correlation between RT and DS (-0.11 ± 0.14) were observed. Furthermore, the approximate genetic correlations between RT, RR, and DS with 12 production, 29 conformation, 5 fertility and reproduction, 5 health, and 9 longevity-indicator traits were assessed. In general, the approximate genetic correlations calculated were low to moderate. In summary, 3 physiological indicators of heat stress response were measured in a large number of animals and shown to be lowly heritable. There is a value in developing a selection index including all the 3 indicators to improve heat tolerance in dairy cattle. All the unfavorable genetic relationships observed between heat tolerance and other economically important traits can be accounted for in a selection index to enable improved climatic resilience while also maintaining or increasing productivity in Holstein cattle.
Collapse
|
244
|
Aker M, Altenmüller K, Beglarian A, Behrens J, Berlev A, Besserer U, Bieringer B, Blaum K, Block F, Bornschein B, Bornschein L, Böttcher M, Brunst T, Caldwell TS, La Cascio L, Chilingaryan S, Choi W, Díaz Barrero D, Debowski K, Deffert M, Descher M, Doe PJ, Dragoun O, Drexlin G, Dyba S, Edzards F, Eitel K, Ellinger E, Engel R, Enomoto S, Fedkevych M, Felden A, Formaggio JA, Fränkle FM, Franklin GB, Friedel F, Fulst A, Gauda K, Gil W, Glück F, Grössle R, Gumbsheimer R, Höhn T, Hannen V, Haußmann N, Helbing K, Hickford S, Hiller R, Hillesheimer D, Hinz D, Houdy T, Huber A, Jansen A, Köllenberger L, Karl C, Kellerer J, Kippenbrock L, Klein M, Kopmann A, Korzeczek M, Kovalík A, Krasch B, Krause H, Lasserre T, Le TL, Lebeda O, Le Guennic N, Lehnert B, Lokhov A, Lopez Poyato JM, Müller K, Machatschek M, Malcherek E, Mark M, Marsteller A, Martin EL, Melzer C, Mertens S, Niemes S, Oelpmann P, Osipowicz A, Parno DS, Poon AWP, Priester F, Röllig M, Röttele C, Rest O, Robertson RGH, Rodenbeck C, Ryšavý M, Sack R, Saenz A, Schaller A, Schäfer P, Schimpf L, Schlösser M, Schlösser K, Schlüter L, Schrank M, Schulz B, Šefčík M, Seitz-Moskaliuk H, Sibille V, Siegmann D, Slezák M, Spanier F, Steidl M, Sturm M, Sun M, Telle HH, Thümmler T, Thorne LA, Titov N, Tkachev I, Trost N, Vénos D, Valerius K, Vizcaya Hernández AP, Wüstling S, Weber M, Weinheimer C, Weiss C, Welte S, Wendel J, Wilkerson JF, Wolf J, Xu W, Yen YR, Zadoroghny S, Zeller G. Bound on 3+1 Active-Sterile Neutrino Mixing from the First Four-Week Science Run of KATRIN. PHYSICAL REVIEW LETTERS 2021; 126:091803. [PMID: 33750167 DOI: 10.1103/physrevlett.126.091803] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/13/2020] [Revised: 01/06/2021] [Accepted: 01/22/2021] [Indexed: 06/12/2023]
Abstract
We report on the light sterile neutrino search from the first four-week science run of the KATRIN experiment in 2019. Beta-decay electrons from a high-purity gaseous molecular tritium source are analyzed by a high-resolution MAC-E filter down to 40 eV below the endpoint at 18.57 keV. We consider the framework with three active neutrinos and one sterile neutrino. The analysis is sensitive to the mass, m_{4}, of the fourth mass state for m_{4}^{2}≲1000 eV^{2} and to active-to-sterile neutrino mixing down to |U_{e4}|^{2}≳2×10^{-2}. No significant spectral distortion is observed and exclusion bounds on the sterile mass and mixing are reported. These new limits supersede the Mainz results for m_{4}^{2}≲1000 eV^{2} and improve the Troitsk bound for m_{4}^{2}<30 eV^{2}. The reactor and gallium anomalies are constrained for 100<Δm_{41}^{2}<1000 eV^{2}.
Collapse
|
245
|
Ablikim M, Achasov MN, Adlarson P, Ahmed S, Albrecht M, Amoroso A, An Q, Bai Y, Bakina O, Baldini Ferroli R, Balossino I, Ban Y, Begzsuren K, Bennett JV, Berger N, Bertani M, Bettoni D, Bianchi F, Biernat J, Bloms J, Bortone A, Boyko I, Briere RA, Cai H, Cai X, Calcaterra A, Cao GF, Cao N, Cetin SA, Chang JF, Chang WL, Chelkov G, Chen DY, Chen G, Chen HS, Chen ML, Chen SJ, Chen XR, Chen YB, Cheng WS, Cibinetto G, Cossio F, Cui XF, Dai HL, Dai JP, Dai XC, Dbeyssi A, de Boer RB, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding Y, Dong C, Dong J, Dong LY, Dong MY, Du SX, Fang J, Fang SS, Fang Y, Farinelli R, Fava L, Feldbauer F, Felici G, Feng CQ, Fritsch M, Fu CD, Fu Y, Gao XL, Gao Y, Gao Y, Gao YG, Garzia I, Gersabeck EM, Gilman A, Goetzen K, Gong L, Gong WX, Gradl W, Greco M, Gu LM, Gu MH, Gu S, Gu YT, Guan CY, Guo AQ, Guo LB, Guo RP, Guo YP, Guo YP, Guskov A, Han S, Han TT, Han TZ, Hao XQ, Harris FA, He KL, Heinsius FH, Held T, Heng YK, Himmelreich M, Holtmann T, Hou YR, Hou ZL, Hu HM, Hu JF, Hu T, Hu Y, Huang GS, Huang LQ, Huang XT, Huang Z, Huesken N, Hussain T, Ikegami Andersson W, Imoehl W, Irshad M, Jaeger S, Janchiv S, Ji Q, Ji QP, Ji XB, Ji XL, Jiang HB, Jiang XS, Jiang XY, Jiao JB, Jiao Z, Jin S, Jin Y, Johansson T, Kalantar-Nayestanaki N, Kang XS, Kappert R, Kavatsyuk M, Ke BC, Keshk IK, Khoukaz A, Kiese P, Kiuchi R, Kliemt R, Koch L, Kolcu OB, Kopf B, Kuemmel M, Kuessner M, Kupsc A, Kurth MG, Kühn W, Lane JJ, Lange JS, Larin P, Lavezzi L, Leithoff H, Lellmann M, Lenz T, Li C, Li CH, Li C, Li DM, Li F, Li G, Li HB, Li HJ, Li JL, Li JQ, Li K, Li LK, Li L, Li PL, Li PR, Li SY, Li WD, Li WG, Li XH, Li XL, Li ZB, Li ZY, Liang H, Liang H, Liang YF, Liang YT, Liao LZ, Libby J, Lin CX, Liu B, Liu BJ, Liu CX, Liu D, Liu DY, Liu FH, Liu F, Liu F, Liu HB, Liu HM, Liu H, Liu H, Liu JB, Liu JY, Liu K, Liu KY, Liu K, Liu L, Liu Q, Liu SB, Liu S, Liu T, Liu X, Liu YB, Liu ZA, Liu ZQ, Long YF, Lou XC, Lu FX, Lu HJ, Lu JD, Lu JG, Lu XL, Lu Y, Lu YP, Luo CL, Luo MX, Luo PW, Luo T, Luo XL, Lusso S, Lyu XR, Ma FC, Ma HL, Ma LL, Ma MM, Ma QM, Ma RQ, Ma RT, Ma XN, Ma XX, Ma XY, Ma YM, Maas FE, Maggiora M, Maldaner S, Malde S, Malik QA, Mangoni A, Mao YJ, Mao ZP, Marcello S, Meng ZX, Messchendorp JG, Mezzadri G, Min TJ, Mitchell RE, Mo XH, Mo YJ, Muchnoi NY, Muramatsu H, Nakhoul S, Nefedov Y, Nerling F, Nikolaev IB, Ning Z, Nisar S, Olsen SL, Ouyang Q, Pacetti S, Pan X, Pan Y, Pathak A, Patteri P, Pelizaeus M, Peng HP, Peters K, Pettersson J, Ping JL, Ping RG, Pitka A, Poling R, Prasad V, Qi H, Qi HR, Qi M, Qi TY, Qian S, Qian WB, Qian Z, Qiao CF, Qin LQ, Qin XP, Qin XS, Qin ZH, Qiu JF, Qu SQ, Rashid KH, Ravindran K, Redmer CF, Rivetti A, Rodin V, Rolo M, Rong G, Rosner C, Rump M, Sarantsev A, Schelhaas Y, Schnier C, Schoenning K, Shan DC, Shan W, Shan XY, Shao M, Shen CP, Shen PX, Shen XY, Shi HC, Shi RS, Shi X, Shi XD, Song JJ, Song QQ, Song WM, Song YX, Sosio S, Spataro S, Sui FF, Sun GX, Sun JF, Sun L, Sun SS, Sun T, Sun WY, Sun YJ, Sun YK, Sun YZ, Sun ZT, Tan YH, Tan YX, Tang CJ, Tang GY, Tang J, Thoren V, Tsednee B, Uman I, Wang B, Wang BL, Wang CW, Wang DY, Wang HP, Wang K, Wang LL, Wang M, Wang MZ, Wang M, Wang WH, Wang WP, Wang X, Wang XF, Wang XL, Wang Y, Wang Y, Wang YD, Wang YF, Wang YQ, Wang Z, Wang ZY, Wang Z, Wang Z, Wei DH, Weidenkaff P, Weidner F, Wen SP, White DJ, Wiedner U, Wilkinson G, Wolke M, Wollenberg L, Wu JF, Wu LH, Wu LJ, Wu X, Wu Z, Xia L, Xiao H, Xiao SY, Xiao YJ, Xiao ZJ, Xie XH, Xie YG, Xie YH, Xing TY, Xiong XA, Xu GF, Xu JJ, Xu QJ, Xu W, Xu XP, Yan L, Yan L, Yan WB, Yan WC, Yan X, Yang HJ, Yang HX, Yang L, Yang RX, Yang SL, Yang YH, Yang YX, Yang Y, Yang Z, Ye M, Ye MH, Yin JH, You ZY, Yu BX, Yu CX, Yu G, Yu JS, Yu T, Yuan CZ, Yuan W, Yuan XQ, Yuan Y, Yuan ZY, Yue CX, Yuncu A, Zafar AA, Zeng Y, Zhang BX, Zhang G, Zhang HH, Zhang HY, Zhang JL, Zhang JQ, Zhang JW, Zhang JY, Zhang JZ, Zhang J, Zhang J, Zhang L, Zhang L, Zhang S, Zhang SF, Zhang TJ, Zhang XY, Zhang Y, Zhang YH, Zhang YT, Zhang Y, Zhang Y, Zhang Y, Zhang ZH, Zhang ZY, Zhao G, Zhao J, Zhao JY, Zhao JZ, Zhao L, Zhao L, Zhao MG, Zhao Q, Zhao SJ, Zhao YB, Zhao YXZ, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng Y, Zheng YH, Zhong B, Zhong C, Zhou LP, Zhou Q, Zhou X, Zhou XK, Zhou XR, Zhu AN, Zhu J, Zhu K, Zhu KJ, Zhu SH, Zhu WJ, Zhu XL, Zhu YC, Zhu ZA, Zou BS, Zou JH. Model-Independent Determination of the Spin of the Ω^{-} and Its Polarization Alignment in ψ(3686)→Ω^{-}Ω[over ¯]^{+}. PHYSICAL REVIEW LETTERS 2021; 126:092002. [PMID: 33750166 DOI: 10.1103/physrevlett.126.092002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/06/2020] [Revised: 10/19/2020] [Accepted: 01/27/2021] [Indexed: 06/12/2023]
Abstract
We present an analysis of the process ψ(3686)→Ω^{-}Ω[over ¯]^{+} (Ω^{-}→K^{-}Λ, Ω[over ¯]^{+}→K^{+}Λ[over ¯], Λ→pπ^{-}, Λ[over ¯]→p[over ¯]π^{+}) based on a dataset of 448×10^{6} ψ(3686) decays collected with the BESIII detector at the BEPCII electron-positron collider. The helicity amplitudes for the process ψ(3686)→Ω^{-}Ω[over ¯]^{+} and the decay parameters of the subsequent decay Ω^{-}→K^{-}Λ (Ω[over ¯]^{+}→K^{+}Λ[over ¯]) are measured for the first time by a fit to the angular distribution of the complete decay chain, and the spin of the Ω^{-} is determined to be 3/2 for the first time since its discovery more than 50 years ago.
Collapse
|
246
|
Takenaka T, Ishihara K, Roppongi M, Miao Y, Mizukami Y, Makita T, Tsurumi J, Watanabe S, Takeya J, Yamashita M, Torizuka K, Uwatoko Y, Sasaki T, Huang X, Xu W, Zhu D, Su N, Cheng JG, Shibauchi T, Hashimoto K. Strongly correlated superconductivity in a copper-based metal-organic framework with a perfect kagome lattice. SCIENCE ADVANCES 2021; 7:7/12/eabf3996. [PMID: 33731356 PMCID: PMC7968839 DOI: 10.1126/sciadv.abf3996] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/23/2020] [Accepted: 01/29/2021] [Indexed: 05/26/2023]
Abstract
Metal-organic frameworks (MOFs), which are self-assemblies of metal ions and organic ligands, provide a tunable platform to search a new state of matter. A two-dimensional (2D) perfect kagome lattice, whose geometrical frustration is a key to realizing quantum spin liquids, has been formed in the π - d conjugated 2D MOF [Cu3(C6S6)] n (Cu-BHT). The recent discovery of its superconductivity with a critical temperature T c of 0.25 kelvin raises fundamental questions about the nature of electron pairing. Here, we show that Cu-BHT is a strongly correlated unconventional superconductor with extremely low superfluid density. A nonexponential temperature dependence of superfluid density is observed, indicating the possible presence of superconducting gap nodes. The magnitude of superfluid density is much smaller than those in conventional superconductors and follows the Uemura's relation of strongly correlated superconductors. These results imply that the unconventional superconductivity in Cu-BHT originates from electron correlations related to spin fluctuations of kagome lattice.
Collapse
|
247
|
Yang H, Lv D, Ye J, Wu X, Xu W, Zhou S, Kong F, Wang W. P48.07 Synergistic Antitumor Effects of Anlotinib Combination With Oral 5-Fluorouracil S-1 in Small Cell Lung Cancer. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.877] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
248
|
Chowdhury M, Hueniken K, Schmid S, Brown C, Khan K, Walia P, Sabouhanian A, Strom E, Herman J, Xu W, Leighl N, Bradbury P, Sacher A, Shepherd F, Liu G, Shultz D. P76.84 EGFR Status, Risk Factors for Brain Metastases and Overall Survival in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.1141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
249
|
Pang D, Chen W, Zhang J, Yang L, Shao G, Liuru T, Xu L, Xu W, Zhao C, Luo M, Ma L, Zhang F, Liang Z, Li S, Kong F. P07.08 IDO Immune Suppression and Post Surgical Toxicity in Patients with Non-Small Cell Lung Cancer. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
250
|
Aguilar M, Cavasonza LA, Allen MS, Alpat B, Ambrosi G, Arruda L, Attig N, Barao F, Barrin L, Bartoloni A, Başeğmez-du Pree S, Battiston R, Behlmann M, Beranek B, Berdugo J, Bertucci B, Bindi V, Bollweg K, Borgia B, Boschini MJ, Bourquin M, Bueno EF, Burger J, Burger WJ, Burmeister S, Cai XD, Capell M, Casaus J, Castellini G, Cervelli F, Chang YH, Chen GM, Chen GR, Chen HS, Chen Y, Cheng L, Chou HY, Chouridou S, Choutko V, Chung CH, Clark C, Coignet G, Consolandi C, Contin A, Corti C, Cui Z, Dadzie K, Delgado C, Della Torre S, Demirköz MB, Derome L, Di Falco S, Di Felice V, Díaz C, Dimiccoli F, von Doetinchem P, Dong F, Donnini F, Duranti M, Egorov A, Eline A, Feng J, Fiandrini E, Fisher P, Formato V, Freeman C, Galaktionov Y, Gámez C, García-López RJ, Gargiulo C, Gast H, Gervasi M, Giovacchini F, Gómez-Coral DM, Gong J, Goy C, Grabski V, Grandi D, Graziani M, Haino S, Han KC, Hashmani RK, He ZH, Heber B, Hsieh TH, Hu JY, Incagli M, Jang WY, Jia Y, Jinchi H, Kanishev K, Khiali B, Kim GN, Kirn T, Konyushikhin M, Kounina O, Kounine A, Koutsenko V, Kuhlman A, Kulemzin A, La Vacca G, Laudi E, Laurenti G, Lazzizzera I, Lebedev A, Lee HT, Lee SC, Li JQ, Li M, Li Q, Li S, Li JH, Li ZH, Liang J, Light C, Lin CH, Lippert T, Liu JH, Liu Z, Lu SQ, Lu YS, Luebelsmeyer K, Luo JZ, Luo X, Lyu SS, Machate F, Mañá C, Marín J, Marquardt J, Martin T, Martínez G, Masi N, Maurin D, Menchaca-Rocha A, Meng Q, Mikhailov VV, Mo DC, Molero M, Mott P, Mussolin L, Negrete J, Nikonov N, Nozzoli F, Oliva A, Orcinha M, Palermo M, Palmonari F, Paniccia M, Pashnin A, Pauluzzi M, Pensotti S, Phan HD, Piandani R, Plyaskin V, Poluianov S, Qin X, Qu ZY, Quadrani L, Rancoita PG, Rapin D, Conde AR, Robyn E, Rosier-Lees S, Rozhkov A, Rozza D, Sagdeev R, Schael S, Schulz von Dratzig A, Schwering G, Seo ES, Shakfa Z, Shan BS, Siedenburg T, Solano C, Song JW, Song XJ, Sonnabend R, Strigari L, Su T, Sun Q, Sun ZT, Tacconi M, Tang XW, Tang ZC, Tian J, Ting SCC, Ting SM, Tomassetti N, Torsti J, Tüysüz C, Urban T, Usoskin I, Vagelli V, Vainio R, Valencia-Otero M, Valente E, Valtonen E, Vázquez Acosta M, Vecchi M, Velasco M, Vialle JP, Wang CX, Wang L, Wang LQ, Wang NH, Wang QL, Wang S, Wang X, Wang Y, Wang ZM, Wei J, Weng ZL, Wu H, Xiong RQ, Xu W, Yan Q, Yang Y, Yashin II, Yi H, Yu YM, Yu ZQ, Zannoni M, Zhang C, Zhang F, Zhang FZ, Zhang JH, Zhang Z, Zhao F, Zheng C, Zheng ZM, Zhuang HL, Zhukov V, Zichichi A, Zuccon P. Properties of Heavy Secondary Fluorine Cosmic Rays: Results from the Alpha Magnetic Spectrometer. PHYSICAL REVIEW LETTERS 2021; 126:081102. [PMID: 33709764 DOI: 10.1103/physrevlett.126.081102] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/20/2020] [Accepted: 01/22/2021] [Indexed: 06/12/2023]
Abstract
Precise knowledge of the charge and rigidity dependence of the secondary cosmic ray fluxes and the secondary-to-primary flux ratios is essential in the understanding of cosmic ray propagation. We report the properties of heavy secondary cosmic ray fluorine F in the rigidity R range 2.15 GV to 2.9 TV based on 0.29 million events collected by the Alpha Magnetic Spectrometer experiment on the International Space Station. The fluorine spectrum deviates from a single power law above 200 GV. The heavier secondary-to-primary F/Si flux ratio rigidity dependence is distinctly different from the lighter B/O (or B/C) rigidity dependence. In particular, above 10 GV, the F/Si/B/O ratio can be described by a power law R^{δ} with δ=0.052±0.007. This shows that the propagation properties of heavy cosmic rays, from F to Si, are different from those of light cosmic rays, from He to O, and that the secondary cosmic rays have two classes.
Collapse
|